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A critical challenge in designing materials for tissue engineering (TE) is to provide essential cues 
that can control cellular behaviour and promote tissue regeneration. TE with fibrous scaffolds by 
using electrospinning is emerging as a major research area in the field of regenerative medicine. 
This thesis presents the development of novel electrospun fibrous acrylate scaffolds for bone TE. 
Acrylate fibrous scaffolds were developed by electrospinning photocrosslinkable and low molecular 
weight acrylate monomers, methyl acrylate (MA) and diethylene-glycol dimethacrylate (DEGMA). 
Photocrosslinked fibres were successfully produced by electrospinning different MA and DEGMA 
compositions and post-UV crosslinking. The ability to produce topologically and mechanically 
diverse fibrous scaffold materials was demonstrated. Varying MA and DEGMA composition 
affected overall fibre morphology, swelling and mechanics of the fibrous scaffold. An assessment 
of biological activity of the acrylate fibrous scaffold was performed to evaluate the effect of varying 
ratios of MA/DEGMA of the fibrous scaffold on the viability of two different cell types, 
osteosarcoma-derived osteoblastic cells (Saos-2) and mesenchymal stromal cells (hMSCs). The 
potential of MA/DEGMA fibrous scaffolds to support Saos-2 cell viability and proliferation was 
demonstrated. However, the considerable increase in apoptosis of hMSCs cultured on both fibrous 
and flat samples suggested a lower potential of the MA/DEGMA scaffolds to support hMSCs cell 
attachment and viability. 
The fibrous scaffolds were immobilized with synthetic peptides utilizing cysteine-functionalized 
RGD or DGEA peptide sequences in combination with MA/DEGMA monomers and by employing a 
photoinitiated mixed-mode thiol-acrylate polymerization mechanism. Cysteine-functionalized 
DGEA and RGD peptides were incorporated efficiently in the synthesized acrylate scaffold. The 
peptide-conjugated fibrous scaffolds showed increased hMSCs adhesion and viability. Through 
cell adhesion and soluble peptide competition assays, the bioactivity and specificity of each 
peptide conjugated to the scaffold was confirmed. Finally, hMSCs cultured on DGEA conjugated 
scaffolds exhibited the activation of osteogenic differentiation markers, alkaline phosphatase (ALP) 
and osteocalcin (OCN). The results presented in this thesis strongly suggest the potential of the 
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Bone is a highly vascularised tissue that rapidly remodels during the life span of an individual [1]. 
However, large bone defects do not heal naturally and requires medical intervention [1]. 
Furthermore, with the increasing aging population there is an increasing prevalence of 
osteoporosis and bone fractures and the existing therapies used to repair bone defects have many 
drawbacks [2]. The development of biomaterials in the area of orthopedics to replace autografts is 
consequently an imperative medical goal. Currently, researchers are focused on the design of 
bioactive materials that can mimic the natural healing process by integrating biological molecules 
and cells to regenerate tissues [3]. Tissue Engineering (TE) scaffolds are no longer regarded 
simply as passive cell carriers but rather as instructive devices with the potential to have 
information that can be sensed and interpreted by transplanted or host cells [4].  
The extracellular matrix (ECM) plays an essential role in directing cellular behaviour [5, 6]. 
Biomaterial scaffolds can be developed to interact with cells by mimicking essential molecular 
events of the ECM [7]. A critical challenge in designing materials for TE is to provide essential cues 
that can control cellular behaviour and promote tissue regeneration. For cells adhering on a 
material, the characteristics of its surface, for example topography, stiffness, wettability and 
specific cell-surface interactions are key to control cellular activity [7-9]. Material-based control of 
cellular response is a potentially powerful approach for regulating the behaviour of different cell 
types, including stem cells that are cells with the potential to differentiate into many tissue types. 
Electrospinning has been widely used to create biodegradable scaffolds for the engineering of 
several tissues, particularly those of the skeletal system [10-12]. As discussed in chapter 2, to 
fabricate electrospun fibrous scaffolds, a polymer solution are electrically charged until charge 
repulsion overrides the surface tension of the droplet at the spinneret tip and a polymer jet is 
generated [10, 13, 14]. Subsequently, as the polymer liquid jet travels and solvent evaporates, a 
fibrous strand is produced and collected onto a grounded collector [10]. The fibrous scaffolds 
mimic the size and structure of the natural ECM which can lead to enhanced cellular interactions 
[10, 15].  
Photopolymerization with acrylate and methacrylate monomers have been shown to have a 
controlled nature of photoinitiated polymerization with a choice of non-cytotoxic photoinitiators and 
degradation products. The spatial and temporal control afforded during photoinitiation is a pivotal 
advantage which has motivated its wide application in the field of TE [16, 17]. Acrylates are 
ubiquitously used in the synthesis of hydrogel networks due to the active double bonds [18-21]. In 
addition, there are a number of commercially available monomers which can be photocrosslinked 
rapidly using a photoinitiator [9]. The photopolymerization of acrylate and methacrylates has been 
used in biomedical research and has become an essential approach for in situ delivery of resins in 
the area of dentistry [22-25] and as bone-replacement materials [17]. Anderson and colleagues 
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demonstrated the ability of acrylates and methacrylate photocrosslinked networks to support cell 
attachment, viability and proliferation [9]. Moreover, using an acrylate/methacrylate microarray 
library, they were able to identify specific monomers that support human embryonic stem cells. 
Hence, based on the ‗hit‘ polymer microarrays which have demonstrated monomers that support 
cell growth, diethylene-glycol dimethacrylate (DEGMA) and methyl acrylate (MA) have been 
chosen to be utilized in the electrospinning system here.   
ECM comprises of many biomacromolecules such as collagens, proteoglycans, laminins and 
fibronectin and it is mainly this biological information that leads to its bioactivity [7, 26]. Interaction 
of integrins which are receptors on the cell surface with specific ECM molecules can activate 
signalling pathways leading ultimately to gene expression [27, 28]. The variety of ECM proteins 
presented to cells in a specific tissue is pivotal in regulating how cells function within that tissue 
type [7]. One approach to include sites of integrin binding in biomaterials is to incorporate purified 
ECM proteins for example fibrin and collagen [7]. However, supplementing full proteins to scaffolds 
can be challenging to execute as proteins are susceptible to denaturation and degradation [29]. 
For this reason, a frequently used technique to enhance cell adhesion is to integrate short peptide 
motifs or analogues derived from binding regions of ECM components [7]. While they may have a 
fraction of the activity of the complete protein, they can be incorporated at very high concentration 
and increase the overall activity of the peptide [7]. Moreover, peptides are easy to synthesize and 
functionalize. Hence, bioactive peptides offer a synthetic and scalable alternative to complex ECM 
proteins [30]. 
The widely used Arg-Gly-Asp (RGD) peptide sequence present in various ECM proteins, including 
fibronectin, laminin, collagen I, fibrinogen and vitronectin was studied as a mode of enhancing cell 
adhesion by inducing focal adhesion through integrin interaction on biomaterial surfaces as early 
as the 1980‘s [31, 32]. Since then RGD has been functionalized into an extensive range of 
surfaces, scaffolds and hydrogels (reviewed in [33], [34] and [35]).  
DGEA (Asp-Gly-Glu-Ala) is a collagen type 1 peptide sequence and has displayed specific binding 
affinity for osteoblasts via the α2β1 integrin. In addition, DGEA has been shown to induce 
osteogenic differentiation [36-38]. Therefore, DGEA could be used to promote cell adhesion and 
stimulate differentiation [38]. Nevertheless, the cellular response of collagen-derived peptides has 
been relatively less studied compared to other ECM peptides, while full collagen has been mostly 
applied for making scaffolds [39-41].  Moreover, it has been revealed that collagen I interacts with 
different integrin receptors than that of fibronectin and the integrin/collagen I binding is RGD-
independent [42].   
This thesis focuses on the development of scaffolds which can actively support bone tissue repair. 
Chapter 2 of the thesis provides a review of the fields on TE specifically bone, summary of 
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functions of ECM and the use of peptides in TE applications, overview of electrospinning, as well 
as summary of UV light polymerization and their use in TE.  Chapters 3-6 describe and discuss the 
main experimental results of this PhD project. The final conclusions, general overview and 
suggestions for future work are presented in Chapter 7. 
 
This project was divided into four main parts. Chapter 3 consists of the development of fibrous 
acrylate scaffolds. Chapter 4 consists of the biological response of the acrylate scaffolds. Chapter 
5 consists of the incorporation of bioactive peptides on the fibrous acrylate scaffolds. Lastly, 
Chapter 6 consists of the biological assessment of the peptide conjugated scaffolds.  
Chapter 3. Development of electrospun fibrous acylate scaffolds 
The feasibility of electrospinning photocrosslinkable and low molecular weight acrylate monomers 
was investigated. MA and DEGMA were the monomer and crosslinker of choice respectively with 
the aid of PEO as a polymer carrier and viscosity modifier. Photocrosslinked fibres were developed 
by electrospinning different MA and DEGMA compositions and post-UV crosslinking. The effects of 
various processing parameters of electrospinning were investigated, including carrier polymer 
concentration, accelerating voltage, rate of delivery and monomer/PEO ratios. The determination 
of the optimal range of parameters required to produce uniform and bead-free electrospun 
MA/DEGMA fibrous scaffolds were determined. The overall UV-reaction of the post-crosslinking 
was investigated. PEO (carrier polymer) was extracted with thorough washing with water and 
changes in fibre morphology were monitored. In addition, the PEO extraction from the fibres was 
characterized. Next, the MA and DEGMA ratio (mol%) was varied to evaluate the effects of 
increasing the crosslinker (DEGMA) concentration on fibre morphology, swelling and mechanics of 
the fibrous scaffolds.  
Chapter 4. Biological evaluation of acrylate fibrous scaffolds with Saos-2 and hMSC 
cells 
The biological response of Saos-2 (osteosarcoma-derived osteoblastic cells) and human MSC 
cells to varying ratios of MA/DEGMA electrospun fibers and flat surfaces with similar chemistry 
were assessed and discussed. These studies were intended to evaluate the effect of varying ratios 
of MA:DEGMA of the fibrous scaffold on the viability of two different cell types, Saos-2 and hMSCs. 
Several techniques were used to evaluate the effect of MA/DEGMA electrospun fibers on cell 
viability. Lastly, the effect of the fibrous scaffolds and flat surfaces on protein adsorption was 
investigated.   
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Chapter 5. Functionalization of acrylate scaffolds with cell adhesive peptides -DGEA 
and RGD  
The development of electrospun acrylate scaffolds conjugated with biologically active peptides, 
RGD and DGEA were described. The synthesis of the functionalized scaffolds utilizes cysteine-
functionalized RGD or DGEA peptide sequences in combination with MA/DEGMA monomers and 
employs a photoinitiated mixed-mode thiol-acrylate polymerization mechanism. Firstly, 
immobilization of DGEA and RGD peptides on the acrylate fibrous scaffold was analyzed by 
varying cysteine-conjugated DGEA and RGD concentrations. Measurement of peptide 
incorporation was determined by measuring the amount of free primary amine. The amount of free 
amine measured was compared to the initial concentration of free amine prior to UV crosslinking. 
The measurement of peptide incorporation was further confirmed by quantifying free sulfhydryl 
groups in solution. Next, the morphology, swelling, mechanical and degradation behaviour of the 
functionalized acrylate scaffold was investigated. Subsequently, the presentation of peptides on 
the surface of the scaffold was studied using ToF-SIMS. Lastly, the effects of varying the number 
of glycine amino acid spacer residues on overall peptide incorporation were assessed.  
Chapter 6. Assessment of effect of DGEA- and RGD-functionalized electrospun 
fibers on hMSC adhesion and differentiation 
The biological response of hMSCs on the peptide immobilized fibrous scaffolds were investigated 
by evaluating the initial cell adhesion, viability and osteogenic differentiation. First, the effect of 
CGDGEA and CGRGD peptides with different concentrations on hMSCs initial cell attachment was 
evaluated. Next, the difference between the two peptides of CGDGEA and CGRGD on hMSCs 
adhesion and viability was assessed. Then, the effect of varying the length of DGEA and RGD 
comprising sequences with the use of glycine was analyzed by looking at hMSCs adhesion and 
viability. Next, the integrin specificity of hMSCs adhesion to the two peptides using competitive 
adhesion assays was evaluated. Finally, the ability of the peptide conjugated scaffolds to stimulate 









CHAPTER  2 
2 Literature Review 
 
Chapter 2. Literature Review 
 
 30 
2.1 TISSUE ENGINEERING 
Cost-effective replacement of the function of injured tissues or failed organs with man-made 
substitutes represents one of the major achievements of biomedical research in the second half of 
the 20th century [43]. Substitute medicine, as it was labelled by Pierre Galletti [44], started in 1955 
with the development of artificial hips, blood oxygenators (artificial lungs), hemodialysis, and 
pacemakers [43]. However, even with numerous achievements, contemporary technico-medical 
strategies are restricted and rely on organometallic materials, which are inherently non-
biocompatible and inert materials that do not grow or ―heal‖ themselves. Furthermore, therapies 
can be invasive and implants can only be sustained in the body for short periods of time, often less 
than the life of the patient [43]. Hence, with these limitations, scientists have progressed to a new 
paradigm of biological man-made replacements, specifically termed Tissue Engineering (TE). This 
new field of research aims to engineer biologically inspired scaffolds that not only integrate with 
native tissue but also induce the human body‘s repair mechanism to regenerate damaged tissue 
and restore function [45]. 
Living tissues often have an innate capacity for regeneration even without intervention [1]. A 
remarkable example of this is the human liver, which can regrow to its initial size even after more 
than half of its mass is removed [7, 46]. Other tissues, such as bone and skin, can also self-repair 
and regenerate to fill injuries below a critical size, facilitated by resident or recruited stem cells to 
the damaged site [7]. However, self-healing is restricted in tissues with low regenerative potential, 
as is the case of cartilage, in older patients, or when the damaged site is larger than the critical 
defect size. Hence, in these instances, or when the original tissue is completely nonviable, 
therapeutic intervention is required for the patient [7]. The use of stem cell therapy is seen as a 
possible popular treatment option; however, it is highly limited by the control of cell fate. Benign 
tumours from selected mature tissues, for example teeth, hair and gut epithelium, have been 
demonstrated to form when stem cells are injected into an immunocompromised mouse [7, 47]. 
Thus, such simple therapeutic approaches do not offer a complete resolution for regeneration; 
biomaterials are required as carriers of either the stem cells to the injury site or of specific 
signalling molecules that can direct the cell function.  
Significant challenges have been involved in early commercialization of TE products due to 
problems related to scale-up, shelf-life, quality control and distribution [7]. In addition, early 
commercialization suffered from withdrawal of corporate finance and from unsuitable business 
models in the early millennium, after rapid growth in the early 1990s through 2001 [7, 43, 48]. 
However, despite these challenges, the field of TE has recovered and matured, which is shown by 
the resurgence of development-stage companies and return of investments for TE corporations 
[49]. Currently, sales of TE products exceed USD 240 million per annum [49]. 
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Although the initial concept of TE was maintained, during the last decade the philosophy of the 
field has changed tremendously due to accumulation of knowledge and experience. The initial 
grand objectives of engineering entire organs have become more specific, achievable goals 
because of the overall complexity of recreating tissues [7]. In addition, the TE community has also 
realized the importance of basic developmental research. Trying to recreate the complexity of 
organs or tissues at a macroscopic level is not enough; TE strategies should aim at stimulating the 





Figure 2.1 Tissue Engineering (TE) common approaches. (1) Cells are harvested from the patient; (2) cells 
are expanded in vitro; (3) cells are seeded in a scaffold with specific cues; (4) cells are cultured in the 
scaffold in vitro; (5) scaffold containing cultured cells is implanted in the patient‘s body. (Figure adapted from 
[51]) 
TE aims to utilize materials to promote new tissue formations and involves interaction of cells with 
the material. The most common approach for TE is to culture cells into a scaffold; a structural 
component which classifies the shape or configuration of the specific tissue and offers specific 
signals which induce tissue regeneration (Figure 2.1) [7, 44]. In traditional TE, for the use of cell-
seeded scaffolds, an in vitro maturation step is included before the scaffold is implanted into the 
patient, to allow cells to attach to the scaffold, differentiate, and deposit functional ECM. These 
processes can be further induced by adding growth factors or, in the case of scaffolds expected to 
have load-bearing role, such as cartilage or heart valve replacements, mechanical conditioning 
[52, 53]. Alternatively, for an in vivo TE approach, the scaffold is implanted directly into the patient 
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with cells [54, 55]. In this case, the body can be used as a bioreactor. Hence, if the body supplies 
the appropriate stimuli, formation of new tissue does not need to take place before implantation. In 
addition, the scaffold material can be implanted without the presence of cells or growth-factor 
administration [7]. Such implantation was demonstrated by Stevens et al., by injecting calcium-
crosslinked alginate or modified HA hydrogels into an artificially-created space between the tibia 
and the periosteum [48]. The gels induced bone and cartilage formation from native progenitor 
cells present in the periosteum [7, 48]. 
2.1.1 Bone TE 
Bone is a highly vascularised tissue that rapidly remodels during the life span of an individual [1]. It 
contributes in movement, supports and protects delicate organs in the body, and provides a frame 
for adequate load-bearing capacity. Apart from these mechanical functions, bone also mediates 
metabolic activity of the body such as homeostasis through its reserves of Ca2+ and phosphate 
ions and by controlling the level of electrolytes in the blood [1]. The highly regenerative nature of 
bone means that most fractures will repair without the need for medical intervention [1, 7]. 
However, large bone defects do not heal naturally and require medical intervention [1]. 
Furthermore, with the increasingly aging population, osteoporosis and bone fractures have 
become more recurrent, and the existing therapies used to repair bone defects cannot tackle this 
problem completely [2]. Current practice for bone repair at the injury site is to graft autologous 
bone from the iliac crest, however supply of bone tissue are insufficient [56]. Moreover, pain 
caused at the donor site affects 18-31% of patients post-operatively, and the surgical treatment 
could also cause blood loss, infection, haematoma, nerve injuries and scarring [57]. The 
development of biomaterials in the area of orthopaedics to replace autografts is, consequently, an 
imperative medical goal and TE scaffolds are beginning to show potential. 
Due to the crucial clinical need, the market for TE-based scaffolds in bone repair is expanding at 
an accelerated rate [1]. Some commercially available scaffold products in orthopaedics are shown 
in Table 2.1. Currently, researchers are focused on the design of bioactive materials that mimic the 
natural healing process by integrating biological molecules, cells and regenerate tissues [3]. For 
bone TE, materials should be osteoinductive (able to induce differentiation of progenitor cells down 
to osteoblastic lineage), osteoconductive (encourage bone growth) and capable of osteointegration 
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Table 2.1 Examples of current commercial bone TE scaffold products  
 
Name Description Of Technology 
Cell 
Seeding 




Bovine type I collagen sponges soaked 





approved in 2002) 
OP-1 Implant 
by Stryker 
Combination of recombinant human 
BMP-7 (rhBMP-7) and purified Type I 








available in 2001 
Pura Matrix by 
3DM 
 A nanofibrous hydrogel that is 
composed of 16 amino acid residues 
that will self-assemble in aqueous 
solution due to hydrophobic and ionic 







Scaffold construct made of 









Porous scaffold comprising β-TCP and 









Human mineralised bone matrix in 




Approved in 2010) 
 
2.1.2 Cranial bone defects 
The use of bone TE biomaterial for non-load-bearing injury sites for application in oral and 
maxillofacial surgery has shown increased interest [58]. Bony defects in the craniomaxillofacial 
skeleton can occur due to congenital defects (for example, in 2001, 37,732 children required 
surgery to repair birth defects) or acquired injuries (for example, in 2001, 24,298 patients required 
maxillofacial surgery for injuries to the face and jaw) [58].  
Bony defects in the craniomaxillofacial skeleton are functionally debilitating, socially incapacitating, 
and economically burdensome. The war on terrorism has brought numerous new challenges to 
surgeons: combat-associated craniomaxillofacial injuries [58]. Increased survival because of body 
armor and advanced battlefield medicine, as well as the increased use of explosive devices, has 
contributed to the increased incidence of craniomaxillofacial combat injuries [58]. This unique 
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patient population ultimately requires reconstruction of the cranial skeleton for protection of the 
brain as well as aesthetic and functional restoration of the calvaria or the bones of the face.  
Thus, a variety of materials and methods have been proposed to restore such defects including 
autogenous bone grafts and allogeneic banked bone, demineralized matrix pastes, ceramic 
scaffolds, and even synthetic materials and bone substitutes such as calcium ceramics [58, 59]. 
The multitude of methods reflects both the inadequacy of each technique, as well as the pressing 
need to adequately reconstruct the skeleton. While each method may achieve craniofacial 
reconstruction, each possesses inherent limitations, such as donor-site morbidity, an obligatory 
graft resorption phase, contour irregularities, insufficient autogenous resources, disease 
transmission, graft-versus-host disease, immunosuppression, structural failure, and foreign body 
Infection [58]. These limitations preclude most large defects from being repaired with these 
materials. Therefore, the need for new and improved treatment options is imperative. 
To overcome these issues in this area, we would focus on developing a fibrous electrospun 
scaffold which will be inserted with cells to the site of injury in the craniomaxillofacial bone. The 
potential of the fibrous scaffold for application in repairing non-load-bearing bone defects will be 
described in the thesis. 
 
2.1.3 Principles of bone TE 
The key requirement of a scaffold is biocompatibility; a scaffold should integrate with native tissue 
without inducing a high immune response. In addition, the scaffold should be porous to permit cell 
attachment and vascular in-growth, besides transport of nutrients in vitro and in vivo [61]. In 
addition, the scaffold should be able to mimic the natural bone mechanical strength to withstand 
the biological stimuli in vivo. Moreover, the scaffold has to be biodegradable so additional surgery 
is not needed to remove the scaffold. A list of characteristics of an ideal TE scaffold for bone 
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Table 2.2 Basic characteristics of a tissue scaffold, adapted from [62] 
Characteristics General remarks 
Biodegradable The rate of degradation must perfectly match the rate of bone tissue 
regeneration and the degraded product(s) should not harm living tissues 
Nontoxic 
Should not evoke toxicity to tissues 
Nonimmunogenic 
Should not evoke immunogenic response to tissues 
Porosity with interconnected pores 
To maximize the space for cellular adhesion, growth, extracellular matrix 
secretion, revascularization, adequate nutrition and oxygen supply 
without compromising mechanical strength 
3D structure 
To assist cellular in-growth and transport of nutrients and oxygen 
High surface area to volume To accommodate high-density osteoblast cells 
Surface modifiable To functionalize chemical or bimolecular groups to improve cell adhesion 
for example, TGF-β and BMPs 
Adequate mechanical strength and 
structure for bone application 
To withstand load bearing mechanical of bone. Mechanical/structural 
strength will be dependent on the rate of degradation and type of bone. 
 
 
2.1.4 Tissue engineering scaffolds for Bone 
There is a variety of structures for TE scaffolds for bone applications based on different materials 
and processing to form scaffolds, most of which can be classified as either fibrous, solid or 
hydrogel (Figure 2.2) [29]. Materials for TE scaffolds can be compose of natural polymers, such as 
fibrin, collagen, hyaluronic acid (HA) or alginate, or synthetic polymers, such as polyethylene glycol 
(PEG), dextran, acrylates, or polyvinyl alcohol [29, 45]. Fibrous scaffolds can be produced by a few 
processing methods, including phase separation and electrospinning. Electrospinning will be 
described in detail in Section 2.3. Hydrogels are composed of hydrated insoluble networks of 
crosslinked polymers, and have been used for applications such as bone tissue regeneration [63]. 
Hydrogels can be produced from synthetic or natural polymers and crosslinked using a variety of 
methods, including self-assembly (non-covalent), ionic crosslinking (non-covalent) and radical 
polymerizations (covalent) [45, 64].  
 




Figure 2.2 Examples of TE scaffolds for bone. Hydrogel, fibrous and porous scaffolds are commonly used in 
TE applications. Custom scaffolds can be designed using solid freeform fabrication methods. Custom and 
porous scaffolds are from [65] and [66]. 
Macroporous solid implants can be produced from polymers, ceramics or metals by a variety of 
engineering processes. They are resistant to mechanical forces and can incorporate pores to 
promote cell infiltration and mass transport of nutrients [29] which can useful for bone applications. 
Porous solid scaffold production methods include particulate leaching, foaming by chemical 
methods or by CO2 expansion, microsphere sintering and phase separation [29, 67-70]. Recently, 
another technologically advanced approach to fabricate solid scaffolds was introduced; it consists 
of using the solid freeform fabrication (SFF) technique. These scaffolds are produced by using 
computer-aided systems whereby layer-by-layer deposition of materials, including potentially, cells, 
into a pre-specified 3D shape, is achieved either by printing or extrusion of a polymer melt [29, 71, 
72]. Also, laser beams can be used to solidify polymers into complex shapes by 
photopolymerization or sintering as the laser is guided over polymer liquids or layers of powder 
[65, 73]. These novel technologies provide precise control over scaffold architectures, and when 
used concurrently with medical imaging techniques can produce solid bone TE scaffolds fitted to 
the shape and dimensions of the damaged site in the patient [29]. 
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2.1.5 Cell source(s) for Bone TE  
The role of osteogenic cells is to contribute to bone remodelling and in fracture repair. After 
specific stimulation in culture, these cells should express osteogenic markers such as alkaline 
phosphatase (ALP) or osteocalcin (OCN) and produce calcified nodules [2, 74]. At present, the 
most suitable osteogenic cells for bone TE have not been identified [2]. Critical requirements for 
cells in clinical use are isolation efficiency, stability of the osteoblastic phenotype in vitro, bone 
induction capability and long-term safety [2]. Our research group have demonstrated the higher 
potential of hMSCs and osteoblasts to produce material similar to native bone in comparison to 
embryonic stem cells [75]. 
MSCs play an important role in bone regeneration because these cells are recruited from the bone 
marrow and are known to migrate into sites of bone injury, where they differentiate into the 
osteoblastic lineage, and produce an osteoid matrix which is consequently mineralized and 
remodelled to bone [76-80]. The use of MSCs to induce tissue regeneration has been extensively 
investigated [81-83]. These cells have been seeded into the scaffold and implanted into the body 
either directly or a few weeks later, after in vitro differentiation [81]. Successful bone and cartilage 
defect repair has been demonstrated [84].  
Osteoblasts reside at the surface of the bone where new matrix is formed and contribute to bone 
development [2, 85]. These cells synthesize osteoids and then mature to osteocytes, which are 
found in the calcified matrix [2].  In vitro osteoblasts exhibit osteogenic differentiation and in vivo 
they stimulate the formation of bone in many types of surfaces [86]. The majority of the cell lines 
currently utilized is acquired from bone tumours or immortalized osteogenic cells [2, 87]. While the 
easy availability and optimum in vitro characterization make these cells attractive for TE 
investigations, however, safety concerns prevent osteoblasts from being utilized in applied TE [2].  
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2.2 EXTRACELLULAR MATRIX 
Biomaterials can be engineered to interact with cells by mimicking key events of the ECM [7]. ECM 
is composed of several distinct types of nanometer-scale fibrous networks of proteoglycans, 
glycosaminoglycans, collagens, non-collagenous glycoproteins and growth factors [26]. These 
fibrous structures exhibit cellular instructive cues to control cell-matrix interactions by presenting 
biochemical ligands that interact exclusively with cellular integrins to activate cascading cellular 
signals [26]. Figure 2.3 describes the different functions of the ECM. Specifically, in addition to 
anchoring cells to mediate cell adhesion and providing tissue organization, integrins convey 
intracellular signals that regulate cell migration, cell cycle progression and differentiation [88-90].   
 
 
Figure 2.3 Summary of ECM functions. Simultaneously, the ECM can influence multiple biochemical and 
mechanical functions. (Figure adapted from [26]) 
Glycosaminoglycans (GAGs) are linear unbranched networks of repeating disaccharides made of 
hexoseamine and uronic acid [26]. Apart from hyaluronan, all GAGs are covalently bound to 
proteins, forming proteoglycans [26]. ECM glycoproteins are composed of collagens and a varied 
range of non-collagenous proteins, for example laminins, tenascins and fibronectin [26].  
Collagens are the most abundant protein in ECM, representing approximately 25% of total protein 
content in mammals [91, 92]. A triple helical organization of pro-α-chain components defines the 
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collagens and plays a part in the remarkable physical properties of the ECM [26]. Currently, there 
are 28 known types of collagen [26, 93] and the most abundant category of collagens is fibrillar 
collagens (type I, II and III), which form the basic scaffolds for connective tissue, while other 
collagens form network-like structures (type IV and VIII) as part of the basement membrane, and 
are critical for epithelial cell organization [26, 92]. The overall organization of fibrils and collagen 
networks vary with different tissue types and the scale of forces to which a specific tissue is usually 
exposed [26]. Even though collagens‘ supramolecular architectures and specialized roles within 
the ECM differ widely, all collagen molecules have a similar basic structure; they are composed of 
three identical or similar strands with the repeating sequence Gly-X-Y. In this triplet sequence, X is 
frequently proline and Y is hydroxyproline [93]. Depending on the type of collagen, the α-chains 
construct trimeric molecules, which are woven collectively into a triple helix in at least one region 
[93]. The stable triple helical domains are formed through interchain hydrogen bonds, resulting 
from glycine being used every third residue which allows the three collagen strands to pack closely 
and form a stable triple helix [92, 93].  
Non-collagenous glycoproteins are comprised of different types of proteins such as laminin, 
fibronectin, and vitronectin [94]. Laminin is ubiquitous in the basal lamina, a tough, thin, sheetlike 
substratum, which is essential for cell adhesion, differentiation and tissue remodelling. Fibronectin 
is an abundant, multi domain dimeric glycoprotein with binding sites for a selection of other ECM 
molecules, such as collagen, heparins A and B, fibrin, and chondroitin sulphate [26, 94]. Each 
fibronectin subunit has a sequence of reiterating modules of type I, II and III repeating units: 12 
type I modules, two type II, and 15 to 17 (depending on splicing) type III, as shown in Figure 2.4 
[95]. For stabilization of the folded structure, two intramolecular disulfide bonds form within each 
type I and type II modules, whereas type III modules are seven-stranded β-barrel structures that do 
not have disulfides [95]. Modules are structured with binding sites for collagen, integrins, heparin 








Figure 2.4  Schematic of a fibronectin subunit. Each subunit consist of three types of subunits, type I, type II 
and type III. (Adapted from [95]) 
Collectively, these different groups of ECM molecules present vast functional complexity. Hence, 
the ECM can be known to contain ―morphogenetic language and code‖ that is understood and 
interpreted by cells that come in contact with it [26]. The ECM has embedded information that is 
―sensed‖ by receptors at the surface of the cell has which has immense influence on the cell 
behaviour by affecting cell attachment, motility and other intracellular cues which control cell fate 
[26].  
 
2.2.1 Role of integrins 
The name ―integrin‖ was chosen to highlight the significance of these receptors in preserving the 
integrity of the cytoskeletal-ECM bond [96, 97]. The interaction between integrins with the ECM is 
though their specific extracellular domains, and with the constituents of the cytoskeleton, through 
their intracellular domains [98]. Integrins comprise of two transmembrane glycoprotein subunits 
that are non-covalently bound, the α chain and the β chain [99]. The extracellular segment of the α 
and β subunits interacts with each other, producing a heterodimer Figure 2.5. Both subunits have 
disulfide bridges that protect them from proteolysis [26, 99]. Many combinations of subunits can be 
achieved, and each combination has the capability to interact with one or more ligands [99]. In 
humans, the family is comprised of 18 α subunits and 8 β subunits, which can generate 24 
different heterodimers [100]. Table 2.3 shows a variety of known combinations of integrin subunits 
and their protein ligands.  
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Table 2.3 Possible combinations of integrin subunits and their protein ligands. (Adapted from [79]) 
 Subunits Ligands 
β1 α1 Collagens, Laminins 
 α2 Collagens, Laminins 
 α3 Laminins, Fibronectin, Thrombospondin 
 α4 Fibronectin, VCAM 
 
α5 Fibronectin 
 α6 Laminins 
 α7 Laminins 
 α8 Fibronectin, Tenascin 
 α9 Tenascin 
 α10 Collagens 
 α11 Collagens 
 αv Fibronectin, Vitronectin 
β2 αL ICAMs 
 αM Fibrinogen, ICAMs, iC3b 
 αX Fibrinogen, ic3B 
 αD VCAM, ICAMs 
β3 αIib Collagens, Fibronectin, Vitronectin, Fibrinogen, Thrombospondin 
 αv Fibronectin, Vitronectin, Fibrinogen, Thrombospondin 
β4 α6 Laminins 
β5 αv Vitronectin 
β6 αv Fibronectin, Tenascin 
β7 α4 Fibronectin, VCAM, MAdCAM 
 
αE E-cadherin 
β8 αv Collagens, Laminins, Fibronectin 
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After binding to ligands, integrins would cluster simultaneously together into focal contacts, a 
region of close contact between a cell and the ECM, comprising of cytoskeletal proteins, adapter 
molecules and kinases [99, 101, 102]. Following to the activation of the clustering, the ―outside-in 
signalling‖ will be triggered with cytoskeletal and signalling molecules recruited and activated. The 
signalling cascade inside the cell involves the interaction of quite a few proteins, such as focal 
adhesion kinase (FAK), Src and cytoskeletal proteins [99]. The early stage begins with the 
autophosphorylation of FAK, which leads to tyrosine phosphorylation and the engagement of other 
protein molecules [27, 79, 99, 103, 104]. In addition to the interaction of signalling molecules, 
integrin binding also triggers alterations in the regulation of the cytoskeleton, consequently 
influencing cell adhesion and migration [99]. Moreover, integrins are bidirectional signalling 
receptors [96, 105]. The inside-out signalling is used to bring the integrin into the active 
conformation, by which signalling pathways in the cell itself can control the ligand-binding of the 
integrins on the cell surface [106]. 
Furthermore, the interaction of integrins with ECM proteins has been shown to affect signal 
transduction and the expression of transcription factors and osteoblast-specific genes in 
osteoblasts [103, 107]. The ECM-integrin-activated interaction induces osteoblastic differentiation 
through the stimulation of the mitogen-activated protein kinase signal (MAPK) transduction 
pathway [77, 108]. Production of ECM osteogenic proteins is due to the aggregation of the α2β1 
[37, 109, 110] and αvβ3 [41] integrins ,which induces intracellular signalling pathways, leading to 
the phosphorylation of the osteoblast-specific transcription factor, Runx2/Cbfa-1 [110-112]. 
The main regulator of osteogenic differentiation and matrix production is influenced by the 
transcriptional activity of Runx2/Cbfa-1 [113]. Post-translational modification and protein 
interactions contribute a central role in controlling Runx2/Cbfa-1 [113, 114]. FAK distributes 




Many attempts have been carried out to emulate the natural microenvironment by using synthetic 
ECM-mimetic macromolecules to mimic the ECM‘s biological, chemical and mechanical properties 
[116-119]. One approach to offer sites of integrin attachment to scaffolds is to immobilize purified 
ECM proteins, such as collagen or fibrin, on the scaffold [7, 120, 121]. However, immobilization of 
full proteins to scaffolds can be difficult, as the proteins are susceptible to denaturation and 
degradation. Consequently, a widely used method to improve bioactivity of the scaffold is to 
incorporate short peptide motifs/analogues derived from the binding regions of ECM components 
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[7]. Peptides have been demonstrated to be adequate molecules for protein-binding-site mimics, 
since peptides can be produced as protein fragments, allowing comprehensive investigation of the 
interaction at the level of individual amino acid residues [122]. Compared to full proteins, peptides 
are more resistant to denaturation due to variations in pH and heat [123]. In addition, while 
peptides may have a fraction of the activity of the complete protein, they can still be immobilized at 
high concentrations to increase overall effect and they are easy to synthesize and functionalize. 
Hence, biologically active peptides allow a synthetic, scalable substitute to ECM proteins [30]. 
Essentially, peptides that influence and induce cell adhesion are derived from sequences found in 
ECM molecules. The amino sequence Arg-Gly-Asp (RGD) (Figure 2.6), is found in the tenth type 
III repeat of fibronectin, can be used to enhance cell adhesion by inducing focal adhesion through 
integrin binding to surfaces, which was known as far back as the late 1980s [31, 32]. A number of 
ECM components, for example, collagen type 1, thrombospondin, osteopontin, vitronectin and 
fibronectin, contain one or more RGD sequences, which are essential for interacting with many 
types of integrins and function as cell attachment signals [26]. Nevertheless, RGD sequences 
located in ECM molecules do not necessarily have to be active and functional [26, 123].  
 
 
Figure 2.6 Peptide sequences of RGD and DGEA 
Apart from RGD peptides, which have been extensively investigated, other adhesion peptide 
motifs have also been studied. These include IKLLI, IKVAV, LRE, PDSGR and YIGSR from 
laminin, DGEA from collagen I and GEFYFDLRLKGDK from collagen IV [29, 116, 124, 125]. 
DGEA (Asp-Gly-Glu-Ala), also shown in Figure 2.6, is a collagen type 1 peptide motif and exhibits 
specific binding for osteoblast via α2β1 integrin. In addition, there is growing literature to suggest 
that activation of a collagen-selective integrin, α2β1 integrin induces osteoblast differentiation 
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mediated by collagen-α2β1 integrin interaction [36-38, 42]. Therefore, DGEA could serve as both a 
cell adhesion and a differentiation factor [42]. It has been demonstrated that collagen I binds to a 
different integrin receptor than fibronectin and the integrin/collagen I interaction is reported to be 
RGD independent [42]. Collagen-derived peptides have been relatively less investigated for their 
cellular response compared to other ECM peptides, while full collagen has been mostly used for 
making scaffolds [39-41].  
Engagement of the α2β1 integrin is associated with the activation of the osteoblast-specific factor 
Runx-2/Cbfa-1, a transcription factor that mediates osteogenic differentiation, specifically the 
osteoblastic phenotype [107, 110, 112, 126, 127]. Moreover, the collagen-α2β1 integrin interaction 
has been shown to induce the osteoblastic phenotype in MSCs [36, 37]. Integrin α2β1 regulated 
interaction to collagen type 1 induces tyrosine phosphorylation of FAK and consequently promotes 
the stimulation of ERK, a mitogen activated protein kinase (MAPK) which has been demonstrated 
in regulating osteoblast-specific gene expression and matrix mineralization [109, 111, 126, 128, 
129]. 
 
2.2.3 Influence of peptide presentation on biological response 
There are numerous approaches by which peptide sequences can be presented to cells with 
respect to the choice of peptide length, sequence arrangement, as well as concentration [35]. For 
example, a biphasic cell response was demonstrated with varying RGD concentrations and 
maximum cell migration was shown at intermediate peptide densities, because low amount of 
adhesion sites fail to sufficiently support contractile force, whereas high concentrations overwhelm 
the cells‘ ability to detach from the substrate [130]. Massia et al. showed that an average distance 
of 440nm between the RGD peptides was necessary for fibroblast adhesion and migration, but an 
interpeptide distance of 140nm was needed for focal contact formation and cytoskeletal 
reorganization into stress fibres [7, 35, 131].  
In addition, the varying affinities of peptides for integrins are greatly affected by ligand sequence, 
conformation and accessibility to integrins [35]. The binding specificity of the peptide to a cell-
surface integrin receptor can be enhanced by ligand conformation [33, 132]. The enhancement of 
cell adhesion can only be achieved if the ligands are spatially accessible to the cell-surface 
integrins [35]. The distance between biomaterial and peptide can be regulated with the use of 
additional amino acid residues in the peptide sequence, by the integration of a spacer arm [35]. 
Varying the length of the spacer arms is essential for cell-scaffold interactions as it has been 
shown to regulate adhesion and spreading of certain cell types [133].  
 




Figure 2.7 Schematic of cellular adhesion onto peptide-modified scaffold with different spacer-arm lengths. 
Providing a distance between the peptides and the biomaterial will present better access for integrin-ligand 
binding. (Figure adapted from [133]). 
The enhancement of integrin-ligand interactions can be achieved by providing a distance between 
the peptide and the biomaterial as shown in Figure 2.7 [133]. Studies conducted by Lee et al. have 
also shown the influence of glycine spacer arms on cell adhesion and viability on RGD sequence 
immobilized on alginate gels [133]. They found that a minimum number of four glycine residues 
were essential for enhanced cell adhesion and viability. This difference could be substrate specific, 
since the gap that the peptide is needed to be from the material relies on the physical properties of 
the bulk material [35].  
Furthermore, a few groups have shown that PEG-diacrylate (PEG-DA) based hydrogels need a 
long spacer arm between the hydrogel and the peptide to enhance cell adhesion and viability [18, 
134, 135], because PEG-DA hydrogels have two acrylate groups and produce a highly cross-
linked network with long chains extending from the backbone [35].  
 
2.2.4 Conjugation of peptides onto TE scaffolds 
There are two approaches of presenting peptides towards cells on scaffolds, physical and 
chemical methods [35]. Physical methods involve deposition, adsorption or precipitation onto or 
into the material; hence, the peptides are not covalently linked to the scaffold [35]. Physical 
adsorption is a relatively weak force, which may therefore not be suitable for TE scaffolds as 
prolonged signalling is needed [136]. In contrast, chemical methods of peptide-conjugation involve 
the formation of covalent bonds between the functionalized-peptide and the material [35]. The 
conjugation can be done as the scaffold is being produced/synthesized or by immobilization onto 
the prepared solid [35]. It is possible to either incorporate the peptides on the surface of the 
scaffold or bulk modification throughout the scaffold. Surface modification on electrospun fibres 
using covalent immobilization of peptides has been accomplished by surface etching [137] and 
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plasma/gamma-ray [138] treatment, which induces the cleavage of a polymer backbone to form 
carboxyl (-COOH) groups or radicals. Hence, these functional groups could react with bioactive 
peptides on the surface of various scaffolds including PLLA, PCL and PLA [45, 139]. 
Peptides can be incorporated into the scaffold by including a reactive group in the peptide 
sequence and copolymerizing it with other monomers [35]. The polymerization can be activated by 
an initiator induced by the use of heat, UV light or chemical reaction. The use of UV radiation will 
be described in detail in Section 2.4. The final concentration of the peptide in the scaffold could be 
regulated by varying the ratio of peptide and/or the other co-monomers before UV-crosslinking 
[35]. A significant amount of research using this bulk modification has been performed in the area 
of hydrogels. For example, the incorporation of RGD peptides into PEG-DA hydrogels was 
demonstrated by Hern and Hubbell [134]. In addition, several studies have utilized mixed-mode 
thiol-acrylate polymerization specifically for the synthesis of hydrogels. Specifically, during UV 
radiation, the reaction mechanism consist of two steps, acrylate homopolymerization and thiol-
acrylate step-growth reaction [140, 141]. Rydholm et al. described the formation of degradable 
thiol-acrylate networks under exposure to UV light with or without the presence of a photoinitiator 
[142, 143]. This method of peptide conjugation will be described in detail in Chapter 5. 
 




Although there are many other techniques of producing nanofibrous scaffolds, such as phase 
separation and self-assembly, these approaches cannot match electrospinning in terms of its 
versatility, cost-effectiveness, flexibility and ability to scale-up [144]. In terms of flexibility, 
electrospinning allows the fabrication of nanofibres from a range of materials, such as polymers, 
composites, semiconductors and ceramics [144, 145]. This technique is capable of generating 
fibres with adjustable dimensions ranging from diameters of several micrometers down to a few 
nanometers. Based on the literature published, it is evident that by using electrospinning most 
polymers are relatively easy to electrospin compared to other methods [146]. Fibres can be 
produced by regulating electrospinning parameters, such as accelerating voltage, flow rate of 
solution and polymer solution parameters like viscosity and conductivity [146]. 
In 1934, the first patent that explained the technique of electrospinning emerged, when Formhals 
described an apparatus for creating polymer filaments by using electrostatic repulsions between 
surface charges [147]. The technique was known as electrostatic spinning up until 1939 and only a 
few papers were published about the production of thin fibres [14]. In the early 1990s several 
research groups, in particular, the Reneker group revived interest in the technique by showing the 
production of fibres from a selection of organic polymers and the term electrospinning was coined 
[14, 148]. 
Electrospinning has been applied ubiquitously in engineering fibrous scaffolds for TE applications. 
The technique is able to produce scaffolds composed of fibres, which creates high surface area to 
volume ratio; excellent conditions to induce cell growth and infiltration [145]. Furthermore, the 
morphological resemblances between the nanofibrous scaffold and the ECM are shown to 
increase biological response and biocompatibility [15, 61]. The large surface area encourages 
cellular adhesion, as well as formation of multiple focal adhesion points because of the nanosized 
diameters of the fibres [61].  




Figure 2.8 Schematic of an electrospinning system. The insets illustrate the Taylor cone and an SEM image 
of electrospun fibres accumulated on the collector. 
The essential configuration of an electrospinning system is illustrated in Figure 2.8. It consists of a 
spinneret (a metallic needle), a fibre collector and high voltage power system. The spinneret is 
connected to the syringe and the polymer solution is provided through the spinneret using a 
syringe pump at a constant and regulated flow rate [62]. The spinneret serves as an electrode to 
which the voltage is applied [62, 149]. In addition, the target collector is placed right below the 
spinneret with a suitable space in between [62].  
 
2.3.1 Electrospinning process and mechanism 
The stable electrospinning jet was illustrated by Reneker et al.; as the polymer solution is injected 
at a constant rate, a droplet begins to form at the end of the needle [13, 14]. When a high voltage 
is employed, the pendant drop of the polymer solution at the tip of the spinneret will become highly 
electrically charged and the induced charges will be dispersed over the surface [14]. 
Consequently, the polymer solution at the tip of the needle is subjected to two different types of 
electrostatic forces: the electrostatic repulsion of the surface charges and the Coulombic forces put 
forth by the external field [13, 14]. Hence, due to these interactions, the drop will form into a cone 
shape, identified as the Taylor cone. Once the charge accumulated exceeds the surface tension of 
the solution, an electrified liquid jet is ejected from the tip of the needle [13, 14]. As the liquid jet 
travels towards the counter-electrode, this electrified jet becomes elongated and the solvent rapidly 
evaporates. A phenomenon called ―splaying‖ occurs, the different polymer strands in the jet gets 
separated because of the mutual repulsion of the charges [62]. The diameter of the filaments will 
greatly reduce from hundreds of micrometers to as small as tens of nanometers [14, 148]. As a 
result, these filaments assemble in a non-woven fashion on the grounded collector. The diameter 
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of the fibres formed on the collector depends on how many splays are produced during 
electrospinning [150].  
Even though the setup for electrospinning is extremely simple, the mechanism of electrospinning 
process is more complex [14]. It has been demonstrated with high speed photography that the jet 
formed which seems to splay is really in fact a single, rapidly whipping and thinning jet [61, 150, 
151]. Under high electric fields, the jet becomes unstable and whips at a high rate and causes 
bending and stretching, mainly due to  the bending instability of the electrified jet [61, 151]. 
Conventional photography was unable to capture the high frequency of whipping, presenting the 
notion that the original jets splits into multiple branches when it travels towards the collector [61]. 
Rutledge and colleagues modelled the behaviour of the jet by describing three different 
instabilities; Rayleigh instability and two conducting modes [61, 151]. The axisymmetric Rayleigh 
instability is greatly influenced by surface tension and is opposed at high electric fields, whereas 
the two conducting modes, one axisymmetric and the other non-axisymmetric (whipping/bending 
instability), are independent of surface tension and are influenced by electric forces [61, 150, 151].  
 
2.3.2 Parameters of electrospinning process 
2.3.2.1 Processing parameters 
There are three important processing parameters that can influence fibre morphology [152]. These 
parameters that can control the production of bead defects during electrospinning are: applied 
voltage, polymer flow rate and tip-collector distance [152].  
 
Applied voltage 
One of the parameters most studied in literature for electrospinning is applied electric field or 
voltage. Deitzel et al. studied a polyethylene oxide (PEO)/water electrospinning system, which 
showed that changes in the electric field alters the shape of the Taylor cone and consequently 
affects the fibre jet [152, 153]. When the electric field is sufficient to dominate the surface tension, 
at specific voltage conditions, the drop is suspended at the tip of the spinneret and a jet will form 
from the Taylor cone creating bead-free electrospinning [61, 153]. However, more beading can be 
produced when the applied voltage is increased because the overall volume of the drop 
decreases, which will trigger the Taylor cone to diminish, thus the jet will originate from the liquid 
surface within the tip [61, 153]. Furthermore, even more beading is produced when the voltage is 
further amplified, the jet will shift around to the side of the tip; no Taylor cone is formed [61, 153]. 
It has also been shown by Meechaisue et al. that, when the solution concentration or viscosity and 
flow rate is constant, an increase in the applied voltage leads to an increase in the jet velocity. As a 
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result of the increase, more solution is being removed from the tip of the droplet. For this reason, 
fibres spun at higher voltage exhibit larger average diameter and causes production of several jets 
[154]. Based on the work of the groups above and others, it is clearly demonstrated that there is an 
optimum range of applied voltage for a specific polymer/solvent electrospinning system, as a 
suboptimal field strength (too high or low) can produce bead defects in the electrospun fibres [152]. 
 
Flow rate 
Many research groups have studied the effects of polymer flow rate on fibre morphology and size. 
It has been demonstrated that decreased flow rates form fibres with smaller diameters [61]. For 
example, Megeski and co-workers investigated the relationship of flow rate on the fibre 
morphology of polystyrene/tetrahydrofuran (THF) solution [61, 155]. They showed that increasing 
flow rate produces higher fibre diameter and pore size [155]. In addition, significant amounts of 
beading were produced when flow rates were too high due to the inability of fibres to dry prior to 
contacting the grounded collector [152, 155-157].  
 
Tip-collector distance 
Another method to regulate fibre diameter and morphology is changing the distance between the 
tip and the collector [61]. Most importantly, this distance can influence whether electrospinning or 
electrospraying occurs. There is a requirement of a minimum distance to facilitate solvent 
evaporation for fibres to dry or elongation of the jet, which leads to further thinning of the fibres 
before reaching the collector [158]. Hence, beaded electrospraying will occur if the tip-collector 
distance is too short. However, it is critical to not exceed the distance between tip and other 
surrounding structures such as the wall of the electrospinning container [158]. This is due to the 
charged polymer deposition, which will try to obtain the path of least resistance as the fibres will be 
accumulated on other substrates in closer proximity than the collector in spite of it being the only 
object of high conductivity [158]. Investigations performed by Doshi and Reneker concluded that 
the fibre diameter decreased with increasing tip-collector distances [148, 152].  
 
2.3.2.2 Solution parameters 
A number of solution parameters also take part in a critical role in fibre production and morphology. 
Listed in order of relative importance to the electrospinning process, the variables include polymer 
concentration, solvent volatility and solvent conductivity [152].  
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Polymer concentration  
Solution concentration or its corresponding viscosity has been established to be one of the critical 
variables that control fibre size and morphology. Moreover, it determines the capability of a 
polymer solution to electrospin, namely whether fibre or droplets form or not. The solution must 
have sufficient polymer concentration for chain entanglement to occur [152]. However it is 
important to note that the polymer also needs sufficient molecular weight for chain entanglement to 
take place.  Concentration is important because it controls both the viscosity and the surface 
tension of the electrospinning solution. At low concentrations, the polymer fibre will break up into 
droplets before reaching the collector due to the effect of surface tension, which will produce 
beading and droplets formation [152]. Nevertheless, if the concentration of the polymer solution is 
too high, which makes it difficult to regulate the flow rate through the needle, consequently, the 
fibres cannot be produced. Hence, there is an optimal window of solution concentration to fibre 
formation when all other variables are constant. In many studies it has been demonstrated that 
when electrospinning is conducted in the optimum range of polymer solution concentration, larger 
fibre diameter forms with increasing polymer concentration [61, 148, 153, 155]. 
 
Solvent volatility 
The selection of solvent is essential to determine if fibres can be produced during the 
electrospinning process, as well as influence fibre porosity. The volatility of the solvent will permit 
the fibres to dry in before their deposition on the target collector [158]. The volatility of the solvent 
influences the phase separation which happens when the fibre jet travels through the atmosphere 
[152]. Megelski et al. showed that high volatile solvent (100% THF) yielded higher porosity for the 
fibres, which increased surface area by as much as 20-40%, depending on fibre diameter [155]. 
On the other hand, a less volatile solvent (100% DMF) produced decreased pore density and 
almost complete loss of microtexture [152, 155]. 
 
Solution conductivity 
Solution conductivity has also been found to influence fibre size, and this dependence can be 
utilized for the electrospinning process. A solution with higher conductivity will have a larger 
charge-carrying capacity compared to a solution with low conductivity [152]. Consequently, in the 
presence of an electric field, the fibre jet with highly conductive solutions will to undergo a higher 
tensile force in comparison to a solution with low conductivity [152]. Zhang et al. studied the effect 
of varying concentrations of ions to PVA/water solution on the diameters of fibres [159]. It was 
shown that by increasing concentrations of NaCl from 0.05 to 0.2% (w/v), the fibre diameter 
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decreased from 214 ± 19nm to 159 ± 21nm [159]. They found that the decrease in fibre diameter is 
caused by the increase of net charge density attributed to the addition of NaCl, which increases 
the voltage applied on the jet [152, 159]. A number of general relationships between 
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Table 2.4 Effect of changes in the electrospinning process parameters on the resultant fibre morphology. 
Adapted from [61, 152]. 
Parameter  Effect on Fibre Morphology 




Increasing the conductivity encourage the production of uniform bead-free fibres 
In general, increasing conductivity produces smaller fibres 
Polymer molecular weight At constant viscosity, increasing molecular weight reduces the number of beads and 
droplets 
Flow Rate Lower flow rates produce fibres with smaller diameters. 
Field strength/Voltage At too high voltage, beading will be observed 
At increased flow rates, fibre diameter decreases 
Distance between tip and 
collector 
A minimum distance is required to obtain dry fibres 
At distances either too close or too far, beading can be observed. 
 
2.3.3 Polymers for electrospinning 
Natural biopolymers have been electrospun to generate fibrous scaffolds for TE such as 
polysaccharides; hyaluronic acid (HA), cellulose, chitosan and proteins; silk, fibrinogen, collagen, 
gelatin [146]. The advantage of using these natural polymers for TE is they provide many 
instructive cues needed for high cell attachment and proliferation, however, unlike synthetic 
polymers, these natural polymers may have the problem of batch-to-batch variation [146]. Many 
research groups have reported combination or blends of synthetic and natural polymers that could 
combine both the biofunctionalities of natural polymers with the capability of properties modification 
of synthetic polymers [146, 160-162]. 
Synthetic polymers which are degradable or hydrolysable under physiological conditions, for 
example aliphatic polyesters, polyanhydrides, and polyphosphazenes, are essential for producing 
electrospun nanofibrous scaffolds for TE [29]. Poly(lactic acid) (PLA), an aliphatic polyester, is one 
of the quintessential biodegradable polymers used for electrospinning [15, 149]. Poly(glycolic-acid) 
(PGA) has also been electrospun but to a limited extent, because of its low solubility in organic 
solvents except for hexafluoroisopropanol (HFIP), whereas poly(є-caprolactone) (PCL) and 
copolymers of PCL, which are soluble in many types of solvents, have been used extensively in 
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electrospinning for scaffolds [149]. Because of their biocompatibility, slow degradation rate and 
ease of electrospinning, these electrospun synthetic polymers are capable of supporting a wide 
variety of cell types [61].  
Electrospinning has been demonstrated to have immense potential in the engineering of many 
tissues including: bone [163-165] and cartilage [162, 166]. In bone TE, electrospun PCL seeded 
with MSCs has been shown to provide an environment that promotes mineralization and tissue 
formation [167]. Yoshimoto et al. cultured rat MSCs on electrospun PCL and incubated the scaffold 
in a dynamic bioreactor [61, 167]. After four weeks, the scaffold showed matrix mineralization and 
collagen type 1 deposition. Furthermore, a similar scaffold was cultured in vivo in the omenta of 
rats and displayed bonelike appearance with osteocyte-like cells in the mineralized matrix [168]. In 
addition, Cai et al. utilized an electrospun PLLA scaffold with the addition of a porous collagen 
membrane [169, 170]. After three weeks, using a rabbit tibia model, defects implanted with the 
dual-layer scaffolds showed 91% bone formation in contrast to 64% and 32% for nanofibrous and 
collagen membrane alone [170]. 
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2.4  POLYMER PHOTOCHEMISTRY  
The past couple of decades have seen many studies of photoinitiated materials used in exploring 
strategies to design a biomaterial for TE especially for cardiovascular materials [22, 23], drug 
delivery systems and biological adhesives [17, 171]. Photochemistry is a process in which 
chemical reactions are induced by light radiation [17, 172]. The light energy utilized is frequently 
ultraviolet (200-400nm) or visible light (400-800nm), but sometimes it is infrared light (800-
2500nm) [17]. Photoinitiated reactions are attractive in the fabrication of biomaterials because they 
have a controlled initiation and termination, and they yield spatial control [17]. Also, photochemical 
reactions can be performed under a wide range of conditions, and may include variations in 
monomer structures, the amount of reactive functional group, temperature, atmosphere, irradiation 
time and photoinitiator type [173]. There are two steps that describe photoinitiation: the absorption 
of light of a photosensitive molecule and the resulting photoreaction of this is the excited molecule 
[17, 174].  
Molecules or macromolecules utilized as photopolymerizable monomers or macromers have a 
general characteristic: a photopolymerizable residue is positioned at one or both ends of the 
molecule [175]. Commonly used monomers in these light-induced systems are acrylates and 
methacrylates because of their high reactivity during photoreactions [173, 175]. Acrylic and 
di(methacrylic) derivatives of poly(ethylene glycol) (PEG) are widely used for TE applications due 
to their active double bond group for photocrosslinking [19, 21, 176-181]. 
A selection of photoinitiators, each with its specific adsorption spectrum, is commercially available 
in the current market. Photoinitiators are molecules that are responsible for initiating the 
photoreaction by producing reactive species when activated by UV light [175]. Critical aspects that 
need to be considered when choosing a suitable photoinitiator include peak absorption wavelength 
of the initiator, reactivity of the initiator towards other species, kinetics of the initiator and, most 
importantly, the biocompatibility of the photoinitiator and its decomposition products towards cells 
and the human body [17]. One of the most commonly used photoinitiators are ketones which are 
associated to acetophenone (Ph-CO-CH3), which has been shown to have a strong absorbance 
band at 280 nm and weaker one at 330nm [17, 172]. The commonly employed 2,2-dimethoxy-2-
phenylacetophenone increases the rate of radical polymerization due to its additional electron 
donating groups, which enhances its ability to absorb light and become excited [17, 174, 182]. On 
the other hand, the production of high-energy radical species have been shown to cause damage 
to cell membranes, nucleic acids and proteins, which causes cell death [183-185].  
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2.4.1 Photopolymerization with acrylates/methacrylates for TE 
The photopolymerization of acrylates has been used for several decades in biomedical research 
and has become an essential approach for in situ delivery of resins in the area of dentistry [22-25] 
and as bone-replacement materials [17]. Recently, a variety of photocrosslinkable and degradable 
acrylate polymers have been utilized for a range of applications such as drug delivery vehicles, TE 
scaffolds and in the fabrication of microdevices [17, 171]. The spatial and temporal control during 
photoinitiation is a pivotal advantage which has motivated its wide application in the field of TE [16, 
17]. For example, photocrosslinkable acrylate hydrogels are synthesized for the delivery of cells to 
injured tissues [21, 178, 180, 181] and for the encapsulation of biological molecules for controlled 
delivery [171, 176, 179]. These applications are achievable because of the controlled nature of the 
photoinitiated polymerization with a choice of non-cytotoxic photoinitiators (and their degradation 
products) [171].  
Acrylates are ubiquitously used in the synthesis of hydrogel networks due to the active double 
bonds [18-21]. In addition, there are a number of commercially available monomers which can be 
photocrosslinked rapidly using a photoinitiator [9]. The bulk properties of the network can be easily 
altered by simple adjustments during synthesis (e.g. amount of crosslinker), thus rendering the 
system tunable with respect to mechanical properties and morphology [177]. When formed as 
films, the acrylate polymers show a wide range of physical properties, such as mechanical 
properties and swelling rates [10, 171]. Anderson and colleagues demonstrated the ability of 
acrylates and methacrylate photocrosslinked networks to support cell attachment, viability and 
proliferation [9]. Moreover, using an acrylate/methacrylate microarray library, they were able to 
identify specific monomers that support growth of human embryonic stem cells [9]. Hence, based 
on the ‗hit‘ polymer microarrays, which identified specific monomers that increased and sustained 
cell growth, diethylene glycol dimethacrylate (DEGMA) and methyl acrylate (MA) were chosen to 
be employed in the electrospinning system described in this thesis.   
There are only few studies in the literature on electrospinning of acrylate monomers. Kim and 
colleagues introduced a novel method of reactive electrospinning whereby 2-hydroxyl 
methacrylate, methacrylic acid, ethylene glycol dimethacrylate, AIBN and a photoinitiator were 
prepolymerized and subsequently photochemically crosslinked during electrospinning [186]. 
However, no cell culture studies were reported in their work. The first study found in literature 
which developed electrospun fibres from monomers and investigated cellular response on the 
fibres was reported by Tan et al. [10]. The authors successfully electrospun photocrosslinked 
macromers from a library of multifunctional poly(β-amino-ester)s, but preliminary cell studies using 
bovine MSCs have shown limited cell adhesion to the fibers, contrary to the results shown in our 
study [10]. Sundararaghavan and his co-workers created multiscale porous scaffolds, utilizing 
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photopatterning and electrospining methacrylated hyaluronic acid, to enhance cellular infiltration of 
hMSCs. However, cell viability was demonstrated to be significantly low [187]. The low cell 
adhesion observed in their investigation could either be due to cytotoxic effects of the macromer 
itself or to the presence of PEO. Failure of PEO extraction would cause PEO to block protein 
adhesion, which would consequently affect cell adhesion.  Subsequently, the same research group 
increased the viability and proliferation of hMSCs by using photocrosslinkable acrylate-
poly(glycerol sebacate) and co-electrospinning with gelatin instead of PEO [177].    
The pore size and overall porosity of scaffolds are essential for cell infiltration and diffusion of 
nutrients and waste, and the design of optimal vascular structures has been a major hurdle for TE. 
However, one of the main disadvantages of electrospun scaffolds is the limitation of cell infiltration 
and vascular construction due to the small pore sizes. Cell infiltration is limited in electrospun fibres 
because of dense fibre packing during the electrospinning process. To address this issue, by 
utilizing the UV system and the use of a UV mask on top of the scaffold during photocrosslinking 
could be investigated to increase porosity of the scaffold. Subsequently, uncrosslinked monomers 
could be leached out during washing and this could produce pores to improve infiltration 
throughout the fibrous scaffold. Alternatively, pores could be introduced by introducing salt 
particles which can then be leached out by thorough washing with water.  
 
2.4.2 Network formation and degradation  
One of the advantages of using free radical polymerization (i.e., photoreaction, thermal, redox) is 
the possibility to introduce specific properties in the polymer networks, such as mechanical 
strength, wettability, biodegradability, surface topology or cell adhesiveness, which can be 
achieved simply by selecting specific monomers or additional molecules (crosslinkers) during the 
design of the biomaterial formulation specific for the TE application [9, 16], for example, a 
hydrophilic monomer could be chosen to be introduced into the network to increase the 
hydrophlicity of the crosslinked network. In addition, mechanical strength of the network can be 
tuned by varying the amount of crosslinker. However, photopolymerization adds another 
advantage of spatial and temporal control during polymerization. 
The reaction mechanism for free radical polymerization, initiation, propagation and termination is 
illustrated in Figure 2.9 [16, 173]. This mechanism was described in detail by Ifkovits et al., and 
Andzejewska et al., [16, 173]. Briefly, the radical polymerization begins with irradiation of an 
initiator. The rate of initiation (Ri) is influenced by efficiency and concentration of the photoinitiator 
and intensity of UV light [173]. This induced initiator divides into two radicals that attack a 
monomer, producing two radical species [17]. Subsequently, the radicals proliferate through 
unreacted double bonds to produce long kinetic chains [16]. The growth ceases with chain transfer 
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or radical termination. The degree of termination (Rt) is a bimolecular reaction and is highly 
dependent on the concentration of radicals in the reaction, while the rate of polymerization (Rp) is 
proportional to the degree at which double bonds are reacted [16, 173]. This reaction happens in 
the propagation step; hence, Rp could be estimated as a reaction which is dependent on the 
double-bond concentration and the radical concentration [16]. In addition, if assumption of a 
pseudo-state of radical concentration (Ri=Rt) is made, Rp becomes proportional to Ri, the monomer 
concentration [M], the propagation (kp) and termination (kt) kinetic constants [16, 172]. Hence, 
although the reaction mechanism is simple, the polymerization behaviour is more intricate, as kp 
and kt are highly influential on the conversion and organization of the network structure [16]. 
 
 
Figure 2.9 Reaction mechanism for photoinitiated polymerizations.Ia is dependent on the initiating light 
intensity, initiator concentration and molar absorptivity coefficient. The polymerization rate equation assumes 
pseudo-state conditions. (Ri) = rate of initiation, (Rt) = rate of termination, (Rp) = rate of polymerization, [M] = 
monomer concentration, (kp) = propagation kinetic constants and (kt) = termination kinetic constants. 
Adapted from [16]. 
 




Figure 2.10 Reaction scheme of network for photocrosslinking of MA and DEGMA after UV radiation with the 
use of a photoinitiator, Irgacure 2959. 
An example of crosslinking between monomer and crosslinker is shown in Figure 2.10 using 
methyl acrylate (MA) and diethylene glycol dimethacrylate (DEGMA). These monomers will be 
used in the current thesis; their use will be described in detail in Chapter 3.  
Central to the TE approach is the degradation of the scaffold over time, to become completely 
replaced by the natural ECM in the bone tissue. Hence, the objective is to implant the scaffold that 
will remain in a robust state for structural/mechanical integrity in the site of injury for long enough to 
allow for the formation of native tissue, but which will in the end degrade and become replaced by 
newly synthesized matrix [29]. The acrylate scaffolds undergo bulk degradation mostly through 
hydrolysis of the ester bonds [16]. In the presence of an aqueous environment, the hydrolytically 
degradable units are cleaved which results in the end products of the degradable units and kinetic 
chains formed during photocrosslinking (usually an alcohol and an oligomer polymer backbone) 
(Figure 2.11). Hence when the hydrolytically degradable units are degraded, the poly-acrylic 
backbone, depending on its molecular weight, can be excreted through the glomerular filtration 
[175]. The molecular weight of the degraded poly-acrylic backbone is an important factor in the 
ultimate excretion.   
A vast majority of biodegradable polymers studied belongs to the polyester family, which includes 
polyglycolides and polylactides. One of the disadvantages of these polymers in TE applications are 
their loss of mechanical properties very early during degradation [188]. The degradation 
mechanism involves both hydrolytically and enzymatically [188]. Hence, in vivo the polyester 
based scaffolds would undergo bulk erosion and quick mass loss after implantation which is 
detrimental to native tissue (due to the high amount of acidic degradation products) and also loss 
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of structural integrity of the scaffold [188, 189].  To overcome this issue, the use of acrylate 
scaffolds offers a more stable degradation profile due to the slower degradation rate through 
hydrolysis of the ester bonds [190, 191]. This will be described in detail in Chapter 5 (Section 
5.4.5).  
 
Figure 2.11 Schematic of degradation for the MA:DEGMA scaffolds after hydrolysis of ester bonds.  
2.4.3 Modifications of electrospun fibres using photocrosslinking 
Post-crosslinking of electrospun fibres was also studied to improve the stiffness and strength of the 
scaffold, all of which are particularly crucial when the fibres have to degrade slowly in the body. 
Recently, crosslinked electrospun polybutadiene (BR) fibres were produced using UV irradiation 
for crosslinking after electrospinning [192]. The crosslinked electrospun fibres retained the fibre 
morphology and did not dissolve in solvent. The same technique of post-photocrosslinking was 
employed by Liu et al., which produced water resistant poly(vinyl alcohol) (PVA) fibres by 
crosslinking the PVA backbones [193]. In addition, Kim et al., introduced a novel method of 
reactive electrospinning whereby 2-hydroxyl methacrylate, methacrylic acid, ethylene glycol 
dimethacrylate, azobisisobutyronitrile (AIBN) and a photoinitiator were prepolymerized into a 
hyperbranched polymer solution and subsequently photochemically crosslinked during 
electrospinning by completing the crosslinking reaction [186]. However, the electrospinning 
process is becoming more technically complex. Recently, Wang and colleagues demonstrated the 
same method of in situ electrospinning with UV photopolymerization of polyurethane with 
polymerizable groups and poly(ethylene glycol) methacrylate (PEGMA) [194] for use in TE 
applications. 
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This thesis will focus on the development of fibrous acrylate scaffolds for bone TE applications 
specifically for injuries in the craniomaxillofacial skeleton using both electrospinning and UV post-
crosslinking. The feasibility of electrospinning photocrosslinkable and low molecular weight 
acrylate monomers, MA and DEGMA was investigated in Chapter 3. The biological response of 
Saos-2 and human MSC cells cultured on the acrylate scaffolds were assessed in Chapter 4. The 
development of the acrylate scaffolds conjugated with biologically active peptides of DGEA and 
RGD were described in Chapter 5. Lastly, in Chapter 6 the biological response of DGEA- and 
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Electrospinning has been widely used to create biodegradable scaffolds for the engineering of 
several tissues, particularly those of the skeletal system [10-12]. As discussed in Chapter 2, to 
fabricate electrospun fibrous scaffolds, a polymer solution is electrically charged until charge 
repulsion overrides the surface tension of the droplet at the spinneret tip and a polymer jet is 
generated [10, 13, 14]. Subsequently, as the polymer liquid jet travels and solvent evaporates, a 
fibrous strand is produced and collected onto a grounded collector [10]. The fibrous scaffolds 
mimic the size and structure of the natural ECM, which can lead to enhanced cellular interactions 
[10, 15].  
A number of synthetic polymers such as polyesters, polyanhydrides, and polyurethanes, as well as 
natural polymers, such as collagen, silk, and fibrinogen have been used in electrospinning to 
produce scaffolds for TE [10, 15]. Each of these polymers has distinctive mechanical and 
degradation properties, which can be translated into a range of scaffold properties that can be 
tuned [10]. By selecting the specific polymer, the mechanical properties and degradation of the 
electrospun scaffold can be controlled [195]. Nevertheless, the capacity to modify the scaffold, for 
example to immobilize peptides or biomolecules on these polymers is limited and requires the 
interaction of synthesis and processing steps. Hence, it may be advantageous to further expand 
the existing polymers used for electrospinning fibrous scaffolds to enhance cellular interactions for 
TE applications [10].  
To achieve this, the use of photopolymerizable acrylate monomers can be utilized. 
Photopolymerization with acrylates has been shown to have a controlled nature of the 
photoinitiated polymerization with a choice of non-cytotoxic photoinitiators and degradation 
products. Acrylates are ubiquitously used in the synthesis of hydrogel networks due to the active 
double bonds [18-21]. In addition, there are a number of commercially available monomers which 
can be photocrosslinked rapidly using a photoinitiator [9]. The bulk properties of the network can 
be easily altered by simple adjustments during synthesis (e.g. amount of crosslinker), thus 
rendering the system tunable with respect to mechanical properties and morphology [177]. When 
formed as films, the acrylate polymers show a wide range of physical properties, such as 
mechanical properties and swelling rates [10, 171]. Anderson and colleagues demonstrated the 
ability of acrylates and methacrylate photocrosslinked networks to support cell attachment, viability 
and proliferation [9]. Moreover, using an acrylate/methacrylate microarray library, they were able to 
identify specific monomers that support growth of human embryonic stem cells [9]. Hence, based 
on the ‗hit‘ polymer microarrays, which identified specific monomers that increased and sustained 
cell growth, diethylene glycol dimethacrylate (DEGMA) and methyl acrylate (MA) were chosen to 
be employed in the electrospinning system described here.   
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The photopolymerization of acrylates has been used for several decades in biomedical research 
and has become an essential approach for in situ delivery of resins in the area of dentistry [22-25] 
and as bone-replacement materials [17]. Recently, a variety of photocrosslinkable and degradable 
acrylate polymers have been utilized for a range of applications such as drug delivery vehicles, TE 
scaffolds and in the fabrication of microdevices [17, 171]. The spatial and temporal control during 
photoinitiation is a pivotal advantage which has motivated its wide application in the field of TE [16, 
17]. For example, photocrosslinkable acrylate hydrogels are synthesized for the delivery of cells to 
injured tissues [21, 178, 180, 181] and for the encapsulation of biological molecules for controlled 
delivery [171, 176, 179]. These applications are achievable because of the controlled nature of the 
photoinitiated polymerization with a choice of non-cytotoxic photoinitiators (and their degradation 
products) [171].  
In this chapter, the feasibility of electrospinning photocrosslinkable and low molecular weight 
acrylate monomers is investigated. Methyl acrylate (MA) and diethylene glycol dimethacrylate 
(DEGMA) (Figure 3.1) were selected as the monomer and crosslinker of choice, respectively, with 
the aid of PEO as a polymer carrier and viscosity modifier. The use of monomers enables the 
tailoring of the scaffold properties by selecting specific monomers that will produce topological and 
functionally diverse fibre scaffold materials.   
 
 
Figure 3.1 Chemical structure of methyl acrylate (MA) and diethylene glycol dimethacrylate (DEGMA). 
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3.2 MATERIALS  
Aluminium Scanning Electron Microscopy (SEM) pin stubs and adhesives carbon tape were 
purchased from Agar Scientific (UK). Ten ml Becton Dickinson plastic syringes and 27G Becton 
Dickinson disposable needles were from Cole Palmer (UK). The high voltage supply was from 
Glassman High Voltage Inc. (UK), the UVB lamp (Transilluminator 2000) from Biorad (UK) and 
single-syringe infusion pump (230 VAC) and static fibre collector (labarotory jiff-jacks) from Cole-
Parmer (UK). Methyl acrylate (MA) (99%), diethylene glycol dimethacrylate (95%) (DEGMA), 
poly(ethylene oxide) (PEO) (200 kDa) (95.5%) and 2-hydroxy-4′-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure 2959) (98%), were obtained from Sigma Aldrich (Poole, England). 
All chemicals were used as received and stored in a dry and dark environment.  
 
3.3 METHODS  
3.3.1 Electrospinning setup 
The electrospinning system used is shown in Figure 3.2 and Figure 3.3. The simple setup consists 
of a syringe pump, spinneret (27G disposable needle), static fibre collector and high voltage power 
system. The spinneret was connected to the syringe [62] and the polymer solution was fed through 
the spinneret by using a syringe pump at a constant and controlled feed rate. A high voltage and 
low current voltage system was needed for the conversion of the polymer solution to a charged jet 
[62]. The spinneret serves as an electrode to which the voltage was applied [149]. The static fibre 
grounded collector was placed right below the spinneret with distance of 10 cm. Parametric 
optimization studies on the electrospinning parameters was investigated and described in Section 
3.3.2. 
 
Figure 3.2 Schematic of the 
electrospinning setup. A polymer 
solution was supplied through a 
needle. At a critical voltage, charge 
imbalance starts to override the 
surface tension of the polymer 
producing an electrically charged jet 
[61]. This electrified jet becomes 
elongated and the solvent rapidly 
evaporates which generates fibres. 
 




Figure 3.3 The electrospinning setup used in the lab. Polymer solution is supplied at a constant rate which is 
controlled by the syringe pump situated on top. The high voltage supply creates the electric field difference 
required for electrospinning. The entire system is set up in the fume hood. 
 
3.3.2 Parametric study of electrospinnning 
3.3.2.1 Preparation of solution and PEO concentration 
Solutions of 2.5, 5, 10, 12.5 and 15% (w/v) solution of PEO were prepared by dissolution in 90% 
ethanol in water and magnetically stirred until a homogenous solution has been formed. The 
polymer solutions were electrospun for 10 minutes at constant voltage of 10 kV over 10 cm 
distance and collected on a static grounded plate. The spinneret was a 27-gauge blunt-ended 
needle and the rate of polymer solution delivery was set to 0.5ml/hr. The electrospun fibres were 
analyzed with scanning electron microscopy (Section 3.3.5). 
 
3.3.2.2 Accelerating Voltage  
A range of high voltages was applied to the tip of the needle and controlled by the voltage supply 
to generate the polymer jet. The voltages used were 2.5, 5, 7.5, 10, and 15 kV. The lower limit of 
the accelerating voltage parameter was set at 2.5 kV as this was found in this investigation to be 
the voltage at which the initiation of the polymer jet occurred. A voltage of 20kV was chosen as the 
upper limit because above this voltage, static discharge occurred around the grounding wires. 
When examining the effects of accelerating voltage at each polymer concentration, the rate of 
polymer solution delivery was set to 0.5ml/hr and target distance of 10cm.  
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3.3.2.3 Flow rate 
Two ml of the polymer solution of 10% (w/v) PEO concentration in ethanol was fed into a syringe 
which was controlled by a syringe pump at constant flow rates of 0.2, 0.3, 0.4, 0.5, and 1.0ml/hr. 
When investigating the effects of flow rate at each polymer concentration, the parameters were set 
constant at target distance of 10cm and accelerating voltage of 10kV. 
 
3.3.3 Preparation of photocrosslinked acrylate fibrous scaffold 
The monomer mixtures were prepared by varying ratios of MA and DEGMA with the aid of PEO as 
a high molecular weight carrier polymer. Table 3.1 lists the compositions of monomer and 
crosslinker. Refer to section 3.4.1 for the final optimal electrospinning compositions and 
parameters, which were investigated and described in the results section and listed in Table 3.2 
(page 81).  Briefly, MA and DEGMA monomer solutions were added together according to specific 
concentrations in a 5ml glass vial. Next, 0.1 mol% 2-Hydroxy-4′-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure 2959) was added to the solution. Then, 10% (w/v) PEO 
concentration in ethanol mixture was added to the solution and mixed thoroughly for 30 minutes 
with help of a magnetic stirrer. The electrospinning solution was added into a syringe with a 27-
gauge blunt-ended needle. Next, electrospinning was carried out in the set-up described previously 
in section 3.3.1. The fibres were immediately exposed to UV light for 10 minutes using a UVB 
(302nm) lamp in an oxygen free environment. After photocrosslinking, PEO from the scaffold was 
extracted from the scaffold by repeated washing with water for 5 days. The process of producing 
the photocrosslinked fibrous scaffold is shown in the schematic below (Figure 3.4). 
Table 3.1. Compositions of the monomer (MA) and crosslinker (DEGMA) used in mol percentages for 
producing the photocrosslinked acrylate fibrous scaffold. 











Figure 3.4 Schematic of photocrosslinked fibrous scaffold production. MA and DEGMA monomer solutions 
were added together according to specific concentrations in a 5 ml glass vial. Next, 0.1 mol% 2-Hydroxy-4′-
(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959) was added to the solution.  Then, 10% (w/v) PEO 
concentration in ethanol mixture was added to the solution and mixed thoroughly for 30 minutes. 
Subsequently, the fibres were photocrosslinked by exposure to UVB light for 10 minutes followed by 
extraction of PEO through repeated washing with water for 5 days. 
 
3.3.3.1 Optimization of (MA:DEGMA): PEO electrospinning formulations 
After the optimal range of parameters of PEO solution concentration, accelerating voltage and flow 
rate were established, the composition of the acrylate components with PEO were varied using the 
optimized electrospinning parameters. The solution flow rate was constant 0.5ml/hr. Solutions 
were electrospun at 10 kV and collected for 120 min on a stationary plate. 
 
3.3.4 Evaluation of varying the monomer/crosslinker concentration on fibre 
morphology 
MA and DEGMA monomer ratios were varied to evaluate the effects of increasing crosslinker 
(DEGMA) concentration on fibre morphology. Mats were electrospun at various ratios of 90:10, 
70:30, 50:50, 30:70 ratio (mol%) of MA to DEGMA solutions with PEO and post-crosslinked with 
UVB light (302nm) prior to visualization under SEM. The monomer: PEO mass ratios were kept 
constant at 50:50.   
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3.3.5 Morphology analysis using SEM 
Fibres produced by electrospinning were examined using scanning electron microscopy (SEM) to 
determine fibre morphology and approximate fibre diameter. Samples of approximately 1.5cm2 
were placed on an adhesive carbon tape and attached to aluminium SEM pin stubs. The samples 
were sputter coated with chromium. The LEO 1525 Gemini SEM was operated at an accelerating 
voltage of 5kV. 
 
3.3.6 Water resistance of crosslinked acrylate fibres 
Water resistance of the crosslinked MA:DEGMA fibres was tested with the incubation of the fibres 
in deionised water. The fibres were incubated with deionised water for 5 days (with gentle shaking 
on orbital shaker) and washed to remove PEO. After washing, the fibres were left to dry at room 
temperature overnight.  Fibre morphology was determined using SEM.  
 
3.3.7 Evaluation of photo-reaction using Attenuated Total Internal Reflectance-
Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
The extent of photoreactions was evaluated using the ATR-FTIR (Nicolet 6700, Thermo Fisher 
Scientific). The disappearance of acrylate double bond band at 1640cm-1 was used to indicate 
double bond conversion. The change of the peak maximum was monitored. For each 
measurement, 128 spectra were accumulated at a resolution of 4 cm-1. 
 
3.3.8 Mass loss analysis of fibres during PEO extractions 
The water solubility of the photocrosslinked electrospun fibres during PEO extraction was studied 
by mass loss analysis. The electrospun membranes were cut into rectangular shapes with 
dimensions of 10 x 3 cm2. The fibre samples were immersed in distilled water and incubated to 
obtain time points of 6 hours, 1, 2, 3, 4 and 5 days. All samples placed under vacuum overnight at 
room temperature for drying before measuring mass loss. Weight of the degraded samples (gd) 
was measured and from it the mass loss was calculated according to: 
Mass loss percentage = (gd – g0)/ g0 x 100 
g0 = initial mass before incubation 
This experiment was performed four times and quantitative data was presented as mean ± S.D.  
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3.3.9 Quantitative 1H-NMR analysis of PEO 
The individual supernatants from the mass loss analysis (see Section 3.3.8) were collected, 
lyophilized and mixed with DMSO-d6 in the NMR tube for 1H-NMR spectroscopy. NMR spectra 
were recorded on a Bruker DRX 400 MHz (operating at 400MHz) using DMSO-d6 as deuterated 
solvent. The quantification of 1H-NMR was carried out using an internal standard, 1,4-
(bistrimethylsilyl) benzene (BTMSB). NMR calibration curves using the unique peaks at 0.2, 3.6 
and 7.5 ppm for each component were calculated relatively to BTMSB integration values using the 
Mestrenova software version 1.8 (Mestrelab Research, US).  
 
3.3.10 Swelling test 
The swelling test was conducted as described in [191]. Briefly, the electrospun samples from which 
PEO had been extracted (refer to section 3.3.8) were cut into rectangular shapes with dimensions 
of 10 x 3 cm2 (n= 5). The fibres were immersed in distilled water and incubated for 6 hours. The 
wet weight of each sample was measured every hour prior to placing each of the samples in the 
vacuum oven at 60°C overnight. The dry weight of the samples was determined. 
Swelling ratio (percentage) = (wet weight/dry weight) x 100%.  
 
3.3.11 Mechanical testing of fibrous scaffolds 
The electrospun samples were cut into rectangular shapes with dimensions of 10 x 3 cm2 (n= 10). 
Uniaxial tensile testing was performed using an Instron Model 5540 with a 50N load cell with a 
constant deformation (5mm/min) on untreated samples (uncrosslinked) and on samples that were 
crosslinked with UV light. Additionally, PEO extracted samples, dry and hydrated (after incubation 
in deionised water for one hour) were evaluated mechanically. Tensile extension and reactive 
forces were recorded using the Bluehill 2 software, and the Young‘s modulus (E) was calculated 
from the linear region of the stress-strain curves. 
 
3.3.12 Wettability measurements  
 
The wettability of flat acrylate surfaces was analyzed using an EasyDrop instrument (Kruss, 
Germany). The sessile drop technique was used in contact angle measurement. The polymer 
samples prepared and were placed in the chamber and 1 µL water droplet was introduced onto the 
polymer surface through a microsyringe. The photographic pictures of droplets on the surfaces 
captured by the camera, and the value of their contact angles were calculated from the drop 
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profiles by using Drop Shape analysis software. All samples were analyzed at five different 
positions on flat polymer surface surface (n= 5).  
 
3.3.13 Statistical analysis 
All experimental data shown are expressed as mean ± standard Deviation (SD) and were obtained 
from experiments performed in triplicates at least. All data analysis was performed in Excel. 
Statistical analyses were performed with a one-way analysis of variance (ANOVA) using multiple 
comparisons (Bonferonni test) and significance was determined by p<0.05. This analysis was 
performed with GraphPad InStat software (GraphPad Software, US).  
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3.4 RESULTS AND DISCUSSION 
3.4.1 Parametric study of electrospinning 
In order to optimize the electrospinning system to aim for smooth and uniform fibre morphology, 
the processing and solution parameters during electospinning were characterized. The effects of 
these parameters on fibre morphology are discussed in Sections 3.4.1.1 to 3.4.1.4  below. 
 
3.4.1.1 Effects of PEO concentration in solvent on fibre formation 
Poly(ethylene oxide)(PEO, 200 kDa) was selected as a carrier polymer to assist in fibre formation 
during electrospinning [10]. Ethanol was chosen as solvent due to its low toxicity in comparison to 
other harsh solvents and because it has been shown to enhance the formation of fibres during 
electrospinning [196].  
Firstly, the optimization of PEO concentrations with the chosen solvent, ethanol was performed 
without the presence of the acrylate monomers. This optimization step is essential because 
polymer concentration is one of most important parameters of the electrospinning solution for 
controlling fibre morphology. The variation of fibre morphology is shown in Figure 3.5. Beaded 
fibres were obtained from 5% (w/v) PEO concentration (Figure 3.5B), whereas 2.5% (w/v) only 
yielded electrospraying droplets (Figure 3.5A). Fibre formation was obtained in 10% (w/v) with only 
slight beading and smooth fibres, without beads, were produced from electrospinning of 10-12.5% 
(w/v) PEO concentrations; an average diameter size of 890 ± 65nm was obtained for 12.5% (w/v) 
(Figure 3.5D). Furthermore, fibre diameter increased to 1550 ± 55nm as PEO concentration 
increased to 15% (w/v) (Figure 3.5E). The ease in fibre formation by increasing polymer 
concentration is due to the effect on the solution viscosity. Consequently, as the viscosity of the 
PEO solution increases, the beads becomes larger, the average distance between beads smaller, 
the fibre diameter bigger and the shape of the beads is altered from spherical to spindle-like [197]. 
The transition observed between the production of electrospraying droplets to the formation of 
uniform fibres with increasing polymer concentration was due to the function of chain entanglement 
with the increase in polymer concentration [152, 198]. Chain entanglements have been illustrated 
as the physical overlapping in polymers, consequently causing the interlocking of chains [158, 
198]. At a fixed polymer concentration, the number of chain entanglements increases with the 
molecular weight of the polymer [158]. On the other hand, the equivalent number of entanglements 
can be attained at a specific molecular weight by increasing the polymer concentration [158, 198]. 
In the electrospinning process, adequate chain entanglements are necessary to override the 
surface tension for the formation of fibres [158, 196, 199, 200]. For the production of a stabilised 
electrospinning jet, it has been shown that more than 2.5 entanglements per chain are needed 
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[158, 198]. Based on the formation of smooth fibre morphology, 10-12.5% (w/v) PEO concentration 
was chosen to be optimal concentration for our electrospinning system. 
 
 
Figure 3.5 SEM images of electrospun fibres with varying PEO concentrations in ethanol. A) 2.5%; B) 5%; C) 
10%; D) 12.5%; E) 15% PEO concentrations in ethanol. During electrospinning, the accelerating voltage was 
kept constant at 10 kV over 10 cm distance and collected on a stationary plate. Scale bar: 10µm.  
 
3.4.1.2 Effect of accelerating voltage on fibre formation 
The effect of varying accelerating voltage at a constant 10% (w/v) PEO concentration was 
assessed and it is shown in Figure 3.6. When investigating the effects of accelerating voltage at 
each polymer concentration, the rate of polymer solution delivery was set to a constant rate of 
0.5ml/hr. This flow rate for the polymer solution was chosen as it was identified to be the initial flow 
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rate where the droplet at the tip of the needle could be maintained during electrospinning. At a rate 
lower than 0.5ml/hr, the removal of polymer solution by electrospinning surpasses the flow rate to 
the needle tip and the droplet was shown to reduce into the needle tip. This was demonstrated by 
other groups [153, 158, 201] and confirmed further in the next section. 
In Figure 3.6 (A and B), SEM images revealed that accelerating voltages of 2.5kV and 5kV only 
produced electrospraying droplets. The transition between droplets and beaded fibres can be seen 
in Figure 3.6C with accelerating voltage of voltage of 7kV. Electrospinning with accelerating 
voltage of 10kV produced smooth fibres with an average diameter of 915 ± 40nm (Figure 3.6D). 
Furthermore, increasing accelerating voltage to 15kV caused fibre diameter to increase to 2100 ± 
153nm (Figure 3.6E).  
The accelerating voltage is a critical aspect for the initiation of the electrospinning process [158]. A 
high voltage source is needed to initiate the required self-repulsive charges in the solution and to 
create an external electric field to overcome the surface tension of the polymer solution [61, 158, 
197]. It has been demonstrated that an accelerating voltage of approximately 7kV is required for 
the production of a Taylor Cone and jet initiation during electrospinning [153, 200]. 
In this investigation, the initiation of electrospinning jets was shown at a similar accelerating 
voltage of 7kV. The increase in fibre diameter when the accelerating voltage was increased from 
10 kV to 15kV may be explained due to increase of the coulomb repulsive forces at the surface of 
the initial electrospinning solution, resulting in more polymer solution being displaced in the 
electrospinning jet, causing an increase in jet diameter [158, 202]. 
 




Figure 3.6 SEM images of electrospun fibres of PEO with varying accelerating voltage at a constant 10% 
(w/v) PEO concentration. A) 2.5kV; B) 4kV; C) 7kV; D) 10kV; E) 15kV accelerating voltages. Scale bar: 
10µm.  
 
3.4.1.3 Effect of the flow rate of the polymer solution on fibre formation  
The effect of the flow rate of PEO solution is demonstrated in Figure 3.7. At a constant PEO 
concentration of 10% (w/w) and accelerating voltage of 10kV, smooth fibre formation can only be 
obtained for electrospinning at the rate delivery of 0.5ml/hr (Figure 3.7D). Electrospraying droplets 
are produced at a flow rate of less than 0.4ml/hr in Figure 3.7 (A and B). Formation of beaded 
fibres can be seen when electrospinning at the flow rate of 0.4ml/hr. However, the flow rate of 
1ml/hr produced larger diameter fibres, from 883 ± 84nm (flow rate of 0.5ml/hr) to 1512 ± 135nm.  
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The flow rate of the polymer solution regulates the amount of solution available to sustain the 
Taylor Cone during electrospinning, and hence it controls the formation of fibres. The balance 
between the delivery of polymer solution to the tip of the needle and the displacement of polymer 
solution during electrospinning is required for the formation of uniform fibres [158]. At a constant 
accelerating voltage, an increase in the flow rate during the electrospinning process would cause 
an increase in the amount of polymer solution accumulated on the collector [158]. As a result of 
this, there may be an increase in fibre diameter and bead formation [156-158, 201]. In fact this is 
evident in Figure 3.7E in our system. However, some research groups have demonstrated that 
flow rate plays a less significant role in controlling the final fibre size and morphology in 
comparison to other parameters such as polymer and solvent concentration [199]. 
 
Figure 3.7 SEM images of electrospun fibres of PEO with varying flow rate of 10% (w/w) of PEO solution in 
ethanol. A) 0.2ml/hr; B) 0.3ml/hr; C) 0.4ml/hr; D) 0.5ml/hr; E) 1ml/hr. At a constant PEO concentration of 
10% (w/v) and accelerating voltage of 10kV. Scale bar: 10µm.  
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3.4.1.4 Optimization of (MA-DEGMA): PEO electrospinning concentration  
Since the effects of electrospinning PEO solution on fibre production have been performed and an 
optimal range of parameters established, the optimization of electrospinning the acrylate 
components with PEO has also been conducted. This is essential as both acrylate components 
and PEO would be co-electrospun to produce the electrospun scaffold. Initial attempts to 
electrospin acrylate monomers alone resulted in electrospraying, likely due to its low molecular 
weight (results not shown). Consequently, PEO was chosen as a high molecular weight carrier to 
help induce fibre formation. The process of utilizing PEO to ease fibre formation during 
electrospinning for low molecular weight polymers has been previously reported by several groups 
[10, 160, 187]. They revealed the importance of the ratio of reactive acrylate components to carrier 
polymer in the blend in determining the resulting smooth and uniform fibre morphology. Even 
though PEO would be eluted and extracted out after post UV-crosslinking, it is essential to promote 
even and smooth formation of fibres during electrospinning to produce a homogenous fibrous 
scaffold. 
The MA-DEGMA:PEO blend solutions with different mass ratio from 70:30 to 20:80 were 
electrospun and morphology of the fibres was examined using SEM. The fibre morphology of the 
fibres before and after PEO extraction is shown in Figure 3.8. The monomer (MA:DEGMA)  
concentration ratios were kept constant at 90:10 mol%. 
 




Figure 3.8 SEM images of monomer:PEO ratios. Electrospinning at an accelerating voltage of 10kV and 
target distance of 10cm. Electrospun fibres of monomers (MA:DEGMA) and PEO at various mass ratios 
(monomers:PEO (see labels)) before and after PEO extraction. The mol ratio of monomers (MA:DEGMA) 
was kept constant at 90:10 mol%. Scale bar: 5µm. 
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For unwashed fibrous scaffolds, slight beading can be observed for 70:30 (monomers:PEO) ratio 
due to the decrease of the PEO content reducing the viscosity of the electrospinning solution 
(Figure 3.8). However, distinct smooth fibres are produced with average fibre diameter of 1020 ± 
64nm for a 50:50 (monomer:PEO) ratio. Inhomogeneous and fragmented larger fibres were 
displayed for the 30:70 and 20:80 (monomer:PEO) ratios and increased webbing could be seen 
between the fibres. Higher PEO concentration increases viscosity, which causes difficulty in the 
control of the solution flow rate through the needle and prevents homogenous fibre formation even 
though larger diameter fibres were formed. Hence, there is an optimal window of monomer:PEO 
solution concentration to facilitate fibre formation when all other parameters are constant. 
In addition, in Figure 3.8 the SEM images of MA-DEGMA photocrosslinked fibres after PEO 
extraction are also shown. The crosslinked fibres were washed repeatedly and soaked with 
deionized water for one day. Noncrosslinked fibres completely disappeared after being immersed 
in water, whereas photocrosslinked fibres could endure the water treatment and maintained a 
fibrous structure but swelled to a certain degree. In the case of high PEO concentration fibres for 
30:70 and 20:80 (monomer:PEO ratio), the starting fibre structure collapsed and adhered together 
after PEO extraction. When the fibres are immersed in water, PEO is mobilized from the fibres thus 
MA and DEGMA components of the fibres melt together resulting in welding of the fibres. Fibres 
with a 50:50 (monomer:PEO) ratio produced a scaffold with distinct uniform fibres of 1124 ± 94 nm. 
However, the diameter of the fibres for other ratios could not be quantified due to inconsistency of 
fibre diameter formation after PEO was extracted. From these SEM characterizations, 50:50 
(monomer:PEO) ratio was chosen based on its ability to preserve fibre form and limit junction 
formation after PEO extraction.   
From the parametric studies described above, the optimal range of parameters required to produce 
uniform and bead-free electrospun acrylate fibrous scaffold was determined and listed is in Table 
3.2. With the use of the electrospinner set-up and UV-crosslinking system, operated at the optimal 
range of parameters determined, a fibrous electrospun acrylate scaffold can be fabricated and 
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Table 3.2 Optimal electrospinning parameters determined for the fabrication of MA:DEGMA fibrous scaffolds. 
This set of parameters form the key processing parameters in the production of the acrylate fibrous scaffold 
for subsequent part of this chapter and this thesis 
Type of solvent and ratio Ethanol: water, 90:10       
PEO concentration in solvent 10% (w/v) 
Target distance  10 cm 
Flow rate 0.5-1.0ml/hr  
Accelerating voltage 10kV 
(Acrylate monomer:PEO) ratio 50:50 
 
3.4.2 Effect of varying the monomer/crosslinker ratio on fibre morphology 
After the optimization of MA-DEGMA (monomer) to PEO ratio was conducted and optimal 
electrospinning conditions have been identified, the MA and DEGMA ratio (mol%) was varied to 
evaluate the effects of increasing the crosslinker (DEGMA) concentration on fibre morphology. 
Mats were electrospun at ratios of 90:10, 70:30, 50:50, 30:70 (MA:DEGMA) mol% solutions with 
PEO and post-crosslinked through photoinitiation of radical polymerisation prior to visualization 
under SEM (Figure 3.9). The four MA:DEGMA ratios were selected because they provided an 
overall range of varying concentrations of monomer and crosslinker for screening and identifying 
the optimal concentration for fibrous scaffold production. 




Figure 3.9 SEM micrographs of PEO/ MA:DEGMA unwashed fibres with varying ratio (mol%) of MA:DEGMA: 
A) 90:10; B) 70:30; C) 50:50; D) 30:70. Scale bar: 5µm. 
Fibres can be seen forming at low crosslinker concentrations (Figure 3.9A) with an average 
diameter of approximately 900 ± 56nm. However, increased DEGMA concentrations caused poor 
fibre formation with inconsistent fibre sizes in the scaffold (Figure 3.9D). The fibre diameters 
ranged from 800 to 2000nm. The microheterogeneity observed within the fibres could affect the 
overall mechanical properties of the fibres. The increase in DEGMA concentration may have 
affected the overall electrospinnability of the monomer/PEO solution. Specifically, varying the 
ratios may have caused some parameters such as conductivity and viscosity to change, which 
affects the electrospinning process. However, the change in conductivity and viscosity of the 
electrospinning solution was not studied in this investigation. 
To discern their stability and morphology in water, PEO was extracted by immersing the fibres in 
deionized water overnight. The photocrosslinked fibres were resistant to water and maintained a 
fibrous structure but swelled to a certain degree (Figure 3.10). The rate of bulk swelling was 
described in detail in Section 3.4.6. Analysis of diameter size quantification could not be performed 
precisely due inconsistency of fibre diameter formation but fibres with MA:DEGMA ratio of 90:10 
were 925 ± 95nm. Specifically, the fibre diameter increased and more welding was observed with 
increasing DEGMA content. However, the diameter of the fibres for other ratios could not be 
quantified due to inconsistency of fibre diameter formation after PEO was extracted. The welding 
and swelling of the crosslinked fibres after water incubation and PEO dissolution into the solution 
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have been reported by a few groups [10, 11]. The crosslinker which Ji and co-workers utilized was 
poly(ethylene glycol) diacrylate (PEG-DA) in a hyaluronic acid scaffold, whereas Tan and 
colleagues used a macromer from library of poly (β-amino esters) to produce fibrous scaffolds [10, 
11]. It was observed that the welding extent depends on the concentration of DEGMA; increasing 
the crosslinker agent somehow increases the extent of the welding. In this case it could be due to 
increased hydrophilicity of the crosslinked fibres, as increasing DEGMA concentrations causes the 
fibres to swell and merge in polar solvents, including water and buffer. Furthermore, the increase in 
DEGMA concentration may have affected the overall electrospinnability of the monomer/PEO 
solution, which was reflected in the morphology of the fibres before PEO extraction. Hence it might 
also have affected the morphology of the fibres after incubation in water.  
Accordingly, due to the non-fibrous morphology of the 30:70 MA:DEGMA scaffold, further 
experiments will not include this composition. 
 
 
Figure 3.10 SEM micrographs of MA:DEGMA fibres that were washed and incubated overnight with varying 
ratios of MA:DEGMA: A) 90:10; B) 70:30; C) 50:50; D) 30:70. The acrylate: PEO concentration percentages 
were kept constant at a 50:50 ratio.  Scale bar: 5µm. 
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3.4.3 Reaction characterization of UV-post crosslinking 
After electrospinning, the crosslinking of the 90:10 (MA:DEGMA) fibres initiated by UV light 
employing a photoinitiator - Irgacure 2959 - was evaluated through the absorption of the reactive 
acrylate peak at approximately 1635cm-1 before and after 10 minutes UV radiation (Figure 3.11). 
Irgacure 2959 was selected for the UV electrospinning system because it has been shown to have 
minimal toxicity over a broad range of mammalian cell types and species [203]. The intensity of the 
absorption increased for the photocrosslinked fibres, which indicates the decrease of acrylate peak 
during photocrosslinking. These results demonstrate the successful crosslinking of the acrylate 
monomers during UV radiation. The reaction scheme of network for photocrosslinking of MA and 
DEGMA after UV radiation is illustrated in Figure 2.10 in Chapter 2 (page 60).  
 
 
Figure 3.11 ATR-FTIR spectra of 90:10 MA-DEGMA photocrosslinkable fibres before and after UV radiation 
for 10 mins showing successful crosslinking of the electrospun fibres. 
In addition, the morphology of the fibres was monitored before and after UV-radiation and the 
result is shown in the SEM images below (Figure 3.12). It was observed that photocrosslinking had 
no effect on the overall morphology of the fibres. Specifically, upon hydration and after PEO 
elution, the fibres become less smooth, less homogeneous and thicker but the morphology of the 











Figure 3.12 SEM micrographs of PEO/MA:DEGMA 
fibres that were washed and incubated overnight 
with 90:10 MA:DEGMA. A) Before UV-radiation; B) 
After UV-radiation; C) After UV and PEO extraction. 
Scale bar:1µm. 
 
3.4.4 Characterization after PEO extraction 
The characterization of the PEO extraction was assessed by monitoring the mass loss and NMR 
analysis of extracted products from the photocrosslinked fibres was performed. The mass loss 
monitoring for three photocrosslinked samples with the different ratios of 90:10, 70:30, and 50:50 
(MA:DEGMA) after incubation in water showed a rapid loss of mass within the first day, followed by 
a more gradual release for the next 5 days, finally reaching a plateau (Figure 3.13). As described 
before in Section 3.3.6, due to the non-fibrous morphology of the 30:70 (MA:DEGMA) scaffold, 
further experiments did not include this composition. Non-crosslinked fibres were soluble in water; 
therefore the fibres were not analyzed. The 50:50 (MA:DEGMA) ratio fibres showed the highest 
mass loss approximately 75% mass loss followed by the 70:30 (MA:DEGMA) fibres (70%) and the 
90:10 (MA:DEGMA) fibres (65%), all after 5 days. The rapid mass loss of these fibres was 
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because of the extraction of PEO from the fibres. This assumption was confirmed by employing 1H-
NMR for a quantitative analysis as shown below (Figure 3.14).  
 
 
Figure 3.13 Mass loss for electrospun and crosslinked fibres. MA:DEGMA fibres that were washed and 
incubated overnight with varying ratios of MA:DEGMA of  90:10, 70:30 and 50:50. Mass loss after incubation 
in water for up to 5 days (n =5 per time point) for PEO extraction after photopolymerization. 
The sol fraction from the fibres after PEO extraction was analyzed using 1H-NMR. In Figure 3.14, 
the spectrum of the aqueous solution after incubation of the 90:10 MA:DEGMA fibres for 6 hours 
showed high intensity peaks at 3.6 ppm attributed to PEO. The absence of MA and DEGMA peaks 
detected relatively to the PEO concentrations in the solution, suggests that most of the monomers 
and crosslinkers have successfully reacted during photocrosslinking of the fibres. However, the 
absence of MA and DEGMA could also be due to rapid evaporation of unreacted MA and DEGMA 
during preparation of NMR samples (lyophilisation) because of the high levels of volatility. The 
visual analysis of the NMR spectrum showed a high PEO peak that decreased significantly over 
time and disappeared after 5 days (Figure 3.14B). This is consistent with the plateau reached by 
mass loss at the same time point (Figure 3.13).   
 






H-NMR spectra of the release products from the 90:10 (MA:DEGMA) fibres after PEO extraction 
in water. (A) a representative spectrum of the collected electrospun solution of MA-DEGMA and PEO; B) a 
representative spectrum of the release products after five days. 
In addition, mass loss for each component of the photocrosslinked fibres of 90:10 MA:DEGMA 
elutants was calculated using NMR integration normalized to an internal standard (Figure 3.15). In 
Figure 3.15, A and B correspond to 6 hours and 5 day time points, for which the 1H-NMR spectra 
are shown in Figure 3.14. The quantification demonstrates that the primary component to be 
released from the fibres to the water is PEO. The rapid increase of PEO on the first day, which 
appears to plateau after 4 days, indicate that most of the PEO in the crosslinked fibres has been 
eluted out. It is important to note that due to the hygroscopic nature of PEO, we have confirmed by 
lyophilisation that the PEO product used adsorbs 4.5% water. This may have cause 4.5% less 
PEO being used during production of the scaffold. However this does not affect the overall 
determination of PEO extraction from the scaffolds since the level of hygroscopy is low. The overall   
 65% mass loss of the photocrosslinkable fibres is consistent with the mass loss calculations 
determined by weight and shown in Figure 3.13. This proves that all of the PEO was eluted out of 
the scaffold.  





Figure 3.15 Mass loss for each component in the 90:10 MA:DEGMA photocrosslinked fibres calculated using 
NMR integration (n = 1). A and B denote the time points reflected in 
1
H-NMR analysis in Figure 3.14. 
 
3.4.5 Effect of varying the monomer/crosslinker concentrations on the mechanical 
properties of the fibrous scaffolds 
Besides surface chemistry and topography, mechanical properties such as modulus are critical for 
the stability and support of implants/scaffolds in the body, and furthermore certain narrow ranges 
of stiffness have been shown in modulating cellular functions such as cell attachment, motility and 
differentiation [4, 204]. Cells are likely to mimic their in vivo behaviour more when they are cultured 
on scaffolds which rigidity matches that of the cell type‘s native tissue matrix [205]. Hence, it is 
essential to characterize the mechanical properties of the fibrous acrylate scaffolds and investigate 
the effect of varying the monomer/crosslinker concentrations. The mechanical properties of the 
formed scaffolds with varying MA:DEGMA ratios were determined under four different conditions: 
before and after photocrosslinking and in dry and hydrated states (after PEO extraction), using an 
uniaxial tensile test to failure (Figure 3.16). Tensile extension and reactive forces were recorded 
using the Bluehill 2 software, and the modulus (E) was calculated from the linear region of the 
stress-strain curves. The mechanical testing studies showed that the crosslinked samples had a 
higher tensile modulus than the uncrosslinked scaffolds. Moduli of 3.0 ± 0.14, 3.5 ± 0.17 and 2.9 ± 
0.2 MPa were determined for the uncrosslinked samples with the 90:10, 70:30 and 50:50 
(MA:DEGMA) concentrations, respectively, while the crosslinked counter parts with the referred 
chemical compositions had a modulus of 14.7± 0.24, 12.1± 0.21 and 10.6± 0.18 MPa, respectively. 
A 
B 
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The increase in tensile modulus of the fibres after UV radiation was expected mainly due to the 
photocrosslinking of the acrylate monomers. Such an effect has been previously reported in 
studies by Tan and co-workers [10]. Though the modulus reported in their work was much lower 
with values of 1.5 MPa after photocrosslinking of macromer from a poly(β-amino ester) library. For 
the crosslinked fibres (before PEO extraction), a lower tensile modulus was measured as DEGMA 
concentration increased. The reduction of the tensile modulus could be explained by the changes 
of the scaffold morphology (shown in Figure 3.9). Increasing DEGMA concentrations caused poor 
fibre formation with inconsistent fibre sizes in the scaffold. The microheterogeneity observed within 
the fibres possibly affected the overall mechanical properties of the fibres. 
 
Figure 3.16 Mechanical properties: Young‘s modulus values of fibrous scaffolds with varied 
monomer/crosslinker ratio. (*) indicates that the difference between the marked bar and the uncrosslinked 
condition with the same chemical composition is statistically significant (p<0.05). (¥) indicates the difference 
between the marked bar and the 90:10 (MA:DEGMA) sample treated in the same condition is statistically 
significant (p<0.05). 
After PEO extraction, for all chemical compositions, the fibrous scaffolds exhibited the lowest 
tensile modulus when compared with initial constructs. This effect is due to the reduction in overall 
mass as PEO was dissolved out from the scaffolds. This linear relationship between PEO content 
removed and overall scaffold properties was also demonstrated by Baker and colleagues with co-
electrospinning PEO with poly-ε caprolactone (PCL) [206]. In contrast, the degree of crosslinking 
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appears to have more influence over the mechanics of the scaffold after PEO extraction. Increase 
in DEGMA (crosslinker) concentration lead to higher tensile modulus, which suggests an increase 
of crosslinking of acrylate within the network. Furthermore, the fibre diameter increased and more 
welding is found when increasing DEGMA content, which could have affected the stiffness of the 
overall structure. This effect of increase in modulus by increasing concentration of DEGMA as a 
crosslinker was also shown by Smith et al. but with photocrosslinking monomers of 2-hydroxyethyl 
methacrylate (HEMA) and DEGMA with varying ratios into polymer discs for bone implants from a 
range of 10 to 600MPa as DEGMA concentration increased [205]. They reported higher modulus 
values for their scaffolds because of difference in scaffold bulk properties since polymer discs were 
produced instead of porous electrospun scaffolds. 
In order to investigate the mechanical properties under more physiologically relevant conditions, 
(i.e. in vivo) the fibrous scaffolds were tested following incubation in water. Hydrated scaffolds 
displayed decreased tensile moduli in comparison with the respective dry scaffolds. The difference 
between the dry and hydrated scaffolds is because of water absorption and swelling, which 
reduces the tensile modulus values. However, a similar trend was displayed whereby an increase 
in DEGMA (crosslinker) concentration leads to higher tensile moduli.  
It has been shown by other research groups that the crosslinking density can be increased by the 
addition of a crosslinker agent, which increased mechanical strength of the networks [207-210]. 
This is relevant in the hydrated state of the fibrous scaffolds because it means that the material 
strength in swollen state can be increased by increasing the concentration of crosslinker agents 
[208]. 
Recently, Wang et al. demonstrated the development of photocrosslinked electrospun fibres with 
polyurethane (PU) and poly (ethylene glycol) methacrylate (PEGMA) by in-situ UV 
photopolymerization [194]. The PU/PEGMA fibres exhibited lower tensile modulus in the range of    
 3 MPa compared to the MA:DEGMA fibres. Another research group, Tan et al. also produced 
fibres with a lower tensile modulus of   5MPa after photocrosslinking a macromer from a poly(β-
amino ester) library [10].  Furthermore, photocrosslinked hydrogels using acrylated hyaluronic acid 
and acrylated poly(glycerol sebacate) demonstrated even lower modulus of  20kPa [211] and  
 1MPa [212] respectively.  
Even though the acrylate fibrous scaffolds exhibits higher tensile modulus than most 
photocrosslinked hydrogels and electrospun fibres described above, the major challenge of 
engineering TE applications for connective tissue, particularly bone is to provide adequate 
mechanical strength prior to cellular deposition of natural ECM [213]. The tensile moduli of 6.5-8 
MPa was displayed for the acrylate fibrous scaffolds in the hydrated state. The tensile modulus is 
comparable to PCL that have been reported to have tensile modulus from a range  of  5-15 MPa, a 
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commonly investigated polymer for electrospinning used for bone TE applications [206, 214]. This 
scaffold could potentially be suitable for regeneration of non-loading areas of bones such as 
craniomaxillofacial bone defects. Work by Motherway and colleagues have shown that cranial 
human exhibiting average moduli of 150 MPa [215]. Though the acylate scaffold has much lower 
moduli, some studies suggests that the overall mechanical strength of a scaffold increases after 
cellular infiltration [213 181].  
However, based on its mechanical properties, this fibrous scaffold may not be strong enough to 
support large defects of load-bearing bone. Studies have shown mineralized cortical and 
trabecular human bone exhibiting average moduli of 9905 and 365 MPa respectively [205].  
3.4.6 Effect of varying the monomer/crosslinker ratio on swelling properties of 
electrospun fibres 
A unique characteristic of the fibrous scaffold was swelling could be observed when the scaffold is 
immersed in aqueous conditions. This hydrated state of the scaffolds is also more physiologically 
relevant, following incubation in water. The swelling can be seen in the bulk morphology of the 
scaffold shown in Figure 3.17. To understand the influence of the MA and DEGMA ratios on the 



















Figure 3.17 Images of the bulk morphology changes 
of the fibrous samples with varying ratios of 
MA:DEGMA  (A) 90:10; B) 70:30; C) 50:50 before 
and after immersion in water. Scale bar: 5cm. 
 
All MA:DEGMA fibres with varying monomer and crosslinker compositions showed similar swelling 
behaviour which are typical swelling curves for crosslinked polymers including hydrogels. An initial 
and short (10-30 mins) rapid swelling phase was followed by a slowing down of the penetrant 
uptakes (30-60 mins) and, eventually, the fibres reaches its maximum swollen state (Figure 3.18). 
Swelling reaches asymptotically to a limit which is the balance between the attractive interactions 
between water and the scaffold surface and then increasing conformational strain which is being 
generated (due to the reduction of conformational entropy) which counteracts this effect. The 
ultimate level of swelling is a compromise of these two effects. Hence, this gives a good indication 
for the degree of crosslinking. Swelling significantly increases with decreasing crosslinker 
concentration, with the 90:10 ratio scaffolds displayed the highest degree of swelling (  160%), 
followed by 70:30 (  140%) and 50:50 (  120%) percentage MA:DEGMA compositions. This 
behaviour demonstrates the increase in water uptake caused by lower levels of crosslinking in the 
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network [216]. In addition, SEM images also show the increase in welding which could affect the 
swelling behaviour (Figure 3.10).   
 
 
Figure 3.18 Swelling ratios (percentages) of electrospun fibres with different MA:DEGMA ratios. (n=5 per 
time point). 
The evaluation of both mechanical and swelling properties demonstrated that the increase in 
swelling ratio is always accompanied by a corresponding decrease in tensile modulus (Figure 
3.16). This is simply due to the increase in the volume of water uptake by the scaffold. Hence, the 
degree of swelling is correlated to the material strength. Typically, increasing the crosslinking 
density reduces the degree of swelling of the material and thus improves its mechanical properties 
[208]. The effects of swelling on tensile modulus is reported by Buyonov et al. for polyacrylamide 
gels crosslinked with N,N-methylene-bisacrylamide by demonstrating that when the degree of 
swelling increases, the tensile modulus decreases dramatically [208, 217].  
Based on the morphology and the mechanical and swelling properties, the 90:10 MA:DEGMA 
composition was considered to have the best overall properties as a tissue engineering scaffold 
among all the fibrous scaffolds synthesized, as it develops the highest swelling ratio yet 
maintaining mechanical integrity. Furthermore, SEM images demonstrated that the 90:10 
MA:DEGMA fibres preserved the fibrous morphology of the scaffold in water incubation. 
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3.4.7 Effect of varying the monomer/crosslinker ratio on wettability properties of 
flat surfaces of MA and DEGMA 
 
To understand the influence of surface chemistry on wettability, contact angle values of different 
acrylate flat surfaces of MA:DEGMA were investigated. Contact angle measurements of the 
electrospun fibres could not be assessed due to the irregular and rough surface topography of the 
scaffold. The contact angle values for different flat surfaces of MA:DEGMA were shown in Figure 
3.19. Depending on the concentration of MA and DEGMA, the hydrophobicity of the surfaces were 
expected to change as the crosslinker:monomer ratio was varied. 
It is evident that the 50:50 MA:DEGMA surface showed the lowest contact angle (39 ± 4.2°) while 
90:10 MA:DEGMA presented the highest (85 ± 2.66°) and followed by 70:30 MA:DEGMA (55 ± 
3.5°). This is due to DEGMA being a more hydrophilic monomer because of the presence of 
oxygen atoms which is in contrast to MA. Hence, by varying the ratios of both MA and DEGMA, the 
hydrophilicity of the flat surfaces changed.   
 
 









In this chapter, the electrospinning of photocrosslinkable and low molecular weight monomers is 
described. The ability to produce topologically and mechanically diverse fibrous scaffold materials 
was demonstrated. Photocrosslinked fibres were successfully developed by electrospinning 
different MA and DEGMA compositions and post-UV crosslinking. The effects of various 
processing parameters of electrospinning were investigated, including carrier polymer 
concentration, accelerating voltage, rate of delivery and monomer/carrier polymer ratios. With the 
use of high molecular weight PEO, all parameters were observed to have a profound effect on the 
electrospun fibres morphology. The analysis of this study lead to the determination of the optimal 
range of parameters required to produce uniform and bead-free electrospun MA:DEGMA fibrous 
scaffold. When exposed to UV light in the presence of a photoinitiator, the crosslinked network was 
produced by conversion of the double bonds and an increase in tensile moduli was observed. PEO 
was extracted with thorough washing with water, and scaffolds swelled after incubation in water. 
Most importantly, varying MA and DEGMA composition affected overall fibre morphology, swelling 
and mechanics of the fibrous scaffold.  
The 90:10 (MA:DEGMA) composition was chosen as the best fibrous scaffold for bone tissue 
engineering purposes among the different compositions analysed, as it developed the highest 
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The extracellular microenvironment plays an essential role in directing cellular behaviour [5, 6, 9]. 
For cells growing on a material, the properties of its surface, such as topography, stiffness, 
wettability and specific cell-surface interactions are key to control cellular activity [7-9]. A critical 
challenge in designing materials for TE is to provide essential cues that can control cellular 
behaviour and promote tissue regeneration. Material-based control of cellular response is a 
potentially powerful way for regulating the behaviour of different cell types, including stem cells, 
cells with the potential to differentiate into many tissue types. Anderson and colleagues 
demonstrated the ability of acrylates and methacrylate photocrosslinked networks to support cell 
attachment, viability and proliferation [9]. Moreover, using an acrylate/methacrylate microarray 
library, they were able to identify specific monomers that support human embryonic stem cells.  
As previously discussed in Chapter 2, the electrospinning technique is able to create ECM-
analogue scaffolds composed of nanoscale fibres. Such scaffolds have high surface area to 
volume ratio, which supports cell growth and infiltration. Moreover, the morphological resemblance 
between the fibrous scaffold and the ECM are shown to enhance cellular response [15]. The high 
surface area permits increased levels of cellular adhesion, and the occurrence of multiple focal 
adhesion points [15, 61]. 
Upon implantation of biomaterials in bone, MSCs have been demonstrated to be recruited from the 
bone marrow to the injury location, where they attach to the biomaterial and subsequently 
differentiate into osteoblasts [79, 218]. MSCs are uncommitted, cells that are characterized by their 
capability to differentiate after stimulation of appropriate cues [82, 84]. Their potential for 
differentiation (or plasticity), and the simplicity with which they can be isolated and cultured in vitro 
without phenotypic alterations before differentiation [76], make MSCs a suitable candidate for TE 
applications [84]. The use of MSCs to induce tissue regeneration has been extensively 
investigated [81-83]. These cells have been seeded into scaffolds and implanted into the body 
either directly or a few weeks later, after in vitro differentiation [81]. Successful bone and sub- 
optimal cartilage defect repair have been achieved [84]. However, the optimal conditions to 
promote MSC growth and differentiation towards a specific lineage have not been defined yet. 
Thus, investigations targeted at defining the optimal environment for MSC attachment and 
proliferation using a scaffold are therefore necessary. 
In Chapter 3, the successful development of photocrosslinked fibres by electrospinning different 
MA and DEGMA compositions and post-UV crosslinking was described. The investigation of the 
material characteristics revealed that varying MA and DEGMA concentrations affected overall fibre 
morphology, swelling and mechanics of the fibrous scaffold. In the present chapter, the biological 
response of Saos-2 (osteosarcoma-derived osteoblastic cells) and human MSC cells to different 
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compositions of MA/DEGMA electrospun fibers and flat surfaces with similar chemistry is 
discussed. Additionally, the effect of the fibrous scaffolds and flat surfaces on protein adsorption is 
also investigated. 
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4.2 MATERIALS  
Roswell Park Memorial Institute 1640 medium (RPMI 1640), Fetal Bovine Serum (FBS), L-
Glutamine, penicillin/streptomycin, Phosphate buffered saline (PBS) and trypsin/ethylenediamine 
tetra-acetic acid (trypsin/EDTA), AlamarBlue® assay, Alexa-Fluor 568 Phallaoidin stain, Total DNA 
assay and the LIVE/DEAD® viability assay were purchased from Invitrogen GIBCO Corporation 
(UK). Caspase-glo®3/7 Assay was purchased from Promega (UK). The human osteosarcoma cell 
line Saos-2 was purchased from ECACC (UK) and human mesenchymal stem cells (hMSCs) 
growth media were purchased from Promocell (UK).  BCA Protein assay kit was purchased from 
Thermo Fisher Scientific (UK).  
 
4.3 METHODS 
4.3.1 Cell culture 
Saos-2 cells (an osteosarcoma-derived cell line) were expanded in RPMI 1640 with 10% (v/v) fetal 
bovine serum (FBS), 1% (v/v) L-glutamine and 1% (v/v) penicillin/streptomycin. Low passage (p3-
p4) hMSCs were cultured using growth medium and supplements (Promocell). The hMSCs were 
obtained commercially from two different patients (48 and 56 years old) (Promocell).  Initial culture 
for both cell types was performed in 75cm2 flasks at 37°C, in a humidified atmosphere of 95% air 
with 5% CO2, and supplied with fresh medium every 2-3 days. At 90% confluence, cells were 
detached using trypsin-EDTA and cell count was determined in a haemocytometer. Cells were 
resuspended to achieve the appropriate concentration for seeding in complete medium.  
 
4.3.2 Preparation of electrospun scaffolds and flat surfaces 
The aluminium foil of the collecting surface of the mandrel was plasma-treated before 
electrospinning. Fibrous membranes were deposited by electrospinning the PEO acrylate solution 
with the specifications mentioned in Chapter 3 (Section 3.3.3). The fibres were exposed to UV light 
for 10 minutes.  Fifteen millimetre diameter scaffolds were excised using a biopsy puncher and 
PEO was extracted from the fibres for five days. Subsequently, the scaffolds were air-dried 
overnight and incubated in deionized water also overnight, before placed in 24-well plates 
previously coated with 1% (w/v) agarose gel (to prevent cell adhesion at the bottom of the plate).  
Flat surfaces with the same chemical composition of the fibres, used as control, were fabricated by 
photocrosslinking. The MA:DEGMA solutions were photocrosslinked in 24-well plates under 
nitrogen purge with UVB light for 10 minutes. The flat surfaces were then washed in acetone and 
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ethanol for 5 days, to extract unreacted monomers thoroughly, before cell culture experiments. The 
sol fraction products from the flat surfaces were analyzed using 1H-NMR to ensure no monomers 
and photoinitiator were present. Before cell culture, the flat surfaces were washed with water and 
PBS. For sterilization, samples in the 24-well plates were incubated with ethanol for one hour, 
soaked in PBS overnight and repeatedly rinsed with PBS and media before cell seeding. Saos-2 
and hMSC cells were seeded on the electrospun fibres and flat surfaces prepared at a density of 1 
x 104 cells/per cm2 and incubated at 37°C overnight to allow cell adhesion. The cell culture medium 
was replaced every 2-3 days.  
 
4.3.3 AlamarBlue® assay 
The alamarBlue® assay was performed to assess the viability of cells on the fibrous scaffolds. The 
mechanism of detection of this assay is the conversion of its active product, resazurin, by cells into 
the fluorescent molecule, resorufin, which produces red fluorescence. Viable cells continuously 
convert resazurin into resorufin, due to their reduction potential. Hence, fluorescence can be used 
as a quantitative indicator of cell viability; the total of fluorescence produced is then directly 
proportional to the amount of living cells. The alamarBlue® assay was performed as specified by 
the manufacturer. Briefly, Saos-2 and hMSCs were seeded in 24-well plates (cell density, 1 x 104 
cells/cm2). At specific time points (1, 5, 10 days), cell-culture media were removed from the well 
plates and the wells were washed with 400 μL of PBS. 300μL of 10% (v/v) alamarBlue® in phenol 
red-free cell culture media were added per well (including one with no cells to be used as blank) 
and the well plates were incubated for 3 hours at 37°C. 100 μL of the reaction product was then 
transferred to a black 96-well plate and fluorescence was measured at an excitation wavelength of 
540 nm and an emission wavelength of 590 nm using a microplate reader (SpectraMax M5, 
Molecular Devices).  
 
4.3.4 Total DNA assay 
DNA concentration was measured using the Hoechst 33258 dye fluorescent assay. This assay is 
based on the enhanced fluorescence and shift in the emission wavelength of the fluorochrome 
Benzamide (Hoescht) when bound to DNA. Briefly, after 1, 5, and 10 days, cell-culture medium 
was removed from the well plates and cells were washed with PBS. 400 μL of water were added 
per well and cells were lysed by freeze-thaw cycles (30 minutes at -80°C and 20 min at 37°C, 
repeated 3 times). 50 μL of the cell lysates were added to 50 μL of Hoescht dye diluted to the 
working concentration (20 μg/mL) and allowed to react for 5 minutes before measurement. 
Fluorescence was measured using an excitation wavelength of 360 nm and an emission 
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wavelength of 460 nm in a microplate reader (SpectraMax M5, Molecular Devices). In addition, 
DNA concentrations were calculated using a standard curve prepared using calf thymus DNA at 
concentrations between 0-100 μg/mL. 
 
4.3.5 Caspase-glo®3/7 Assay  
The Caspase-glo®3/7 assay is a luminescent apoptosis assay that measures caspase-3 and -7 
activities, two members of the protease (caspase) family participate in critical effector roles in 
apoptosis in cells. The assay uses a luminogenic substrate DEVD sequence that has been shown 
to be specific to both caspase-3 and -7. The Caspase-glo®3/7 assay was performed as indicated 
by the manufacturer. Briefly, cell culture medium was removed and 300 μL of Caspase-glo®3/7 
reagent were added to each well. The plates were gently mixed by using a plate shaker for 30 
seconds and incubated in room temperature for one hour. Luminescence was measured using a 
microplate reader (SpectraMax M5, Molecular Devices). As positive control for caspase activation, 
cells were exposed to 0.1% (w/v) staurosporine overnight, a known inducer of apoptosis. 
 
4.3.6 LIVE-DEAD® viability assay 
The LIVE-DEAD® assay simultaneously detects live and dead cells, based on intracellular esterase 
activity and plasma membrane integrity. Live cells are detected by intracellular esterase activity, 
affected by the enzymatic conversion of the non-fluorescent cell-permeant calcein AM to the 
fluorescent calcein. Whereas Ethidium homodimer (ethD-1) penetrate cells with damaged 
membranes and produces red fluorescence upon interaction with nucleic acids for dead cells. 
Firstly, 1.5µl Calcein AM and 3µl of Eth-D were mixed with 6ml of PBS to make up the working 
solution. After rinsing the samples with PBS, 500 μl of working solution were added to each well 
and the cells were incubated for 20 minutes at room temperature. The labelled cells were viewed 
and photographed under the fluorescence Olympus IX51 inverted microscope.   
 
4.3.7 SEM for cell attachment 
Samples were washed with PBS twice and fixed with 2.5% (v/v) glutaraldehyde in PBS. Then 
samples were rinsed with PBS twice and dehydrated with a graded series (increasing 
concentration of 25%, 50%, 70%, 90% and 100%) of ethanol for 5 minutes/each concentration. 
After samples were dry, the samples were sputtered with gold and observed using SEM (LEO 
1525, Gemini 1525 FEGSEM) at 10 kV. 
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4.3.8 Actin Immunostaining 
The distribution/organization of actin fibres were observed by staining the cells with Alexa Fluor 
Phalloidin 488/568. Nuclei were stained with Diamidino-2-phenylindole (DAPI) staining. Firstly, the 
electrospun samples were washed twice with pre-warmed PBS and fixed with 4% (w/v) 
paraformaldehdye solution for 15 minutes at room temperature. After washing the samples twice 
with PBS, the cells were permeablized with 0.1% (v/v) Triton X-100 solution for 5 minutes at room 
temperature. After further washing, the samples were incubated with Alexa Fluor Phalloidin 
solution in 1% (w/v) BSA for 20 minutes at room temperature. The samples were then washed with 
BSA and PBS twice, repeatedly and, finally, Vectashield mounting medium with DAPI staining 
solution was added to samples and incubated for 5 minutes. Samples were rinsed with PBS twice 
and viewed with a fluorescence microscope (Olympus IX51 inverted microscope).   
 
4.3.9 Protein adsorption 
Fibrous scaffolds and thin films of identical composition were placed in a 24-well plate, sterilized 
with 70% ethanol for an hour, washed thoroughly and incubated overnight with PBS. All samples 
were incubated with 1ml of 25% (w/v) FBS for 4 hours at 37°C. The samples were then removed 
from the protein solution and washed with 600µl of PBS under gentle agitation. The free and 
loosely adsorbed proteins were removed by repeated washing. Proteins adsorbed on the surface 
of the samples were recovered by incubations in 200µl of 1% (w/v) sodium dodecyl sulphate (SDS) 
for 1 hour. The retrieved protein concentration was assessed, using BCA Protein assay kit. A 
microplate reader (SpectraMax M5, Molecular Devices) was used for the measurement and the 
result was normalized to surface area.  
 
4.3.10  Statistical analysis 
All experimental data shown were expressed as mean ± SD and were obtained from experiments 
performed in triplicate, at least. All data analysis was performed in Excel. Statistical analysis was 
performed with one-way analysis of variance (ANOVA) using multiple comparisons (Bonferonni 
test) and significance was determined by p<0.05. This analysis was performed with Graphpad 
InStat (Prism) software. 
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4.4 RESULTS AND DISCUSSION 
The previous chapter describes the development of MA:DEGMA photocrosslinked fibrous scaffolds 
by electrospinning different MA and DEGMA compositions and post-UV crosslinking. Varying the 
MA:DEGMA composition was shown to affect overall fibre morphology, swelling and mechanics of 
the fibrous scaffold. Nevertheless, the biological response of cells to the fibrous scaffolds should 
be investigated. Hence, the Saos-2 cell line, an osteosarcoma cell line commonly used in our 
laboratory, was chosen to model osteoblastic behaviour and to assess the biological activity of the 
MA:DEGMA scaffolds. Saos-2 cells have been ubiquitously utilized as model systems for 
elucidating osteogenic cell behaviour on biomaterials [87, 218, 219]. Compared to other 
osteosarcoma cell lines, MG-63 and U-2 OS, Saos-2 cells exhibited the most mature osteoblastic 
phenotype with positive results for ALP, OCN, BSP, decorin and collagen I and III [220, 221]. 
Hence, rendering these cells as a good candidate for an in vitro model of osseointegration. To 
further investigate the biological effects of the fibrous scaffolds, the response of hMSCs was also 
evaluated. Their potential for differentiation (or plasticity), and the efficiency with which they can be 
isolated and cultured in vitro without phenotypic alterations before differentiation [76], make MSCs 
a suitable candidate for TE applications [84] 
This chapter was divided into three main sections. Firstly, the Saos-2 cells response to different 
MA:DEGMA compositions and a comparison with flat surfaces with the same monomer 
concentrations will be described. Secondly, a similar study using hMSCs will be presented and 
finally, the protein adsorption studies on the scaffolds will be demonstrated. 
 
4.4.1 Determination of the effect of varying MA:DEGMA compositions on Saos-2 
cells behaviour (comparison to 2D surfaces) 
Total DNA assay was performed to ensure the fibrous scaffolds were not cytotoxic. This assay is 
commonly used to assess cell number or cell viability. The various MA:DEGMA fibrous scaffolds 
used in the present study did not significantly affect Saos-2 cells viability (Figure 4.1). Total DNA 
content of the Saos-2 cells grown in the fibrous scaffolds was not significantly reduced in 
comparison with those grown in TCP, after both 1 and 2 days in culture. Increased cell number 
was observed for all MA:DEGMA fibres after 2 days, except for 50:50 MA:DEGMA ratio, which 
showed significant lower cell viability in comparison to TCP. 




Figure 4.1 Effect of varying the MA:DEGMA ratio of the fibrous scaffolds on Saos-2 cell viability, determined 
using total DNA assay. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (TCP) of the same time period is statistically significant (p<0.05).  
Saos-2 cell viability and proliferation on the photocrosslinked fibres was evaluated at days 1, 5 and 
10, using the AlamarBlue® assay (Figure 4.2), an assay that measures enzymatic activity by 
assessing the cytoplasmic reduction potential of metabolically active cells. During the first 24 
hours, no significant differences in cell viability between all samples were observed. However, the 
flat surfaces of photocrosslinked polymers presented slightly higher cell viability in comparison to 
the fibrous scaffolds. After 5 days in culture, this trend changed. The 90:10 (MA:DEGMA) fibres 
significantly enhanced Saos-2 cellular activity and the 70:30 and 50:50 (MA:DEGMA) fibres 
followed the trend in this specific order. At this time-point, cell viability was significantly lower for 
the MA:DEGMA flat surfaces in comparison to the fibrous scaffolds with equivalent chemistry. The 
concentration-dependent trend of MA:DEGMA continued to rise up to 10 days in culture. The 90:10 
(MA:DEGMA) fibres supported the highest level of cell viability, followed by the 70:30 and 50:50 
(MA:DEGMA) fibres. The flat surfaces with same chemical composition maintained a significantly 
lower cell viability when compared with their corresponding fibrous scaffold of the same chemistry.  
Interestingly, flat surfaces displayed the opposite trend of effect on cell viability. The 50:50 ratio 
(MA:DEGMA) showed the highest cell viability for flat surfaces, followed by the 70:30 and finally 
the 90:10 ratios (MA:DEGMA). 
 




Figure 4.2 Effect of the photocrosslinked fibrous scaffolds on Saos-2 cell viability, determined using 
AlamarBlue
®
 assay. Comparison of the effect of the photocrosslinked fibrous scaffolds with the flat surfaces 
with equivalent chemical compositions. Mean ± SD, n = 3. (*) indicates the difference between the marked 
bar and the control (TCP) of the same time period is statistically significant. (¥) indicates that the difference 
between the marked bar and flat surface with same chemical composition of the same time period is 
statistically significant (p<0.05). 
The AlamarBlue® results were confirmed using a LIVE-DEAD® viability assay, shown in Figure 4.3, 
Figure 4.4, and Figure 4.5. The LIVE-DEAD® staining results demonstrated the Saos-2 cells 
seeded on the fibrous scaffolds remained largely viable. After 24 hours in culture, the cells seeded 
onto the photocrosslinked fibrous scaffolds and flat surfaces were green fluorescent, indicating 
viability was maintained after seeding into the scaffold. As observed with the AlamarBlue® assay 
(Figure 4.2), at this time-point, the cells grown in the flat surfaces presented higher viability 
compared to those grown in the fibrous scaffolds. After 5 days in culture, a significant increase in 
cell number was observed for Saos-2 cells grown in the 90:10 ratio (MA:DEGMA) fibrous scaffolds; 
growth that continued up to day 10 (Figure 4.5). This increase in cell viability was followed by 
Saos-2 cells growing in the 70:30 and 50:50 (MA:DEGMA) fibrous scaffolds, respectively. Only a 
small number of cells was found to be apoptotic (red fluorescent). Confluency was reached at day 
10. On the flat surfaces, however, such enhancement of cell viability was not observed. A small 
increase in cell proliferation was only detected for cells seeded in the flat surfaces from day 5 to 
day 10. The cells on TCP showed larger size compared to cells on fibres and flat surfaces due to 
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the differences in magnification. The thickness of the fibres and flat surfaces samples in the 24-






 viability assay of Saos-2 cells cultured on MA-DEGMA photocrosslinked fibrous 
scaffolds, flat surfaces and TCP after 24 hours. The green fluorescence represented live cells whereas the 
red fluorescence, represented dead cells. Scale bar: 1.0 mm.   






 viability assay of Saos-2 cells cultured on MA-DEGMA photocrosslinked fibrous 
scaffolds, flat surfaces and TCP after 5 days. The green fluorescence represented live cells whereas the red 
fluorescence, represented dead cells. Scale bar: 1.0 mm.   






 viability assay of Saos-2 cells cultured on MA-DEGMA photocrosslinked fibrous 
scaffolds, flat surfaces and TCP after 10 days. The green fluorescence represented live cells whereas the 
red fluorescence, represented dead cells. Scale bar: 1.0 mm.   
To further confirm the viability of the cells on the different scaffolds, actin and nuclei (DAPI) 
immunostaining were performed (Figure 4.6). The increase in cell number in the 90:10 
(MA:DEGMA) fibrous scaffolds over 10 days in culture demonstrated in the AlamarBlue® and the 
LIVE-DEAD® assays was also observed here, clearly confirming the scaffolds synthesized support 
cell growth. In addition, to examine the morphological shape of the cells on the MA:DEGMA fibres, 
actin and nuclei (DAPI) higher magnification images were shown (Figure 4.7). At day 10, the 
spindle shape cells on the fibres displayed organized actin filaments indicating cell spreading and 
cells were healthy.  
 




Figure 4.6 Actin and DAPI immunostaining of Saos-2 cells cultured on the 90:10 (MA:DEGMA) 
photocrosslinked fibrous scaffolds, at day 1,5 and 10. Actin filaments are labelled with Alexa-phalloidin 568, 
and appear in red and nuclei are labelled with DAPI, appearing in blue. Scale bar: 1.0mm.   
 
 
Figure 4.7 Higher magnification of actin and DAPI immunostaining of Saos-2 cells cultured on 90:10 
(MA:DEGMA) photocrosslinked fibrous scaffolds at day 10. Actin filaments are labelled with Alexa -phalloidin 
568, appearing in red, and nuclei are labelled with DAPI, appearing in blue. White box indicates higher 
magnification showed in the right image. Scale bar: 200µm. 
The results presented here strongly demonstrate the potential of MA:DEGMA fibrous scaffolds to 
support Saos-2 cell viability and proliferation. The fibrous scaffolds were significantly better in 
promoting cell growth when compared with their equivalent flat surfaces. Amongst the fibrous 
scaffolds, however, the 90:10 (MA:DEGMA) fibres were the ones that presented the highest 
cellular activity. Both cell viability and cell number were significantly higher in the 90:10 scaffolds 
when compared to the other fibrous scaffolds tested. This could be correlated with the most 
uniform fibrous morphology (typical characteristic of electrospun fibres) of the 90:10 scaffolds in 
comparison to other scaffolds, as described in Chapter 3. Badami et al. revealed that MC3T-E1 
cells adhere better in fibres in comparison to smooth flat surfaces [222], which is in agreement with 
our results that show that scaffolds with fibrous features were preferred by Saos-2 cells compared 
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to smooth surfaces. The fibrous architecture can alter the mode of cell anchorage and filopodia of 
the cells [223]. Elements of the fibrous architecture allow filopodia to anchor more tightly, and such 
mode of anchorage could also contribute to enhance the adhesion strength to the fibrous scaffold 
[223]. Interestingly, cell viability and proliferation reduced as fibre diameter size increased due to 
the welding of the fibres with high DEGMA concentrations after PEO extraction.  The effect of 
surface topology on cell response will be discussed in detail in Section 4.4.2 using hMSCs. 
To confirm the orientation and penetration of cells with respect to the fibres, Figure 4.8 shows a 
SEM image of Saos-2 cells cultured on 90:10 (MA:DEGMA) photocrosslinked fibrous scaffolds at 
day 5. The Saos-2 cells do not penetrate into the fibrous scaffold due to the small pore sizes of the 
fibrous scaffold in comparison to the size of the cells. In addition, the cells do not orientate 
themselves to the surface of the fibres. Moreover, Figure 4.12 also shows the lack of hMSCs 
penetration into the scaffold. Hence, one of the major limitations of the acrylate fibrous scaffolds is 
the lack of cell infiltration. The improvement of cell infiltration throughout the scaffold was 
discussed in page 55.    
 
Figure 4.8 SEM image of of Saos-2 cells cultured on 90:10 (MA:DEGMA) photocrosslinked fibrous scaffolds 
at day 5. Scale bar: 30µm. 
 
Contradicting results have been shown in the cytotoxic effects of MA based dental resins, Engel 
[224 ] and Tao [225] research groups presented positive results in cell proliferation on MA based 
matrices while Kojima [226], Nocca [227] and Chang [228] groups showed MA has cytotoxic 
effects on cell viability. The cytotoxic effects are probably due to unreacted monomers leaching out 
from the network rather than the polymer itself. There is a possibility that photocrosslinking of 
resins produces varying levels of crosslinking due to uneven UV light intensity throughout the 
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volume of the sample which may cause some unreacted monomers to be produced and leach out 
in vitro. Cytotoxic effects of free MA monomers were demonstrated by Eiichi Yoshii [229].  
Investigations by About et al. showed decreasing amounts of unreacted acrylate monomers 
improved cell viability and differentiation of human pulp cells into odontoblasts [230, 231].   
Consequently, it is critical that no monomers are leaching out from the fibrous scaffolds and flat 
surfaces investigated in this study. To ensure this, the flat surfaces were washed in acetone and 
ethanol for 5 days. The unreacted monomers were then thoroughly extracted before cell culture 
experiments and the elutant products were collected for 1H-NMR studies.  No monomers or 
photoinitiator were detected in the 1H-NMR (results not shown), which ensures the biological 
response was not affected by monomer leaching.  Also, 1H-NMR studies described in the previous 
chapter showed no monomers and photoinitiator were present in the fibrous scaffold. It is possible 
that, during the PEO extraction process, unreacted monomers leached out. However, this effect of 
monomers leaching is probably less seen in fibrous scaffolds because the UV light intensity 
throughout the fibres is more uniform/constant due to a decreased overall mass and the topology 
of the scaffolds. Moreover, it might be more difficult to extract the unreacted monomers from the 
resin compared to the fibres. 
The type of acrylate monomers used for crosslinking also plays a pivotal role. A study by Imazato 
et al. showed hydroxyethyl methacrylate (HEMA) decreased MC3T3-E1 viability and osteogenic 
differentiation in contrast to the same concentration of triethylene glycol dimethacrylate (TEGMA) 
and methyl methacrylate (MMA) monomers which did not affect growth and differentiation [232]. In 
contrast, another study demonstrated increased cell viability of MG63 osteoblast cells on HEMA 
hydrogels [205]. 
A range of photoinitiators, each with its unique adsorption spectrum, is currently available or being 
developed.  Nonetheless, the production of high-energy radicals generates a potential for oxidative 
damage to the cells [185]. The free radicals can cause cell death by damaging cell membranes, 
nucleic acids and proteins [183, 184]. Irgacure 2959 was selected for the UV electrospinning 
system because it has been shown to have minimal toxicity over a broad range of mammalian cell 
types and species [203]. Bryant et al. investigated the toxicity profile of multiple photoinititors on 
NIH/3T3 fibroblast cell line and demonstrated that Irgacure 2959 had negligible effects on these 
cells viability [233]. Currently, Irgacure 2959 is used ubiquitously in many UV hydrogel systems 
[21, 178, 179, 216, 234].  
The effect of chemistry on Saos-2 viability was also assessed. However, surface morphology took 
precedence in the effect on cell viability when assessed on fibrous scaffolds. The fibres 
morphology was what most significantly affected cell viability. Flat surfaces displayed a different 
trend of increase of cellular viability. The cells growing on the 50:50 ratio (MA:DEGMA) surfaces 
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showed the highest cell viability on flat surfaces, followed by the cells grown in the 70:30 surfaces 
and finally those grown on the 90:10 surfaces. The increase in hydrophilicity of the surface, due to 
increased DEGMA concentration, enhanced the overall cell viability. This result directly contrasts 
the trends of wettability for cell adhesion/behaviour, suggesting the role of other properties of the 
scaffold should be considered.  
 
4.4.2 Determination of the effect of varying MA:DEGMA compositions on hMSCs 
(comparison between fibrous scaffolds and 2D surfaces)  
To further investigate the biological potential of the fibrous scaffolds, their ability to sustain viability 
of hMSCs was evaluated. MSCs are uncommitted cells that are characterized by their ability to 
differentiate in response to specific cues [82, 84].  Many research groups are investigating the 
development of scaffolds for three dimensional MSCs culture. Thus, similarly to what was 
described in the previous section, the effect of varying concentrations of MA:DEGMA fibres and flat 
surfaces on hMSC cell viability was evaluated using total DNA and AlamarBlue® assays.  
Firstly, total DNA assay was performed to evaluate the effect of varying MA:DEGMA ratios on 
hMSCs viability cultured in the fibrous scaffold (Figure 4.9). At day 1, the cell activity of hMSCs 
was clearly reduced by the MA:DEGMA fibrous scaffolds. Total DNA content significantly 
decreased for all MA:DEGMA concentrations in comparison to the control. A slight increase in cell 
viability was observed at day 2 but, similarly to what was seen at day 1, hMSCs viability in the 
fibrous scaffolds was significantly lower when compared to hMSCs cultured in TCP.  
 
 
Figure 4.9 Effect of varying ratios of MA:DEGMA fibrous scaffolds on hMSCs cell viability using total DNA 
assay. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the control (TCP) of the 
same time period is statistically significant (p<0.05). 
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At day 1, the AlamarBlue® results (Figure 4.10) showed a significant reduction of cell viability when 
hMSCs were cultured on both MA:DEGMA fibrous scaffolds and flat surfaces in comparison to the 
control (TCP). Similarly, this trend was observed at days 5 and 10. At day 5, the 50:50 
(MA:DEGMA)  flat surface displayed significantly lower cell viability in comparison to the fibrous 
scaffold with the same chemistry. Interestingly, a concentration-dependent trend was observed. 
MSCs cultured in the 90:10 (MA:DEGMA) fibrous scaffolds showed the highest level of cell activity, 
followed by the 70:30 and finally the 50:50 (MA:DEGMA) scaffolds. This concentration-dependent 
trend was also observed at day 10, both for fibrous scaffolds and flat surfaces. Moreover, hMSCs 
cultured on flat surfaces presented a significantly lower cellular activity when compared to cells 
grown in fibrous scaffolds with an equivalent chemical composition.  
 
 
Figure 4.10 Viability of hMSC cultured on MA-DEGMA photocrosslinked fibrous scaffolds, flat surfaces with 
equivalent compositions and TCP assessed by AlamarBlue
®
 assay. Mean ± SD, n = 3. (*) indicates the 
difference between the marked bar and the control (TCP) of the same time period is statistically significant. 
(¥) indicates that the difference between the marked bar and flat surface with same chemical composition of 
the same time period is statistically significant (p<0.05). 
To further investigate the biological potential of the fibrous scaffolds, their ability to sustain cell 
viability over a longer period was conducted (Figure 4.11). The results obtained displayed no 
significant increase in cell viability at early time-points (1, 5 and 10 days) for all fibrous scaffolds. 
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However, from day 15 onwards, a significant enhancement of hMSC viability was observed for 
cells cultured in the 90:10 (MA:DEGMA) constructs. This enhancement in cell growth was not 
shown for other compositions. Hence, it indicates that, in the long term, the 90:10 ratio 
(MA:DEGMA) scaffolds support hMSCs viability better than the other scaffolds produced.   
 
 
Figure 4.11 Long-term viability of hMSCs cultured on MA-DEGMA photocrosslinked fibrous scaffolds with 
varying MA:DEGMA ratios, using the AlamarBlue
®
 assay. Mean ± SD, n = 3. (*) indicates the difference 
between the marked bar and the control (TCP) of the same time period is statistically significant (p<0.05).  
The attachment and cell morphology of hMSCs cultured on the fibrous scaffolds are shown in the 
high magnification SEM images (Figure 4.12). A reduction in cell number was observed in a 
concentration-dependent manner following MA:DEGMA concentration. The highest cell number 
was observed on the 90:10 (MA:DEGMA) fibrous scaffolds, followed by the 70:30 and finally the 
50:50 (MA:DEGMA) constructs. Clear differences in cell morphology were observed in all 
MA:DEGMA constructs when compared to TCP. The hMSCs cultured on the 90:10 (MA:DEGMA) 
scaffolds exhibited a more spread out morphology, more comparable to the cells grown on TCP. 
However, as DEGMA concentration was increased in the scaffolds, the hMSCs displayed a 
spindle-like morphology. This was especially seen for cells cultured on the 50:50 (MA:DEGMA) 
fibres. Similar results on cell attachment and morphology for the fibres can be seen in the 
immunostaining images in Figure 4.13. 
 




Figure 4.12 SEM 
images of hMSC 
cultured on fibrous 
scaffolds with varying 
ratios of MA:DEGMA 





Figure 4.13 Actin and nuclei 
(DAPI) immunostaining of hMSC 
cells cultured on fibrous scaffolds 
with varying ratios of MA:DEGMA 
at day 10. Actin filaments were 
labelled with Alexa-phalloidin 488, 
appearing in green. Nuclei were 
labeled with DAPI, appearing in 
blue. Scale bar: 100µm. 
 
To determine whether varying ratios of MA:DEGMA and the architecture of the scaffold affects 
hMSCs death, the level of apoptosis was evaluated using the Caspase-glo® assay that measures 
the activity of caspases-3 and -7 (Figure 4.14). Confirming the results obtained with the 
AlamarBlue® assay discussed previously, a significant increase in apoptosis was observed for 
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hMSCs cultured in the MA:DEGMA fibrous scaffolds when compared to the control (TCP). 
Furthermore, at day 5, the MA:DEGMA flat surfaces presented significant higher levels of 
apoptosis if compared to the fibrous scaffolds. This increase in apoptosis levels was more evident 
at day 10, which reflects the decrease in cell viability on flat surfaces in contrast to fibrous 
scaffolds. At day 5, the effect of chemistry on programmed cell death was also observed. As 
DEGMA concentration was increased, for 70:30 and 50:50 (MA:DEGMA) scaffolds, caspases-3 




 assay of hMSCs cultured on MA-DEGMA photocrosslinked fibrous scaffolds, flat 
surfaces and TCP. Cells treated with Staurosporine for 6 hours was used the positive control. Mean ± SD, n 
= 3. (*) indicates the difference between the marked bar and the control (TCP) of the same time period is 
statistically significant. (¥) indicates that the difference between the marked bar and flat surface with same 
chemical composition of the same time period is statistically significant (p<0.05). 
The increase in apoptosis when hMSCS were cultured on the fibrous scaffolds or the flat surfaces 
demonstrated the lower potential of the MA/DEGMA scaffold to support hMSCs attachment and 
viability. This was also evident in the total DNA and AlamarBlue® results, which showed decreased 
hMSCs viability in comparison to TCP. Human MSCs behaviour is markedly different from the 
Saos-2 cells. The MA:DEGMA fibrous scaffolds were able to support viability of Saos-2 cells. This 
difference in overall cell viability could be due to the fact that Saos-2 cells are an immortalized cell 
line and they have the ability to grow for an indefinite number of passages. In addition, a study by 
Chapter 4. Biological evaluation of acrylate fibrous scaffolds with Saos-2 and hMSC cells 
 
 117 
Kilpadi and colleagues has shown that Saos-2 and MSCs use different integrins when adhering to 
serum-coated surfaces and that these cells also display a different preference for selected ECM 
biomolecules [218, 235]. Furthermore, Saos-2 cells and MSCs utilize different mechanisms during 
cell attachment, exhibiting different adhesive behaviours and integrin expression profiles [218]. 
Thus, although the osteoscarcoma cells represent a suitable model for studying osteoblastic 
differentiation on scaffolds, these cells do not mimic the behaviour of MSCs during the stages of 
cellular adhesion to a biomaterial [218]. It is recognized in literature that the attainment of a 
transformed phenotype effects aberrant expression and/or activity of integrin receptors [218, 236-
238]. 
There are only few studies in the literature on electrospinning of monomers. Kim and colleagues 
introduced a novel method of reactive electrospinning whereby 2-hydroxyl methacrylate, 
methacrylic acid, ethylene glycol dimethacrylate, AIBN and a photoinitiator were prepolymerized 
and subsequently photochemically crosslinked during electrospinning [186]. However, no cell 
culture studies were reported in their work. The first study found in literature which developed 
electrospun fibres from monomers and investigated cellular response on the fibres was reported by 
Tan et al. [10]. The authors successfully electrospun photocrosslinked macromers from a library of 
multifunctional poly(β-amino-ester)s, but preliminary cell studies using bovine MSCs have shown 
limited cell adhesion to the fibers, contrary to the results shown in our study [10]. Sundararaghavan 
and his co-workers created multiscale porous scaffolds, utilizing photopatterning and 
electrospining methacrylated hyaluronic acid, to enhance cellular infiltration of hMSCs. However, 
cell viability was demonstrated to be significantly low [187]. The low cell adhesion observed in their 
investigation could either be due to cytotoxic effects of the macromer itself or to the presence of 
PEO. Failure of PEO extraction would cause PEO to block protein adhesion, which would 
consequently affect cell adhesion. Such effect was not shown in the present investigation.  
Subsequently, the same research group increased the viability and proliferation of hMSCs by using 
photocrosslinkable acrylate-poly(glycerol sebacate) and co-electrospinning with gelatin instead of 
PEO [177].    
The data presented here showed that surface architecture of the scaffold significantly affected 
viability and apoptosis of both Saos-2 and hMSC cells. Specifically, the 90:10 (MA:DEGMA) 
fibrous scaffolds were shown to better enhance cell activity, followed by the 70:30 and finally the 
50:50 (MA:DEGMA) scaffolds. The fibrous morphology was preferred by both Saos-2 and hMSC 
cells when compared to flat surfaces. Furthermore, as fibre diameter size increased due to the 
welding and swelling of the fibres with high DEGMA concentrations after PEO extraction¸ cell 
viability and proliferation decreased considerably. It is well known that cells respond differently to 
various topographic substrates and to the geometry of the surfaces [239-242]. In vivo, cells are 
enveloped by nanostructures, formed by biomolecules organized in different arrangements, when 
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interacting with other cells or with the ECM [242]. Numerous studies have shown topography 
influences cell adhesion and proliferation [222, 224, 239, 243, 244]. Surface architecture can alter 
the mode of cell anchorage and filopodia of the cells have been reported to direct certain 
structures [223]. Elements of the surface architecture allow filopodia to anchor more tightly, and 
such mode of anchorage could also contribute to enhance the adhesion strength to the fibrous 
scaffold [223]. Thus, the role of scaffolds is more than that of offering mechanical support but also 
act as surfaces providing topographical cues to influence cell adhesion, spreading, proliferation 
and even differentiation [241, 242].  Engel and colleagues have shown that microstructured poly 
(methyl-methacylate) promoted rat MSC adhesion and induced osteogenic differentiation in 
comparison to flat surfaces [224]. Hence, the results presented in this chapter are in agreement 
with these studies.  
The effect of surface chemistry on hMSC cellular activity was observed for all fibrous scaffolds 
produced. However, surface morphology (the presence of fibrous surfaces) took precedence in 
affecting cell viability, as it was described above. A trend of enhanced cell proliferation was 
observed with increased scaffold hydrophobicity, as MA concentration was increased for both 
fibrous and flat surfaces. The increase in hydrophobicity with increasing MA content on flat 
surfaces was investigated and described in Section 3.4.7 (page 94). This is in agreement with the 
work of Metter et al., that showed that hMSCs activity was dependent on chemistry, using a library 
of photopolymerizable poly (β-amino ester)s [245]. This is likely to be because of differences in 
protein adsorption on the surfaces, which regulates adhesion to the scaffold [245]. It is established 
that protein adsorption is higher on hydrophobic surfaces and decreases on hydrophilic surfaces 
[246, 247] [245]. This has been further confirmed with protein absorption studies conducted and 
described in the next section. 
 
4.4.3 Determining the effect of varying MA:DEGMA compositions on protein 
adsorption (comparison between fibrous scaffolds and 2D surfaces) 
Protein adsorption is the first step that occurs when a foreign surface is placed in contact with 
blood [94]. Therefore, understanding the mechanism of protein adsorption is pivotal for the design 
of biomaterials surfaces. Protein adsorption to all fibrous scaffolds and flat surfaces synthesized 
was assessed. For this purpose, fibrous samples were incubated in 25% (w/v) FBS for four hours 
and the adsorbed proteins were later extracted with 1% (w/v) sodium dodecyl sulphate (SDS) and 
assessed using the BCA assay. Both fibrous scaffolds and flat surfaces displayed significantly 
lower protein adsorption compared to TCP (Figure 4.15). However, the fibrous scaffolds adsorbed 
higher amounts of serum proteins than the flat surfaces. This was most evident for the 90:10 
(MA:DEGMA) ratio constructs, whereby the protein adsorption of the flat surface decreased to half 
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when compared to the fibrous scaffold. This interesting data gives evidence that the fibrous 
architecture can alter protein adsorption.  
In addition, the 50:50 (MA:DEGMA) ratio exhibited lowest protein adsorption compared to different 
chemical concentrations for both fibrous and flat samples. Such low protein adsorption could be 
due to decreased hydrophobicity of the samples as DEGMA concentration is increased. The 
changes in hydrophobicity of flat surfaces were observed as DEGMA concentration was increased. 
This was investigated and described in Section 3.4.7 (page 94). In general, hydrophobic surfaces 
tend to adsorb larger amounts of proteins than hydrophilic surfaces [94, 246]. This is explained by 
the fact that high water levels within the surface of the materials encourage a low interfacial energy 
and reduce both protein adsorption and cell adhesion on the polymeric surface [94].    
Exposure of a biomaterial to a biological environment causes immediate adsorption of proteins to 
its surface [248, 249]. It has been demonstrated that the material surface characteristics governs 
the type, amount and conformation of the adsorbed proteins and moreover the cell-mediated 
protein turnover [118, 246, 250, 251]. Hence, a critical feature in influencing the response of cells 
with the material surface and to its performance in vitro and in vivo is the composition and 
conformation of the adsorbed proteins [246].  
Therefore, protein adsorption results could also explain the higher cell viability of both Saos-2 cells 
and hMSCs on fibrous scaffolds observed in the total DNA and Alamarblue® assays. Most cells are 
anchorage-dependent and need attachment to the substrate for maintenance of viability and 
growth [252]. In consequence, the early occurrences that happen when a cell contacts a surface 
are critical [253]. It is established that cell adhesion and successive cellular events are regulated 
by proteins adsorbed onto biomaterial surfaces [94, 252]. Therefore, this suggests that the 
electrospun scaffolds offer a more favourable environment for cells due to their fibrous features. 
The fibrous morphology of the scaffolds can increase cell adhesion to the fibrous scaffolds through 
enhanced protein adsorption [223, 253]. The improvement of protein adsorption for scaffolds with 
fibrous architecture was demonstrated by Woo and co-workers [253]. The author demonstrated 
that PLLA nanofibrous scaffolds adsorbed four times more proteins than scaffolds with solid walls 
[253], which could be due to higher surface-to-volume ratio of fibrous scaffolds. 
 




Figure 4.15 Protein adsorption studies on MA:DEGMA photocrosslinked fibrous scaffolds, flat surfaces and 
TCP. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the control (TCP) of the 
same time period is statistically significant. (¥) indicates that the difference between the marked bar and flat 
surface with same chemical composition of the same time period is statistically significant (p<0.05). 




The present chapter describes cell studies performed with the acrylate fibrous scaffold developed 
and described in the previous chapter. These studies were intended to evaluate the effect of 
varying ratios of MA:DEGMA of the fibrous scaffold on the viability of two different cell types, 
namely Saos-2 and hMSCs. Additionally, the effect of surface morphology on cellular activity was 
assessed by comparing the fibrous scaffolds to flat surfaces with equivalent chemical 
compositions. Lastly, the response of protein adsorption to all fibrous scaffolds and flat surfaces 
was evaluated. 
The results presented here strongly demonstrated the potential of MA:DEGMA fibrous scaffolds to 
support Saos-2 cell viability and proliferation. In agreement with literature, the MA:DEGMA 
photocrosslinked fibres increased the viability of Saos-2 cells in comparison to flat surfaces with 
similar chemistry. However, the considerable increase in apoptosis of hMSCS cultured on both 
fibrous and flat samples suggested a lower potential of the MA:DEGMA scaffold to support hMSCs 
cell attachment and viability. This was also evident in cell activity results, which showed decreased 
hMSCs viability in both the fibrous scaffolds and the flat surfaces when compared to TCP. On the 
other hand, to further investigate the biological potential of the fibrous scaffolds, their ability to 
sustain cell viability over a longer period of time was evaluated. From day 15 onwards, a significant 
increase in cell viability was observed for hMSCs cultured on the 90:10 (MA:DEGMA) fibres. Such 
a result was not observed for the other fibre compositions. Hence, this gives evidence that the 
90:10 (MA:DEGMA) fibrous scaffolds could potentially support hMSCs viability better than the 
other scaffolds produced.   
Furthermore, amongst the fibrous scaffolds and flat surfaces, the 90:10 (MA:DEGMA) fibres 
presented the highest cellular activity for both Saos-2 and hMSCs, which could be correlated to 
them displaying the best fibrous morphology compared to all the scaffolds (shown in Chapter 3).  
Hence, as it has shown the highest cell response, uniform fibrous morphology and capability of 
maintaining mechanical integrity, the 90:10 (MA:DEGMA) composition was chosen as the best 
fibrous scaffold for bone tissue engineering purposes among the different compositions analysed. 
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CHAPTER  5 
5 Functionalization of 
acrylate scaffolds with cell 
adhesive peptides - DGEA 
and RGD 
 




Biomaterial scaffolds can be designed and developed to interact with cells by mimicking key 
molecular events of the ECM [7]. ECM is comprised of many bio-macromolecules such as 
collagens, proteoglycans, laminins and fibronectin and it is mainly this biological information which 
is responsible for ECM bioactivity [7, 26]. Interaction of integrins which are receptors on the cell 
surface with specific ECM molecules can activate signalling pathways leading ultimately to gene 
expression [27, 28]. The variety of ECM proteins presented to cells in a specific tissue is pivotal in 
regulating how cells function within that tissue type [7].  
One approach to include sites of integrin binding in biomaterials is to incorporate purified ECM 
proteins for example fibrin and collagen [7]. However, supplementing full proteins to scaffolds can 
be challenging to execute as proteins are susceptible to denaturation and degradation [29]. For 
this reason, a frequently used technique to enhance cell adhesion is to integrate short peptide 
motifs or analogues derived from binding regions of ECM components [7]. While they may only 
have a fraction of the activity of the complete protein, they can be incorporated at very high 
concentration and increase the overall activity of the peptide. Moreover, peptides are easy to 
synthesize and functionalize. Hence, bioactive peptides offer a synthetic and scalable alternative to 
complex ECM proteins [30]. 
The widely used Arg-Gly-Asp (RGD) peptide sequence present in various ECM proteins, including 
fibronectin, laminin, collagen I, fibrinogen and vitronectin was studied as a mode of enhancing cell 
adhesion by inducing focal adhesion through integrin interaction on biomaterial surfaces as early 
as the 1980‘s [31, 32]. Since then RGD has been functionalized into an extensive range of 
surfaces, scaffolds and hydrogels (reviewed in [33], [34] and [35]). The binding specificity of the 
peptide to cell surface integrins receptor can be enhanced by flanking peptides, peptide 
conformation and immobilisation strategies [33, 35, 132]. Higher affinities for integrins can be 
improved by flanking the key peptide sequence with extra amino acids such as glycine [35]. For 
example, GRGDS is the most commonly used RGD sequence [254].  
DGEA (Asp-Gly-Glu-Ala) is a collagen type 1 peptide sequence and has displayed specific binding 
affinity for osteoblasts via the α2β1 integrin. In addition, DGEA has been shown to induce 
osteogenic differentiation [36-38]. Therefore, DGEA could be used to promote cell adhesion and 
control differentiation [38]. Nevertheless, the cellular response of collagen-derived peptides has 
been relatively less studied compared to other ECM peptides, while full collagen has been mostly 
applied for making scaffolds [39-41].  Moreover, it has been revealed that collagen I interacts with 
different integrin receptors than that of fibronectin and the integrin/collagen I binding is RGD-
independent [42].   
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There are numerous strategies for immobilising peptide sequences on materials. One of the key 
advantages of the UV electrospinning system investigated here (electrospinning of acrylate 
monomers and post-crosslinking (refer to section 3.3.3)) is the capability of conjugating peptides in 
a simple yet elegant and potentially efficient ―one pot synthesis‖ manner. In this chapter, the 
research will focus on using cysteine-functionalized RGD or DGEA peptide sequences in 
combination with MA/DEGMA monomers and employing a photoinitiated mixed-mode 
polymerization mechanism. Specifically, the acrylate monomers/crosslinkers are mixed with the 
cysteine-conjugated RGD or DGEA peptides and electrospun. During UV radiation, the reaction 
mechanism consists of two reactions, acrylate homopolymerization and the thiol-acrylate step 
growth reaction widely known as thiol-ene reaction [140, 141]. The reaction sequences are 
summarized below: 
 
RSH + R·        RS· + R‘H                            (Step 1) 
RS-H          RS· + H·                (Step 2) 
H· + H·        H2 
RS· + R‘CH=CH2         R‘C·H      CH2          SR                                       (Step 3) 
R‘C·H      CH2         SR + RSH         R‘CH2     CH2       SR +RS·         (Step 4) 
 
R‘C·H     CH2       SR + R‘CH=CH2                R‘CH-CH2-SR                       (Step 5) 
                                                                             R‘C·H     CH2          
 
The polymerization is initiated photochemically and progresses through the reactions outlined 
above. The radical can be generated by radical abstraction from the photoinitiator and also 
simultaneously by photochemical S-H bond cleavage (steps 1 and 2), this is followed concurrently 
by step growth reactions (steps 3 and 4), the thiol-acrylate or more generally thiol-ene reaction. 
Next, this is followed by the acrylate homopolymerization (step 5) [140, 141, 255]. 
As previously described in Chapters 3 and 4, photocrosslinked fibres were successfully developed 
by electrospinning different MA and DEGMA compositions and post-UV crosslinking. Varying MA 
and DEGMA concentrations affected the overall fibre morphology, swelling and the mechanical 
properties of the fibrous scaffold. In addition, studies described in the same chapter determined the 
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optimal range of parameters required to produce uniform and bead-free electrospun MA/DEGMA 
fibrous scaffolds. Moreover, the results presented in Chapter 4 provided strong evidence that 
MA/DEGMA fibrous scaffolds can support Saos-2 cell viability and proliferation. However, the 
considerable increase in apoptosis of hMSCs for all fibrous scaffolds and flat samples 
demonstrates lower potential of the MA/DEGMA scaffolds to support hMSCs attachment and 
viability. Hence, to increase the overall bioactivity of the scaffold, conjugation of signalling peptides 
onto the scaffold was investigated. In this chapter, the development of electrospun polyacrylate 
scaffolds conjugated with biological active peptides, RGD and DGEA, will be described.  
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5.2 MATERIALS  
Aluminium Scanning Electron Microscopy (SEM) pin stubs and adhesive carbon tape were 
purchased from Agar Scientific (UK). Ten ml Becton Dickinson plastic syringes and 27G Becton 
Dickinson disposable needles were from Cole Palmer (UK). Ellman‘s and OPA assays were 
purchased from Thermo Scientific (UK). The high voltage supply was acquired from Glassman 
High Voltage Inc. (UK), the UVB lamp (Transilluminator 2000) from Biorad (UK) and single-syringe 
infusion pump (230 VAC) and static fibre collector (labarotory jiff-jacks) from Cole-Parmer (UK). 
Amino acids were purchased from AGTC Bioproducts (UK) or Novabiochem, (UK). Ninhydrin 
assay, poly(ethylene oxide) (PEO)(200kDa) (95.5%), methyl acrylate (MA) (99%), diethylene glycol 
dimethacrylate (DEGMA)(95%), 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 
2959) (98%), trifluoroacetic acid (TFA) (≥99%), diethyl-ether (DEE) (≥99%) were obtained from 
Sigma Aldrich (Poole, England). All chemicals were used as received and stored in a dry and dark 
environment to maintain photoreactivity.  
 
5.3 METHODS 
5.3.1 Synthesis of Peptides 
The peptides, CGDGEA (cysteine-glycine-aspartic acid-glycine-glutamine-alanine, N-terminus to 
C-terminus) and CGRGD (cysteine-glycine-arginine-glycine-aspartic acid, N-terminus to C-
terminus) were synthesized using a Solid Phase Peptide Synthesis (SPPS) [256] using Fmoc-
protected amino acid monomers and HOBt/HBTU activation on a peptide synthesiser 433A 
(Applied Biosystems, UK). In each coupling step, a 10-fold excess of amino acids was used. After, 
the peptide sequences were cleaved from the resin and deprotected using trifluoroacetic acid 
(TFA), phenol and diethyl ether (DEE) before they were desiccated for 2 days. The dried product 
was redissolved in dH2O and lyophilized. Molecular weight and purity of the peptide were 
determined by high performance liquid chromatography (HPLC) system model GX-271 (Gilson, 
Sweden) and matrix-assisted laser desorption/ionization (MALDI) mass spectrometry courtesy of 
the Chemistry Department, Imperial College London, using a MALDI micro MX (Micromass, UK). 
HPLC analysis showed that the purity of the peptides was ≥95% and MALDI-ToF mass spectral 









Figure 5.1 Chemical structure of the peptides used in this study, CGDGEA and CGRGD. 
 
5.3.2 Preparation of peptide conjugated electrospun fibres 
The preparation of the acrylate scaffold was illustrated in Chapter 3 (Section 3.3.3) however in this 
chapter with the addition of cysteine-conjugated peptides (Figure 5.1). One refers to Table 3.2 in 
Chapter 3 (page 81) for details on electrospinning solution and parameters. The conditions 
identified for the (90:10) mol% MA:DEGMA concentration was used for all the scaffolds in this 
chapter. The peptides were added at different concentrations (0.5, 1, 2 and 5 mol%) to the 
MA:DEGMA composition.  
Briefly, the monomer mixtures were prepared by mixing (90:10) mol% of methyl acrylate (MA) and 
diethylene glycol diacrylate (DEGMA) and varying concentrations of peptides (0.5, 1, 2 and 5 
mol%). Next, 0.1 mol% 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959) 
was added to the solution. Then, 10% (w/v) PEO concentration in ethanol mixture was added to 
the solution and mixed thoroughly for 30 minutes with help of a magnetic stirrer. The 
electrospinning solution was added into a syringe with a 27-gauge blunt-ended needle. Next, 
electrospinning was carried out in the set-up described previously in Section 3.3.3. The fibres were 
immediately exposed to UV light for 10 minutes using a UVB (302nm) lamp in an oxygen free 
environment. After photocrosslinking, PEO from the scaffold is extracted from the scaffold by 
repeated washing with water for 5 days. The process of producing the photocrosslinked peptide 
immobilized fibrous scaffolds with in situ peptide conjugation is shown in the schematic below 
(Figure 5.2). 
 




Figure 5.2 Schematic of the preparation of a photocrosslinked fibrous scaffold with in situ peptide 
conjugation. The fibrous scaffolds were produced by electrospinning monomer mixtures prepared by mixing 
(90:10) mol% of methyl acrylate (MA) and diethylene glycol diacrylate (DEGMA) and varying concentrations 
of peptides (0.5, 1, 2 and 5 mol%). Next, 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 
2959) was added to the solution. Then, 10% (w/v) PEO concentration in ethanol mixture was added to the 
solution and mixed thoroughly for 30 minutes with help of a magnetic stirrer. Subsequently, the fibres were 
photocrosslinked by exposure to UVB, which induces a photoinitiated mixed-mode polymerization 
mechanism to conjugate the peptides. Finally, PEO was extracted by repeated washing with water. 
 
5.3.3 Ninhydrin assay 
Ninhydrin (2,2-dihydroxyindane-1,3-dione) is a chemical used to specifically determine the 
presence of primary amine groups. The reaction of ninhydrin with primary amine groups produces 
a dark blue (Rheumann‘s Blue) colour. The assay was performed as previously described [117, 
257] to quantitatively detect the amount of amine groups on scaffolds. Briefly, the scaffolds and 
controls were immersed in 1M ninhydrin solution for 6 hours in glass vials. The vials were then 
incubated at room temperature for 4 hours, placed on an orbital shaker, to ensure the reaction 
occurred between ninhydrin and the amine groups on the scaffolds. The scaffolds were then 
removed and the absorbance of the solution was measured at 570nm, on a microplate reader 
(Spectramax M5, Molecular devices). A calibration curve was obtained using glycine standards 
(please refer to Appendix for protocol). The amount of free amine measured was compared to the 
initial concentration of free amine in the soluble fraction solution prior to UV crosslinking to 
determine the percentage of peptide incorporation.  
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5.3.4 Fluoraldehyde (OPA) assay 
OPA (o-phtalaldehyde) reagent is a primary-amine fluorescent detection reagent. When OPA 
interacts with primary amines in the presence of mercaptoethanol, OPA produces an intense blue 
colour fluorescent that has an excitation wavelength of 340nm and emission at 455nm [258, 259].  
The assay was performed accordingly to the manufacturer‘s instructions. The scaffolds and 
controls were immersed in OPA solution for 1 hour in glass vials, in a dark room.  The scaffolds 
were then removed and the fluorescence of the solution was measured at excitation at 330-390nm 
and emission at 436-475nm, on a microplate reader (Spectramax M5, Molecular devices). A 
calibration curve was obtained using glycine standards (please refer to Appendix for protocol). The 
amount of free amine measured was compared to the initial concentration of free amine in the 
soluble fraction prior to UV crosslinking to determine the percentage of peptide incorporation. 
 
5.3.5 Ellman’s assay 
The Ellman‘s reagent [260], which contains 5-5‘-dithio-bis(2-nitrobenzoic acid) and is also known 
as DNTB, is a chemical used for measuring free sulfhydryl groups in solution. A solution of DNTB 
yields a yellow-colour sample when it interacts with sulfhydryls. DNTB reacts with free sulfhydryl 
molecules to produce a mixed disulfide and 2-nitro-5-thiobenzoic acid (TNB) product. The amount 
of sulfydryl groups in a sample can be calculated by using a standard curve comprised of known 
concentrations of a sulfhydryl solution, such as cysteine. The assay was performed as indicated by 
the manufacturer. Briefly, the scaffolds and controls were immersed in the Ellman‘s reagent 
solution, which contained Ellman‘s reagent and reaction buffer solution, for 3 hours in glass vials, 
at room temperature and placed on an orbital shaker. The scaffolds were then removed and the 
absorbance was measured at 412nm, on a microplate reader (Spectramax M5, Molecular 
devices). A calibration curve was obtained using cysteine standards (please refer to Appendix for 
protocol).The amount of sulfydryl groups measured was compared to the initial concentration of 
free thiols prior to UV crosslinking to determine thiol conversion. 
 
 
5.3.6 Surface analysis of CRGD conjugated scaffolds using Time of Flight-
Secondary Ion Mass Spectrometry (ToF-SiMS)  
The ToF-SIMS investigation on the surface of the RGD-conjugated scaffolds was analyzed by Nia 
Bell, another Ph.D. student from Prof. Stevens‘s group. Samples were prepared by electrospinning 
cysteine-conjugated peptide and acrylate monomer mixtures as described in the previous section 
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(Section 5.3.2). Importantly, samples were electrospun as thinly as possible, 10 – 20 µm on 
aluminium foil. After UV post-crosslinking and PEO extraction, the samples were sectioned into 1x 
1 cm2 dimensions and mounted on silicon wafer chips and the samples were stored under nitrogen. 
The samples were analyzed within 24 hours. ToF-SIMS analysis was carried out on an IonTOF V 
instrument (IONToF, Germany) using a 25 keV Bi3
+ primary ion from a liquid metal ion gun (LMIG). 
Positive ion mass spectra from 100µm x 100µm were collected in the high current bunched mode 
(HCBM) with a typical mass resolution of 7,000 for the C2H5O
+ ions at m/z 45. All spectra were 





+ . Chemical maps were 
acquired in burst alignment mode (BAM). The fibres were imaged over 50 µm x 50 µm with 256 x 
256 pixels with 20 shots per pixel. All spectra were normalised to CHO+, an intense polymer 
derived ion peak. It also normalised for the variable fibre coverage in each analysis area. To 
display the main findings of the imaging experiment, RGB plots were produced in the IonToF 
software. A polymer, a peptide and a substrate derived ion were normalised and allocated to the 
red, green and blue channels respectively. Triplicates of each sample were prepared and high 
resolution spectra from twelve areas across these were used to investigate the effect of peptide 
concentration on the peptide derived ion intensities. The areas under the peaks of interest, 
including those corresponding to the CH4N
+ and C4H8N
+ ions, were normalised to that of CHO+, 
averaged and recorded along with their associated standard error as a function of peptide 
concentration. 
 
5.3.7 Morphology analysis of SEM 
Fibres produced by electrospinning were examined using scanning electron microscopy (SEM) to 
analyse fibre morphology and determine approximate fibre diameter. Samples of approximately 
1.5cm2 were placed on adhesive carbon tape and attached to aluminium SEM pin stubs. The 
samples were sputter coated with chromium. The LEO 1525 Gemini SEM was operated at an 
accelerating voltage of 5kV. 
 
5.3.8 Mechanical testing of fibrous scaffolds 
The electrospun membranes where cut into rectangular shape with dimensions of 10 x 3 cm2 (n= 
10). Uniaxial tensile testing was performed using an Instron Model 5540 with a 50N load cell with 
constant deformation (5mm/min) on the PEO extracted samples, dried and hydrated (after 
incubation in deionised water for one hour). Tensile extension and reactive forces were recorded 
using the Bluehill 2 software, and Young‘s modulus (E) was calculated from the linear region of the 
stress-strain curves. 
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5.3.9 Swelling test 
The swelling test was conducted as described in [191] and in Chapter 3 (Section 3.3.10). Briefly, 
PEO extracted electrospun samples were cut into rectangular shape with dimensions of 10 x 3 cm2 
(n= 5). The fibres were immersed in distilled water and incubated for 6 hours. The wet weight of 
each sample was measured every hour prior to placing the samples in the vacuum oven at 60°C 
overnight and weighed again. The dry weight of the samples was determined. 
Mass swelling percentage = (wet weight/dry weight) x 100%.  
 
5.3.10 In vitro degradation of scaffolds 
The in vitro degradation study was performed as described in [177] but with longer experimental 
duration. Five mol% CGDGEA and unfunctionalized scaffolds were used in this study. Briefly, PEO 
extracted electrospun membrane samples were cut into a rectangular shape with dimensions of 10 
x 3 cm2 (n = 5). The dry scaffolds were weighed before incubating the scaffolds in 150mM NaCl 
PBS and placed on an orbital shaker at 37°C. The buffer was changed every week to maintain the 
accelerated degradation conditions. At each time point (2, 4, 8, 12 and 16 weeks) samples were 
removed and dried in a vacuum oven at 60°C overnight and weighed afterwards. The dry weight of 
the samples was determined. 
Mass loss (%) = ((gd – g0)/ g0) x 100 
g0 = initial mass before incubation 
 
5.3.11 Statistical analysis 
All experimental data shown were expressed as mean ± SD and were obtained from experiments 
performed in at least in triplicates. All data analysis was performed in Excel. Statistical analysis 
was performed with one-way analysis of variance (ANOVA) using multiple comparisons 
(Bonferonni test) and significance was determined by p<0.05. This analysis was performed with 
Graph Pad InStat software.  
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5.4 RESULTS AND DISCUSSION 
Chapters 3 and 4 described the development of MA/DEGMA photocrosslinked fibrous scaffolds by 
electrospinning different MA and DEGMA ratio compositions and post-UV crosslinking. The 
photocrosslinked scaffolds produced were characterized and the cellular response to the fibres 
was investigated. The results obtained provide strong evidence for the potential of MA/DEGMA 
fibrous scaffolds to support Saos-2 viability and proliferation. However, the considerable increase 
in apoptosis of hMSCS grown in all fibrous scaffolds and flat samples demonstrates the rather poor 
ability of the MA/DEGMA scaffold to support hMSCs attachment and viability. This was also 
evident in the cell activity assays, which showed decreased hMSCs metabolic activity assessed by 
Alamarblue® assay in comparison to the negative control, TCP. Hence, to increase the overall 
bioactivity of the scaffold, the effect of conjugating CGDGEA and CGRGD peptides onto the 
acrylate scaffolds was investigated.  
This chapter is divided into four main sections. Firstly, immobilization of DGEA and RGD peptides 
on the acrylate fibrous scaffolds by mixed-mode thiol-acrylate photopolymerization was analyzed 
by varying cysteine-conjugated DGEA and RGD concentrations. Next, the morphology, swelling, 
mechanical and degradation behaviour of the functionalized acrylate scaffolds was investigated. 
Subsequently, the presentation of peptides on the surface of the scaffolds was studied using ToF-
SIMS. Lastly, the effects of varying the glycine spacer length on peptide immobilization on the 
scaffolds were assessed.  
As described previously in Chapter 3, Section 3.3.3, post-photocrosslinking was method chosen to 
obtain a scaffold made up of acrylate fibrils by employing UV radiation to initiate polymerization 
after electrospinning. In this chapter, the CGRGD and CGDGEA peptides were incorporated into 
the fibrous scaffold through a photoinitiated thiol-acrylate reaction with the thiol groups located on 
the cysteines. This reaction was previously described in [141]. The preparation of the acrylate 
scaffold was illustrated in Chapter 3 (Section 3.3.3) however in this chapter with the addition of 
cysteine-conjugated peptides. The conditions identified for the (90:10) mol% MA:DEGMA 
concentration was used for all the scaffolds in this chapter. The peptides were added at different 
concentrations (0.5, 1, 2 and 5 mol%) to the MA:DEGMA composition. These different 
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5.4.1 Determination of the effect of varying peptide concentration on overall 
peptide incorporation 
5.4.1.1 Measurement of peptide incorporation by measuring free primary amine  
Both the amount of peptide presented to the cells and the degree of functionalization are essential 
parameters that influence the success of a system as a cell adhesive material [35]. The 
approximate final concentration of peptides in a scaffold can be regulated by the feed 
concentration [35]. In addition, the concentration of the peptide can be regulated by varying the 
ratio of peptide-containing thiol monomer with acrylate co-monomers during synthesis of the 
scaffold. Hence, the thiol-acrylate peptide functionalization was studied with varying cysteine-
conjugated DGEA and RGD concentrations (Figure 5.3). This was performed by determining the 
amount of primary amine groups on the scaffolds, which was performed using the ninhydrin and o-
phthalaldehyde (OPA) assays. The final amount of unreacted amine measured was compared to 
the concentration of free amine prior to UV crosslinking. The CGDGEA and CGRGD peptide 
sequences were utilized for this study. The glycine amino acid was chosen in the peptide 
sequence to study the reactivity of the thiol groups with the presence of glycine during the thiol-
acrylate polymerization. Glycine was used as a spacer residue to increase bioactivity of the 
peptide sequence, this will be described further in Section 5.4.7 and in Chapter 7 (Section 6.4.3). 
Determination of the peptide incorporation into the scaffolds was attempted using ATR-FTIR but 
clear differences in IR-spectra were not detected and could not be analyzed quantitatively (data 
now shown).  
Figure 5.3 shows that no significant differences in peptide incorporation were observed for both 
CGRGD and CGDGEA peptides between all peptide concentrations tested. The cysteine-
conjugated peptides showed above 85% of peptides were incorporated into the scaffolds. The only 
exception was displayed for 0.5 mol% concentration of both CGRGD and CGDGEA peptides, 
which showed 82% and 78% conjugation, respectively. However, complete peptide incorporation 
(100%) could not be achieved. Both ninhydrin and OPA assays gave very small differences in 
amine concentrations but the ninhydrin assays showed slightly higher amine measurements. This 
could be due to difference in the sensitivity of the assay. A qualitative method, using ninhydrin 
spray was also used to successfully confirm peptide immobilization on the surface of the scaffold 
(results not shown). These results prove that a very large proportion of peptides were incorporated 









Figure 5.3 Variation of peptide incorporation of either CGRGD or CGDGEA with different concentrations of 
peptides (0.5, 1, 2 and 5 mol%) onto 90:10 MA:DEGMA scaffolds using ninhydrin and OPA assays. Mean ± 
SD, n = 3.  
The measurement of peptide incorporation was further confirmed by quantifying the free sulfhydryl 
groups in solution using the Ellman‘s assay (Figure 5.4). The amount of thiol conversion measured 
was compared to the initial concentration of free thiol, prior to UV crosslinking. No significant 
differences in thiol conversion (around 85%) were observed between all peptide concentrations 
tested above 1 mol% for both CGRGD and CGDGEA peptides. Moreover, no significant 
differences were found between peptide incorporation of the CGDGEA and CGRGD peptides. A 
decrease in thiol conversion was however shown for the lowest peptide concentration tested (0.5 
mol%) for both peptides, but was with no statistical significance. This may be due to the assay‘s 
sensitivity to low concentrations.  





Figure 5.4 Determination of thiol conversion of peptides of either CGRGD or CGDGEA with different 
concentrations of peptides (0.5, 1, 2 and 5 mol%) onto 90:10 MA:DEGMA using Ellman‘s assay. Mean ± SD, 
n = 3.  
The ninhydrin, OPA and Ellman‘s assay results herein demonstrated that both peptides, CGRGD 
and CGDGEA, could be efficiently conjugated into the fibrous acrylate scaffolds, for all different 
peptide concentrations, using a thiol-acrylate reaction. Complete peptide incorporation (100%) 
could not be achieved for any of the scaffolds. Salinas and co-workers reported a higher degree of 
peptide incorporation (  95%) using the thiol-acrylate conjugation to conjugate thiol-presenting 
peptides copolymerized with PEG diacrylate hydrogels [141]. In addition, Salinas and Anseth 
reported a final concentration of   1mM of CGRGD peptides conjugated on a PEG-hydrogel system 
using a fluoraldeyde assay which is based on amine measurements similar to ninhydrin and OPA 
assay utilized in our study [135]. The higher degree of peptide incorporation in their studies may be 
due to the high concentration of thiol-peptides added into the hydrogel system, 20% overall thiol-
peptide concentration in comparison to monomers in comparison to the studies investigated here 
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[141]. Nonetheless, the peptide incorporation displayed is comparable to other studies using other 
peptide immobilization chemistries. Using NHS chemistry, 80% of an RGD-containing peptide 
derivatised with acrylamidohexanoic acid was incorporated when copolymerized with acrylamide 
and bisacrylamide to form crosslinked gels [31]. Also, the incorporation of different peptides into a 
poly(ethylene glycol)-diacrylate (PEGDA) hydrogel was investigated by Hern and Hubbell, who 
found that acrylol-PEG-YGRGDS was incorporated with 84% efficiency [134]. However, these 
reactions are mechanistically different because these studies utilized vinyl monomers which are 
conjugated to peptide sequences which will affect the location (in the backbone of the polymer) 
and presentation of the peptides in the polymer network. Whereas in our study, the use of mono-
thiol peptides was utilized, subsequently the peptides will always be incorporated at the chain start. 
Several studies have utilized mixed-mode thiol-acrylate polymerization especially for the 
production of hydrogels. Rydholm and colleagues described the production of degradable thiol-
acrylate networks in physiological conditions under exposure to UV light with or without presence 
of a photoinitiator [142, 143]. Also, work from the same group, by Reddy et al., reported the 
modelling results on the formation and degradation of the thiol-acrylate networks by 
copolymerization of the thiol monomer with PLA-b-PEG-PLA-based diacrylate macromers [261]. 
The conjugation of peptides through the mixed-mode thiol-acrylate photopolymerization for 
synthesis of PEG-peptide hydrogels was introduced by the same research group [135, 141]. 
Melkoumian and colleagues have demonstrated the synthesis of surfaces made of acrylates-
conjugated to biologically active peptides for the culture of undifferentiated hESCs though levels of 
peptide immobilization were not reported [30]. Peptides derived from active domains of ECM 
proteins, such as bone sialoprotein, vitronectin, laminin and long or short fibronectin, were 
conjugated using EDC/NHS chemistry [30]. 
Alternatively, cysteine-conjugated peptides have been immobilized into hydrogels through Michael-
type addition [262-264]. However, this reaction requires a careful balance and tuning of the thiol-
acrylate ratio to allow controlled crosslinking and the reaction time is relatively slow compared to 
radical-mediated photopolymerization [141]. Herein we have utilized the thiol-acrylate 
polymerization in the UV-electrospinning system to produce RGD and DGEA peptide-
functionalized fibrous acrylate scaffolds. This method provides a facile and robust way to 
incorporate peptides into electrospun scaffolds without the requirement to chemically modify the 
functional peptide motifs.  Moreover, it allows for rapidly incorporating peptides into the fibrous 
scaffolds at relatively low quantities without the need for a second di-thiol to copolymerize. In 
addition, the mixed-mode thiol-acrylate approach has the advantage by introducing the peptide at 
the chain start to control the level of incorporation onto the scaffold.  
It is important to note that there are many analytical methods and representations of the amount of 
peptide immobilized onto the scaffolds in the literature making quantitative comparisons between 
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the scaffolds developed here and other systems difficult. The nature of the scaffolds should have 
an impact on the level of quantification based on the same assay. Correspondingly, even if the 
same methodology for reporting quantification has been used, difference in degrees of swelling or 
bulk or surface modifications mean that actual ligand densities or concentrations can be different to 
those reported. For this reason, we have not compared the specific amount of peptides 
immobilised to many systems but chose the most similar to the scaffolds developed here and used 
peptide incorporation percentage to make comparisons discussed above.  
 
5.4.2 Determination of the effect of peptide conjugation on fibre morphology  
The morphology of the fibres was monitored after PEO extraction for both CGDGEA- and CGRGD-
conjugated scaffolds with the varying concentration of peptides (Figure 5.5 and Figure 5.6). It was 
essential to analyze the fibre morphology as varying the peptides concentration could change the 
electrospinning parameters and affect fibre formation. Additionally, PEO extraction of the 
functionalized scaffolds was quantified by determining the mass loss and performing NMR analysis 
(methods described in detail in Chapter 3 (Section 3.3.8). The results obtained confirmed that PEO 
was extracted from the functionalized scaffold (results not shown).  
It is clearly shown that thiol-acrylate conjugation of CGRGD peptides had no major effect on the 
overall morphology of the fibres as peptide concentration increased up to 1 mol% (Figure 5.5B and 
C). Similarly to unfunctionalized scaffolds (Figure 5.5A), upon hydration and after PEO elution out, 
fibres swelled but maintained the fibrous structure. The fibre diameter for the 0.5 mol% CGRGD 
concentration was approximately 938 ± 76nm, which was similar to the fibre diameter of the 
unfunctionalized scaffold (approximately 925 ± 60nm).  However, increasing cysteine-conjugated 
peptides increased the fibre diameter to 1105 ± 67nm and 1204 ± 78nm, for 1 mol% and 2 mol% 
CGRGD concentrations, respectively. The highest concentration of CGRGD peptides (5 mol%) 
produced fibres with increased diameter and welding. It is possible that the welding is a result of 
fibres being brought together through attractive interactions between peptides. The peptides could 
aggregate during UV-polymerisation or peptides may have agglomerated during the PEO 
extraction process. 
 




Figure 5.5 SEM micrographs of fibres with varying concentrations of CGRGD peptides after PEO extraction. 
After electrospinning, the fibres were immediately exposed to UV light for 10 minutes using a UVB (302nm) 
lamp in an oxygen free environment. After photocrosslinking, PEO from the scaffold is extracted from the 
scaffold by repeated washing with water for 5 days.CGRGD concentration: A) 0; B) 0.5; C) 1; D) 2 and E) 5 
mol%. Scale bar: 5µm.  
Similarly, thiol acrylate conjugation of CGDGEA peptides had no major effect on the overall 
morphology of the fibres as the peptide concentration increased up to 1 mol% (Figure 5.6B and C). 
Comparable to unfunctionalized scaffolds (Figure 5.6A), after PEO extraction, fibres swelled but 
maintained the fibrous structure. The fibre diameter for 0.5 and 1 mol% CGRGD was 
approximately 933 ± 86nm and 928 ± 80nm, respectively, which was similar to unfunctionalized 
scaffolds.  However, increasing cysteine-conjugated peptides increased fibre diameter up to 1080 
± 96nm and 1154 ± 78nm, for 2 mol% and 5 mol% CGRGD concentrations, respectively. In 
contrast, incorporation of the CGDGEA peptide did not produce fibres with the high welding shown 
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for the CGRGD peptides. This may suggest that CGDGEA peptides aggregate less than that of 
CGRGD peptides causing less welding in fibre morphology.  
 
 
Figure 5.6 SEM micrographs of fibres with varying concentrations of CGDGEA peptides after extracting 
PEO. After electrospinning, the fibres were immediately exposed to UV light for 10 minutes using a UVB 
(302nm) lamp in an oxygen free environment. After photocrosslinking, PEO from the scaffold is extracted 
from the scaffold by repeated washing with water for 5 days. CGDGEA concentrations: A) 0; B) 0.5; C) 1; D) 
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Some research groups have reported the functionalization of peptides into fibres. RGD was 
successfully functionalized onto the surface of poly(D,L-lactic-co-glycolic acid) (PLGA) electrospun 
fibrous [137]. A solution of PLGA and PLGA-b-PEG-NH2 was electrospun to develop a fibrous 
membrane with functional amine groups on the surface of the electrospun membrane and the RGD 
was immobilized onto the aminated surface under hydrated conditions [137]. However, this surface 
functionalization was limited to the surface of the scaffold and required a two-step process. 
Another group showed a different peptide immobilization technique by electrospinning a blend of 
poly(ε-caprolactone) (PCL) and self-assembling oligopeptides [265]. Self-assembled polymer 
nanofibres were formed due to alternating hydrophilic and hydrophobic side chain groups that was 
capable of generating extended ordered structures [265]. In addition, our group has recently 
reported on RGD functionalized-poly(γ-glutamic acid) (PGA) fibrous scaffolds [266]. The peptide 
was conjugated onto γ-PGA-benzyl via N,N‘dicyclohexylcarbodiimide (DCC) and N,N- 
diisopropylethylamine (DIPEA) coupling reaction and the polymer was electrospun into a fibrous 
scaffold. These studies shown by Gentilini et al. have demonstrated that the functionalizing 
reactions to immobilize the peptides on the electrospun scaffolds did not affect the overall 
morphology of the fibres similarly shown to the studies presented here. Moreover, in the system 
investigated here, the peptides are introduced directly and without the need of additional chemicals 
which yielded similar desirable results in fibre scaffold morphology as post-conjugation. 
 
5.4.3 Determination of the effect of increasing DGEA peptide concentration on the 
swelling properties of scaffolds 
A unique characteristic of the fibrous scaffold was that swelling could be observed when the 
scaffold was immersed in water or media. This was discussed in detail in Chapter 3 (Section 
3.4.6). The hydrated state of the scaffolds is also more physiologically relevant (i.e. in vivo) 
following incubation in water. To better understand the effect of functionalization of the scaffold 
with cysteine-conjugated peptides on the gel structure and swelling properties of the scaffold, a 
swelling study was conducted using a range of different concentrations of CGDGEA-conjugated 
acrylate scaffolds and compared to unconjugated scaffolds. CGRGD conjugated scaffolds showed 
similar swelling ratios compared to CGDGEA (results not shown). Systems with acrylate scaffolds 
were reacted with 0.5, 1, 2 and 5 mol% concentrations of CGDGEA (Figure 5.7). Similar to 
unfunctionalized fibrous scaffolds, all conjugated fibres with varying concentrations of CGDGEA 
showed similar swelling behaviour. An initial and short rapid swelling phase (10-30 min) was 
followed by a slow down of the penetrant uptakes (30-60 mins) and, eventually, the fibres become 
fully swollen. A trend of increased swelling as CGDGEA concentration increased was observed. 
The unconjugated scaffolds showed the lowest swelling of   160% and, in contrast, the fibrous 
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scaffolds with the highest CGDGEA concentration presented swelling ratios significantly higher (  
180%) than the scaffolds with lower concentrations of CGDGEA attached.  Moreover, swelling was 
higher for peptide immobilized scaffolds despite larger diameter fibres shown in Figure 5.6. The 
peptide containing fibres seems to be more hydrophilic which consequently increases the overall 
swelling of the scaffolds. In addition, this illustrates the fact that the swelling ratio depends on the 
network crosslink density [141, 261]. Hence, as concentration of the peptide increases from 0.5 to 
5 mol%, there is the increase in thiol content which alters the network structure, as a result of 
greater chain transfer, and subsequently the number of crosslinks per kinetic chain decreases, 
which increases the swelling rate.  
 
Figure 5.7 Swelling ratios of electrospun fibres for different concentrations of CGDGEA-functionalized 
scaffolds (0.5, 1, 2 and 5 mol%) and unfunctionalized acrylate scaffolds. Mean ± SD, n = 3.  
 
5.4.4 Determining the effect of increasing DGEA peptide concentration on the 
mechanical properties of the fibres  
Besides surface chemistry and topography, mechanical properties such as modulus are critical for 
the stability and support of implants/scaffolds in the body, and furthermore certain narrow ranges 
of stiffness have been shown to modulate cellular functions such as cell attachment, motility and 
differentiation [4, 204]. Hence, it is essential to characterize the mechanical properties of the 
fibrous acrylate scaffolds and investigate the effect of varying the peptide concentrations. The 
mechanical properties of the scaffolds functionalized with varying CGDGEA concentrations were 
determined in two different conditions: in dry and hydrated states (after PEO extraction), using the 
uniaxial tensile test to failure (Figure 5.8). The CGDGEA scaffolds were chosen to represent the 
peptide-conjugated scaffolds for this study however the CGRGD scaffolds needs to be tested. 
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Different CGDGEA concentrations exhibited no significant differences in the dry scaffolds except 
for a slight decrease of   0.6 MPa in the tensile moduli of the functionalized scaffolds compared to 
unfunctionalized scaffolds. In order to investigate the mechanical properties under more 
physiological relevant conditions, the fibrous scaffolds were tested following incubation in water. 
Hydrated scaffolds displayed significantly decreased tensile moduli (  1.6 MPa) in comparison to 
the respective dry scaffolds. The variability between the dry and hydrated samples is due to water 
absorption and swelling, which reduces the tensile modulus values hence the scaffold becomes 
softer becoming more gel-like with increased hydration. However, a trend was displayed for 
hydrated scaffolds whereby increase in CGDGEA peptide concentration lead to a lower tensile 
moduli and the highest concentration of CGDGEA (5 mol%) displayed a significant decrease in 
tensile moduli when compared to the unfunctionalized scaffolds. This relates to the swelling ratios 
of the scaffolds shown in Figure 5.7.  
 
 
Figure 5.8 Fibres‘ mechanical properties: Young‘s modulus values of fibrous scaffolds after varying the 
CGDGEA peptide concentrations and unfunctionalized scaffolds. Mean ± SD, n = 3. (*) indicates that the 
difference between the marked bar and the unfunctionalized fibrous scaffold (90:10 MA:DEGMA) is 
statistically significant (p<0.05).  
The major challenge in regenerating connective tissue for TE, particularly bone, is to present 
sufficient mechanical strength prior to cellular deposition of natural ECM [213]. This was discussed 
previously in Section 3.4.5. A tensile modulus of 6.5-7 MPa was measured for the DGEA peptide 
functionalized scaffolds. The tensile modulus is comparable to PCL scaffolds that have been 
reported to have tensile modulus from a range of 5-15 MPa. PCL is a commonly investigated 
polymer for electrospinning used for bone TE applications [206, 214]. This scaffold could 
potentially be suitable for regeneration of non-loading areas of bones such as craniomaxillofacial 
 * 
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bone defects. Work by Motherway and colleagues have shown that cranial human exhibiting 
average moduli of 150 MPa [215]. Though the acylate scaffold has much lower moduli, some 
studies suggests that the overall mechanical strength of a scaffold increases after cellular 
infiltration [213 181].  
However, based on its mechanical properties, this fibrous scaffold may not be strong enough to 
support large defects of load-bearing bone. Studies have shown mineralized cortical and 
trabecular human bone exhibiting average moduli of 9905 and 365 MPa respectively [205].  
 
5.4.5 Determining the in vitro degradation of scaffold 
Central to the TE approach is the degradation of the scaffold over time, to become completely 
replaced by the natural ECM in the tissue. Hence, the objective is to implant the scaffold that will 
remain in a robust state in the site of injury for long enough to allow for the formation of native 
tissue, but which will in the end degrade and become replaced by newly synthesized matrix [29]. 
Hence it was critical to investigate the degradation of the fibrous scaffolds over time. 5 mol% 
CGDGEA and unfunctionalized fibrous scaffolds were used in this investigation to study the 
difference in degradation between peptide immobilized scaffolds and scaffolds without peptides. 
Figure 5.9 shows the degradation of both scaffolds after 4 months in NACl PBS. Both types of 
scaffolds demonstrated mass loss as early as the second week (  9%) and to four weeks (  14%). 
The peptide conjugated scaffolds showed higher mass loss after 8 weeks and reached a maximum 
of   51% at 16 weeks. While, the unconjugated scaffolds showed a maximum degradation of   45% 
at 16 weeks. This effect of higher degradation may be due to the peptide-network being more 
hydrophilic and also the thiol-conjugated peptides ability to act as a catalyst for degradation. The 
increase in overall mass loss by adding thiol groups in an acrylated PEG-PLA hydrogel network 
was demonstrated by Rydholm and colleagues [142]. However, they reported faster degradation 
rates as the PEG-PLA-diacrylate hydrogels achieved 90% mass loss after 7 weeks compared to        
 51% after 16 weeks for the CGDGEA scaffolds. This difference is due to higher number of 
degradable units due to the presence of PEG-PLA segments which can be degraded quickly [142].  




Figure 5.9 In vitro degradation of fibrous scaffolds with 5 mol% DGEA-peptide conjugation and without 
peptide conjugation on the fibrous scaffolds at 2, 4, 8, 12 and 16 weeks in 150mM NaCl PBS and placed on 
an orbital shaker at 37°C. Mean ± SD, n = 3. 
The degradation rate of the acrylate scaffolds are comparable to the work of Ifkovits et al. that 
demonstrated  33% degradation after 8 weeks for acrylated (poly-glycerol) scaffolds [212]. In 
addition, Atzet et al. showed lower mass loss compared to the acrylate fibrous scaffolds studied 
here, with  30% mass loss after 12 weeks for poly(2-hydroxyethyl methacrylate)-co-
polycaprolactone hydrogels [191]. This difference may be due to the hydrophobicity of PCL in the 
network. The fibrous scaffolds undergo bulk degradation mostly through hydrolysis of the ester 
bonds. In the presence of an aqueous environment, the hydrolytically degradable units are cleaved 
which results in the end products of the degradable units and kinetic chains formed during 
photocrosslinking (usually an alcohol and an oligomer polymer backbone). Hence when the 
hydrolytically degradable units are degraded, the poly-acrylic backbone, depending on its 
molecular weight, can be excreted through the glomerular filtration [175]. The molecular weight of 
the degraded poly-acrylic backbone is an important factor in the ultimate excretion.  
Though the scaffolds did not reach 100% mass loss, it is predicted that at longer periods, the 
scaffolds would further degrade and in vivo the scaffold in the site of injury would become replaced 
by newly synthesized matrix. Some studies have shown that the degradation rates would increase 
in vivo due to a more dynamic surrounding because of fluid movement and exchange in the body 
to eliminate degradation products from the implant region compared to in vitro conditions [212]. 
While polyesters have been vigorously studied and considerable achievements made in their 
fabrication into TE scaffolds, a fundamental dilemma that is associated with their use is their bulk 
degradation. In general, polyester based scaffolds undergo bulk degradation with a non-linear 
degradation profile [189]. For example, after placement in media, the molecular weight of the 
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polymer begins to decrease on day one (PGA, PDLA) or after a few weeks (PLLA) [189, 267]. This 
is consequently followed by the mass loss of the scaffold when the molecular chains are reduced 
to a size which allows them to diffuse out of the polymer matrix [189, 268]. This phenomenon 
described and analyzed in detail by a number of research groups [269, 270], results in accelerated 
degradation (non-linear) and resorption kinetics until the physical integrity of polymer matrix is 
compromised [189]. Consequently, this phenomenon would decrease the overall mechanical 
properties of the scaffold drastically which is an important factor for bone TE applications. In 
addition, the mass loss is accompanied by a release gradient of acidic by-products which is 
detrimental to native tissues.  
Bone is able to remodel in vivo under physiological loading [1]. It is a requirement that the 
degradation of the scaffold has to be in a controlled manner so that the scaffold maintains its 
physical properties for at least 6 months [189]. Subsequently, it will start decreasing its mechanical 
properties and should be degraded without a foreign body reaction after 12-18 months [189]. The 
fibrous acrylate scaffold showed an almost linear degradation profile which is suitable for bone TE 
applications. For example,  ResorPin Systems (screws, nails, pins) and Leadfix Systems (screws, 
nails, pins) used in the area of craniomaxillofacial surgery observed similar degradation profiles 
[189, 271, 272].  Based on these degradation results, the fibrous scaffolds developed here are 
suitable for the use of TE applications which requires a scaffold to persist for long time periods to 
heal for example, bony defects in the craniomaxillofacial skeleton.  
 
5.4.6 Surface characterization of peptide presentation on the scaffolds surfaces  
The presentation and distribution of the peptides on the surface of the scaffolds were investigated 
using ToF-SIMS (performed and analyzed by Ms Nia Bell). There is a general assumption that the 
peptides are distributed uniformly over the surface of a scaffold however, the peptides could be 
distributed inside the scaffold or localized into clusters on the surface [35]. Consequently, it is 
important to study the presentation and distribution of peptides on the scaffolds surface. ToF-SIMS 
was chosen to characterise our system due to its ability to derive molecular information and its 
shallower information depth compared to XPS [273]. Additionally, we intended to exploit the 
imaging capabilities of modern ToF-SIMS instrumentation to investigate the distribution of the 
peptide on the scaffolds surface. 
 




Figure 5.10 ToF-SIMS images (RGB mapping) showing the distribution of CRGD peptides on the surface of 
the fibres. A) scaffold with CRGD peptide, B) and scaffold without peptide (control). The substrate derived 
Al
+
 ion (blue), the peptide fragment NH4
+
 (green) and the polymer derived C2H5O
+
 ion (red) are mapped in 
RGB plots. Scale bar: 5µm. 
All plot mapping were normalised to CHO+, an intense polymer derived ion peak. Normalisation is 
known to reduce the occurrence and severity of spectral artefacts caused by differential sample 
charging and primary ion scattering from topographical surfaces [274]. The imaging are also 
normalised for the variable fibre coverage in each analysis area. The substrate derived Al+ ion 
(blue), the peptide fragment NH4
+ (green) and the polymer derived C2H5O
+ ion (red) are mapped in 
RGB plots. The images display the distribution and availability of the immobilized peptides on the 
surface of the fibres (Figure 5.10). There was clearly more NH4
+ ion (green) detected in the 
scaffold sample incorporating the peptide when compared to the peptide free sample. Also, the 
NH4
+ ion co-localised with the polymer derived ion C2H5O
+ (red) in the sample with peptide, as 
opposed to being scattered at a very low density across the whole sample of scaffold without 
peptide. The density of green spots in the sample of scaffold without peptide is indicative of the 
background signal due to the small H2O
+ ion interference. Hence, the peptides represented in 
green were clearly present and distributed evenly on the surface of the fibres. This novel method of 
using ToF-SIMS to analyze peptide conjugation distribution was critical because the process of 
functionalization was performed in bulk throughout the whole scaffold and not specifically on the 
surface. It is important that the peptides are distributed on the surface of the fibres to ensure the 
peptide ligands are spatially accessible to the cell-surface integrins.  
In the image of the peptide-containing scaffold, it appears that the number of counts from the 
peptide derived ion is higher at the edges of the fibres than on the top. This is an artefact which, in 
spite of the precautions taken, was caused by uneven charging of the polymer fibres, due to the 
sample holder geometry of the instrument. This artefact would have been reduced and higher ion 
intensities would have been recorded for the polymer and peptide-derived ion fragments if the 
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fibres had been aligned with the primary ion beam, as demonstrated by Van Royen et al. [273]. 
Nevertheless, the peptide-derived ions were detected in fibres of all diameters and at all 
orientations with respect to the primary ion source, which suggests a homogeneous distribution of 
the CRGD peptide on the scaffold‘s surface. 
The surface availability of a target molecule was also demonstrated recently using ToF-SIMS on a 
hexyldimethylammonium (PCLhexaq) functionalised PCL electrospun scaffolds at varying 
concentrations [273]. Surface characterization of electrospun fibres has been investigated by some 
researchers to analyze bio-functional groups immobilized on the surface of fibres, usually 
quantified using the nitrogen content inferred from XPS [275]. However, ToF-SIMS was selected 
as the primary characterisation tool in this study due to superior surface sensitivity and ability of 
ToF-SIMS to detect lower concentrations of an analyte, compared to XPS [276].  
 
5.4.7 Effect of the spacer arm length on peptide incorporation  
It is well known that to enhance cell adhesion the peptide ligands must be spatially accessible to 
the cell-surface integrins [35]. Creating a distance between the peptide and the biomaterial can 
provide enhanced access required for integrin-ligand binding [135]. Thus, adding extra amino acids 
residues to act as a spacer arm between the peptide motif and the biomaterial surface provide 
mobility and reduces steric hindrance for the adhesive peptide to bind and interact with the cell 
surface integrin [32, 135]. However, the lengthening of a peptide can result in the formation of 
disulfide bonds or rearrangement of the peptides or sections of the peptide in a secondary 
structure (i.e folding) [141]. Glycine, an aliphatic amino acid, was chosen as spacer because it has 
been previously shown to have a nominal effect on the reactivity of the thiol groups since glycine is 
extremely inert [141]. Thus, we investigated the effect of varying the length of spacers (glycine) in 
the sequence on the peptide incorporation onto the scaffolds. The amount of glycines added was 
varied between 1, 3 and 6 amino acid residues.  





Figure 5.11 Effect of different number of spacer residues (glycine) on peptide incorporation either CGRGD or 
CGDGEA in acrylate scaffolds assessed using the Ninhydrin and OPA assays. Mean ± SD, n = 3.  
The ninhydrin and OPA assays demonstrated that all different peptide sequences analysed were 
immobilized onto the fibrous scaffolds (Figure 5.11). Additionally, the ninhydrin and OPA assays 
showed no significant differences in the percentage of peptide incorporation onto the scaffolds 
amongst all peptides. For all peptide sequences, independently of the length of the spacer arm, the 
percentage of incorporation was approximately 80-86%. Both ninhydrin and OPA assays showed 
only very small non-significant differences in amine content. 





Figure 5.12 Effect of different number of spacer residues (glycine) on peptide incorporation either CGRGD or 
CGDGEA in fibrous acrylate scaffolds as assessed by Ellman‘s assay (thiol conversion of sulfydryl groups). 
Mean ± SD, n = 3. 
The measurement of peptide incorporation was further confirmed by quantifying the free sulfhydryl 
groups in solution using the Ellman‘s assay (Figure 5.12). Similarly to the ninhydrin and OPA 
results, no significant differences were observed in thiol conversions between the RGD and DGEA 
sequences with different numbers of glycine spacers. For all the different peptides investigated, the 
percentage of thiol conversion was approximately 80-85%. Moreover, no difference was depicted 
between DGEA and RGD peptides. This gives evidence that all peptides were equally incorporated 
onto the scaffolds which is essential as the biological response of hMSCs to varying length of 
spacer arms was investigated and described in Chapter 6. 
Glycine was selected as spacer because it has been previously demonstrated to have a nominal 
effect on the reactivity of the thiol groups [141]. Hence, it would have negligible effects on the thiol-
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acrylate reaction during scaffold functionalization. This may explain the similar levels of peptide 
incorporation for the scaffolds with different glycine spacer lengths by not affecting the reactivity of 
the thiol groups during functionalization.  
 




As described in Chapters 3 and 4, photocrosslinked fibres were successfully developed by 
electrospinning different MA and DEGMA compositions and post-UV crosslinking. However, the 
considerable increase in apoptosis of hMSCs for all fibrous scaffolds demonstrates a lower 
potential of the MA/DEGMA scaffold to support hMSCs attachment and viability. Thus, in this 
chapter, to increase the overall bioactivity of the scaffold, the functionalization of the previously 
developed acrylate UV-crosslinked fibrous scaffolds was investigated. Novel fibrous acrylate 
photo-crossslinked scaffolds were successfully developed introducing different amounts of 
cysteine-conjugated DGEA or RGD peptides onto the fibrous scaffolds. The synthesis of the 
functionalized scaffolds utilizes cysteine-functionalized RGD or DGEA peptide sequences in 
combination with the MA/DEGMA acrylates discussed in Chapter 3 and employs a photoinitiated 
mixed-mode thiol-acrylate polymerization mechanism. Cysteine-functionalized DGEA and RGD 
peptides were shown to be efficiently incorporated in the synthesized acrylate scaffolds with   85% 
peptide incorporation. It was observed that immobilization of the peptides had no major effect on 
the overall morphology of the fibres, even as the peptide concentration was varied from 0.5 to 5 
mol%. Except for the highest peptide concentration (5 mol%), all fibres conjugated with different 
concentrations of CGDGEA showed no significant differences for swelling behaviour and 
mechanical properties when compared to the unfunctionalized fibrous scaffolds. In addition, the 
degradation of the CGDGEA and unfunctionalized scaffolds were studied and both scaffolds 
degraded with mass loss of   51% and   45% at 16 weeks. 
Most importantly, the peptides were accessible and homogeneously displayed on the surface of 
the scaffolds using ToF-SIMS for surface characterization. The efficiency of the peptides‘ 
conjugation using the thiol-acrylate reaction was similar, regardless of the length of the glycine 
spacer arms. For all peptide sequences, independently of the length of the arm spacer, the 
percentage of incorporation determined was approximately 80-86%. 
Herein we have utilized the thiol-acrylate polymerization in the UV-electrospinning system to 
produce RGD and DGEA peptide-functionalized fibrous acrylate scaffolds. This method provides a 
facile and robust way to incorporate peptides into electrospun scaffolds without the need to 
chemically modify functional peptide motifs. The biological response of hMSCs to the 
functionalization with different peptide sequences and the use of different spacer arms on the 
DGEA and RGD peptides were investigated and will be described in Chapter 6.  
 
 





CHAPTER  6 
6 Assessment of effect of 
DGEA- and RGD-
functionalized electrospun 
fibres on hMSC adhesion 
and differentiation 
 





A pivotal challenge in designing materials for TE is to provide critical cues that can direct cellular 
behaviour and promote tissue regeneration. Many attempts have been carried out to emulate the 
natural microenvironment using synthetic ECM-mimetic macromolecules that manipulate the 
ECM‘s biological, chemical and mechanical properties [116-119]. The ECM is primarily made of 
abundant nanometer-scale fibrous networks of proteins, glycoproteins and glycosaminogylcans 
including collagens, laminins, fibronectins, hyaluronic acids and growth factors [26]. These fibrous 
structures present cellular instructive cues to control cell-matrix interactions as they present 
biochemical ligands that interact exclusively with cellular integrins and activate cascading cellular 
signals [26]. Specifically, in addition to anchoring cells to mediate cell adhesion and presenting 
tissue organization, integrins convey intracellular signals that regulate cell migration, cycle 
progression and differentiation [88-90, 126].   
Various ECM ligand peptide sequences have also been identified and demonstrated to regulate 
cellular functions. For example, RGD peptides from various ECM proteins, including fibronectin, 
laminin, collagen I, fibrinogen and vitronectin, have been demonstrated to enhance cell adhesion 
by inducing focal adhesion through integrin interaction [32]. Many integrins have been 
demonstrated to interact with ECM biomolecules in an RGD-dependent manner such as α3β1, α5β1, 
αIIbβ3, α8β1, αvβ1, αvβ3, αvβ5, αvβ6, α5β8 and α4β1 [33]. Inspired by the bioactivity of the RGD 
sequence, many groups have worked on immobilizing the peptide to an extensive range of 
surfaces, scaffolds and hydrogels (reviewed in [33, 34] and [35]).  
DGEA is a peptide sequence derived from collagen type 1 that has displayed a specific binding 
affinity for osteoblast via the α2β1 integrin [42, 126]. In addition, DGEA has been shown to induce 
osteogenic differentiation [36-38]. Therefore, DGEA could serve as both a cell adhesion and 
differentiation factor. Nevertheless, collagen-derived peptides have been relatively less studied for 
their cellular response compared to other ECM peptides such as RGD [39-41]. However, it has 
been identified and demonstrated that collagen I binds to a different integrin receptor than 
fibronectin, and that the integrin-DGEA interaction is RGD-independent [42].   
There are numerous approaches to present peptide sequences to cells with respect to the choice 
of peptide length, sequence arrangement as well as concentration [35]. These significantly affect 
the peptides‘ affinity for integrins as determined by the flanking residues, the conformation and/or 
the accessibility towards the integrins [35]. For instance, the binding specificity of the peptide to the 
cell surface integrin receptor can be enhanced by flanking residues and conformation [33, 132].  
MSCs play an essential role in bone regeneration [75, 80]. These cells are recruited from the bone 
marrow and migrate into location of bone injury, differentiate into osteoblasts, and then produce an 




osteoid matrix which is then mineralized and form new bone [76-80]. The potential for 
differentiation, and the relative simplicity with which they can be isolated and cultured in vitro 
without phenotypic alterations before specific differentiation, [76] make MSCs a suitable candidate 
for TE strategies [84].  The use of MSCs to induce tissue regeneration has then been extensively 
investigated [81-83]. These cells have been seeded into the scaffold and implanted into the body 
either directly or a few weeks later or after in vitro differentiation [81].  Relatively successful bone 
repair have been achieved but truly successful cartilage repair remains elusive [84]. Hence, 
studies aimed at defining the optimal scaffold environment to promote MSCs adhesion are needed. 
Previously, we reported the successful development of novel fibrous acrylate photo-crossslinked 
scaffolds introducing different amounts of cysteine-conjugated DGEA or RGD peptides in the 
fibrous scaffolds. The synthesis of the functionalized scaffolds utilized cysteine-functionalized RGD 
or DGEA peptide sequences in combination with MA/DEGMA acrylates and employed a 
photoinitiated mixed-mode thiol-acrylate polymerization mechanism. In the present chapter, the 
biological response of hMSCs to the peptide-functionalized fibrous scaffold will be investigated.  
 




6.2 MATERIALS  
Roswell Park Memorial Institute 1640 medium (RPMI 1640), Fetal Bovine Serum (FBS), L-
Glutamine, penicillin/streptomycin, Phosphate buffer saline (PBS) and trypsin/ethylenediamine 
tetra-acetic acid (trypsin/EDTA), alamarBlue® assay, Alexa-Fluor 568 Phallaoidin stain, Total DNA 
assay and the LIVE/DEAD® viability assay were purchased from Invitrogen GIBCO Corporation 
(UK). Caspase-glo®3/7 Assay was purchased from Promega (UK). Human mesenchymal stem 
cells (hMSCs) were purchased from Promocell (Germany) and hMSCs growth media and 
osteogenic media was purchased from Promocell (UK). BCA Protein assay kit was purchased from 
Thermo Fisher Scientific (UK). Alkaline Phosphatase Assay kit was purchased from BioAssay 
Systems (US) and the enzyme immunosorbent assay (EIA) from Takara Bio Inc (Japan). The 
antibodies anti-α2, anti-β3, and anti-hamster IgG were purchased from Abcam (UK). 
 
6.3 METHODS 
6.3.1 Cell culture 
Low passage (p3-p6) human mesenchymal stem cells (hMSCs) were cultured using growth 
medium and supplements (Promocell). Initial culture of hMSCs was performed in 75 cm2 flasks at 
37°C, in a humidified atmosphere of 95% air with 5% CO2, and supplied with fresh medium every 
2-3 days. At 90% confluence, cells were detached using trypsin-EDTA and cell count was 
determined in a haemocytometer. Cells were resuspended in complete growth medium to achieve 
the appropriate concentration for seeding.  
 
 





Figure 6.1 Sequences of the peptides used in this study. A) CGDGEA; B) CGRGD; C) CGDEGA and D) 
CGRGE 
 
6.3.2 Preparation of peptide-conjugated electrospun fibres  
The preparation of the peptide-functionalized scaffolds was described in Chapter 5 (Section 5.3.2). 
The schematic of the sequences of the peptides used in this study is illustrated in Figure 6.1. 
Briefly, the monomer mixtures were prepared by mixing (90:10) mol % of MA and DEGMA and 
varying concentrations of each peptide (0.5, 1, 2 and 5mol%) with the aid of PEO as a high 
molecular weight carrier polymer and ethanol as solvent. 2-hydroxy-4′-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure 2959) was added to the polymer solution as a photoinitiator and 
the solution was electrospun under conditions specified in Chapter 3 (Section 3.3.3) and (Table 
3.2). After electrospinning, the fibres were immediately exposed to UV light for 10 minutes using a 
UVB (302nm) lamp in an oxygen free environment. Subsequently, 15mm diameter scaffolds were 
excised using a biopsy puncher and PEO was extracted from the fibres for five days in water. The 
scaffolds were air-dried overnight and the scaffolds were incubated in deionized water overnight 
before being placed in 24-well plates pre-coated with 1% (w/v) agarose gel (to prevent cell 




adhesion at the bottom of the plate). Bovine type 1 collagen (1 mol% in PBS) was adsorbed 
overnight on TCP plates as controls.  
For sterilization, samples in the 24-well plates were incubated with ethanol for one hour, soaked in 
PBS overnight and rinsed repeatedly with PBS and media before cell seeding. hMSCs were 
seeded on the electrospun fibres at a density of 1 x 104 cells/per cm2 and incubated at 37°C 
overnight to allow cell adhesion. The cell culture medium was replaced every 2-3 days.  
For the differentiation studies, hMSCs were seeded on the electrospun fibres at a density of 2 x 
105 cells/per cm2 and allowed to attach and grow for 7 days in order to reach confluency. After this 
period, growth media was changed to osteogenic media and the cells cultured for an additional 2 
weeks. The osteogenic media was changed every 2 days. For experiments without osteogenic 
media, growth media was utilized throughout the three weeks. 
 
6.3.3 AlamarBlue® assay 
The alamarBlue® assay was performed to assess the viability of hMSCs on the fibrous scaffolds. 
The detection mechanism of this assay is the conversion of its active product, resazurin, into the 
fluorescent molecule, resorufin, by cells, which produces red fluorescence. Viable cells 
continuously convert resazurin into resorufin, due to their reduction potential. Hence, fluorescence 
can be used as a quantitative indicator of cell viability; the amount of fluorescence produced is 
then directly proportional to the number of living cells. The alamarBlue® assay was performed as 
specified by the manufacturer. Briefly, hMSCs were seeded in 24-well plates (1 x 104 cells/cm2). At 
specific time points (1, 5, 10 days), cell-culture media was removed from the well plates and the 
wells were washed with 400 μL of PBS. 300μL of 10% (v/v) alamarBlue® in phenol red-free cell 
culture media were added per well (including one with no cells to be used as blank) and the well 
plates were incubated for 3 hours at 37°C. 100 μL of the reaction product were then transferred to 
a black 96-well plate and fluorescence was measured at an excitation wavelength of 540 nm and 
an emission wavelength of 590 nm using a microplate reader (SpectraMax M5, Molecular 
Devices).  
 
6.3.4 MTS assay  
In order to study the cell adhesion on the fibrous scaffolds, the number of viable cells was 
determined using the MTS assay. The mechanism behind this assay relies on the fact that 
metabolically active cells react with a tetrazolium salt (present in the MTS reagent) to produce a 
soluble formazan dye that can be detected at 490 nm.  Firstly, stock MTS reagent was mixed with 




media in a 1:5 ratio to make a working solution. The samples in the 24-well plates were rinsed with 
PBS and 600 µl of working solution were added to the wells. The samples were then incubated 
with the working solution for 3 hours at 37°C. Thereafter, 100µl from each well were aliquoted into 
a new 96-well plate. The 96-well plate was placed into a microplate reader (SpectraMax M5, 
Molecular Devices) and the absorbance of the content of each well was measured at 490 nm.  
 
6.3.5 Caspase-glo®3/7 Assay  
The Caspase-glo®3/7 assay is a luminescent apoptosis assay that measures the activity of 
caspases 3 and 7, two members of the cysteine aspartic acid-specific protease (caspase) family 
that play key effector roles in apoptosis in mammalian cells. The assay uses a luminogenic 
substrate DEVD sequence that has been shown to be specific to both caspase-3 and -7. The 
Caspase-glo®3/7 assay was performed as indicated by the manufacturer. Briefly, cell culture 
medium was removed and 300 μL of Caspase-glo®3/7 reagent were added to each well. The 
plates were gently mixed using a plate shaker for 30 seconds and then incubated at room 
temperature for 1 hour. Luminescence was measured using a microplate reader (SpectraMax M5, 
Molecular Devices). As a positive control for caspase activation cells exposed to 0.1% (w/v) 
staurosporine overnight, a known inducer of apoptosis, were used. 
 
6.3.6 Actin immunostaining 
The distribution/organization of the actin fibres were assessed by staining the cells with Alexa-
Fluor Phalloidin 488/568. Nuclei were stained with Diamidino-2-phenylindole (DAPI). Firstly, the 
electrospun samples were washed twice with pre-warmed PBS and fixed with 4% (w/v) 
paraformaldehdye solution for 15 minutes at room temperature. After washing the samples twice 
with PBS, the cells were permeabilized with 0.1% (v/v) Triton X-100 solution for 5 minutes at room 
temperature. After further washing, the samples were incubated with Alexa-Fluor Phalloidin 
solution in 1% (w/v) BSA for 20 minutes at room temperature. The samples were then washed with 
BSA and PBS twice and, finally, Vectashield mounting medium with DAPI staining solution was 
added to samples and incubated for 5 minutes. Samples were rinsed with PBS twice and viewed 
with a fluorescence microscope (Olympus IX51 inverted microscope).   
 
  




6.3.7 Cell adhesion assay  
The cell adhesion assay protocol was performed as described in [42] but hMSCs adhesion to 
peptide-conjugated scaffolds was quantified using the MTS assay. The cells were seeded onto the 
scaffolds and allowed to adhere for specific time points (1, 2, 3 and 6 hours) with serum-free 
media. These time intervals were chosen because hMSCs are well spread between 1-6 hours and 
because at those time intervals, differences in cell spreading can be specifically attributed to the 
adhesion peptides immobilized on the scaffolds [42]. At later time intervals, cells produces their 
own adhesion molecules, which complicates the assessment of the peptides‘ effect [42]. After the 
specific binding time intervals, loosely bound cells were extracted by washing with PBS and the 
remaining cells were analyzed using the MTS assay. The cell adhesion experiments were 
performed with serum-free media.   
 
6.3.8 Competitive cell adhesion assay 
Human MSCs were pre-incubated in the presence of soluble CGDGEA, CGRGD and scrambled 
peptides with varying concentrations (0-5 mol%) in culture media for one hour. Then, the cells 
were seeded on the different peptide conjugated scaffolds as described above. After one hour, cell 
adhesion was analyzed using the MTS assay. The cell adhesion experiments were performed with 
serum-free media. For the integrin-blocking experiments, rather than pre-incubating the cells with 
soluble peptides, hMSCs were incubated with 1:200 dilution of three antibodies (anti-α2, anti-β3, or 
anti-hamster IgG) and cell adhesion was assessed using an MTS assay.  
 
6.3.9 Alkaline Phosphatase assay 
The Alkaline Phosphatase assay was used to detect/measure ALP activity. The assay utilizes p-
nitrophenyl phosphate, which is hydrolyzed by ALP into a yellow product (maximal absorbance at 
405nm). The reaction rate is directly proportional to the enzyme activity. For the differentiation 
studies, hMSCs were seeded on the electrospun fibres at a density of 2 x 105 cells/per cm2 and 
allowed to attach and grow for 7 days in order to reach confluency. After this period, growth media 
was changed to osteogenic media and the cells cultured for an additional 2 weeks. The osteogenic 
media was changed every 2 days. For experiments without osteogenic media, growth media was 
utilized throughout the three weeks. Briefly, the ALP solution was prepared as follows: 5 mg 4-
nitrophenyl phosphate disodium salt hexahydrate (PNP) tablet was thoroughly mixed in 5 ml of a 
solution containing 100 mM glycine, 0.1 mM ZnCl2 and 0.1 mM MgCl2 in dH2O. The pH was 
adjusted to 10.4 at 37°C. At the indicated time points, cultures were lysed in dH2O and 50 µl of 




ALP solution were added per well. The samples were then placed on an orbital shaker, for 30 
minutes, at room temperature, and the reaction was stopped with the addition of 100 µl of 1 M 
NaOH. Subsequently, absorbance was read at 405 nm in a microplate reader (SpectraMax M5, 
Molecular Devices). 
 
6.3.10 Osteocalcin Production 
The osteocalcin (OCN) production on the different peptide-conjugated scaffolds was determined 
using a enzyme immunosorbent assay (EIA) kit for intact OCN. The assay was performed 
according to the manufacturer‘s instructions, using the cell-culture supernatants. Briefly, 100 µl of 
each sample and carboxylated-type of osteocalcin (Gla-OCN) was added to the plate supplied by 
the manufacturer, which was previously coated with anti-Gla-OCN. The plate was then incubated 
for 2 hours, at room temperature, and the supernatant was aspirated. The plate was washed three 
times with 400 μl of PBS wash buffer. Next, 100 μl of horseradish peroxidase anti-OCN reagent 
were pipetted into all wells. The plate was mixed throughly by swirling and incubated at room 
temperature for 1 hour. Another wash was performed and 100 μl of substrate solution and 
hydrogen peroxide were added to each well and incubated, at room temperature, in the dark, for 
15 min. The reaction was stopped by addition of 100 μl of stop solution (sulfuric acid) and 
absorbance was measured at 450 nm, using a microplate reader (SpectraMax M5, Molecular 
Devices). The amount of OCN in the culture medium was expressed as ng/ml and calculated using 
a standard curve constructed using a range of osteocalcin standards (0-16 ng/ml) provided in the 
kit and then normalised to total DNA content. 
 
6.3.11 Total DNA assay 
DNA concentration was measured using the Hoechst 33258 dye fluorescent assay. This assay is 
based on the enhanced fluorescence and shift in the emission wavelength of the fluorochrome 
Benzamide (Hoescht) when bound to DNA. Briefly, after 1, 5, and 10 days, cell-culture medium 
was removed from the well plates and cells were washed with PBS. 400 μL of water were added 
per well and cells were lysed by freeze-thaw cycles (30 minutes at -80°C and 20 min at 37°C, 
repeated 3 times).  50 μL of the cell lysates were added to 50 μL of Hoescht dye diluted to the 
working concentration (20 μg/mL) and allowed to react for 5 minutes before measurement. 
Fluorescence was measured using an excitation wavelength of 360 nm and an emission 
wavelength of 460 nm in a microplate reader (SpectraMax M5, Molecular Devices). DNA 




concentrations were calculated using a standard curve prepared using calf thymus DNA at 
concentrations between 0-100 μg/mL. 
 
6.3.12 Statistical analysis 
All experimental data shown were expressed as mean ± SD and were obtained from experiments 
performed in triplicates, at least. All data analysis was performed in Excel. Statistical analysis was 
performed with one-way analysis of variance (ANOVA) using multiple comparisons (Bonferonni 
test) and significance was determined by p<0.05. This analysis was performed with Graphpad 
InStat (Prism) software. 
 




6.4 RESULTS AND DISCUSSION 
The study reported in Chapter 4 demonstrated that hMSCS cultured on the MA/DEGMA fibrous 
scaffolds presented increased apoptotic levels. Such increase suggested the MA/DEGMA 
scaffolds have a low potential to support hMSCs cell attachment and viability. Hence, in order to 
increase bioactivity of the acrylate scaffold, different amounts of cysteine-conjugated DGEA or 
RGD peptides were incorporated in the scaffolds. Chapter 5 described the functionalization of the 
referred scaffolds utilizing cysteine-functionalized RGD or DGEA peptide sequences in 
combination with MA/DEGMA monomers and employing a photoinitiated mixed-mode thiol-acrylate 
polymerization mechanism. Cysteine-functionalized DGEA and RGD peptides were demonstrated 
to be incorporated efficiently during the synthesis of the acrylate scaffolds.  Subsequently, the 
investigation of the biological response of hMSCs to the peptide-immobilized fibrous scaffolds will 
be described in the present chapter. Initial hMSCs adhesion to the scaffolds, viability and 
osteogenic differentiation were evaluated. 
Firstly, the effect of the presence of the CGDGEA and CGRGD peptides immobilized on the 
fibrous MA:DEGMA scaffolds at different concentrations, on hMSCs initial attachment was 
evaluated. Next, the difference of the effect of the two peptides (CGDGEA and CGRGD) on 
hMSCs adhesion and viability was assessed. Then, the effect of varying the length of spacer arms 
of DGEA and RGD on hMSCs adhesion and viability with glycine was analyzed. Next, the integrin 
specificity of hMSCs adhesion to the two peptides was evaluated using competitive adhesion 
assays. Finally, the ability of the peptide conjugated scaffolds to stimulate osteogenic hMSC 
differentiation was investigated.  
 
6.4.1 Determination of the effect of CGDGEA and CGRGD peptide concentration on 
hMSCs adhesion 
In order to further explore the biological potential of the peptide-immobilized fibrous scaffolds, their 
ability to sustain adhesion and viability of hMSCs was evaluated. Cell adhesion is critical for the 
assembly of individual cells into a scaffold, as most cells grown in vitro must adhere to the 
substrate to survive and proliferate [277]. Human MSCs are uncommitted, non hematopoietic 
progenitor cells that are characterized by their ability to differentiate in response to appropriate 
cues [82, 84]. The ease with which hMSCs can be isolated and cultured in vitro without phenotypic 
alterations before differentiation [76] make hMSCs a suitable candidate for TE purposes [84].  
Thus, with the use of these cells, the effect of varying concentrations of CGDGEA and CGRGD 
ligands immobilized on the MA:DEGMA fibrous scaffolds on cell adhesion and viability was 




evaluated. Firstly, the effect of varying CGDGEA concentrations on hMSCs adhesion on the 
fibrous scaffold was characterized using an MTS assay (Figure 6.2). The hMSCs were cultured 
directly on the peptide-conjugated scaffolds to evaluate the bioactivity of CGDGEA and CGDEGA 
peptides at different concentrations, unfunctionalized acrylate scaffolds, collagen 1 coated 
surfaces and TCP in serum free media were used as controls. Cells that adhere to the scaffold 
after specific binding time intervals were quantified using the MTS assay, which detects 
metabolically active cells as they react with a tetrazolium salt in the MTS reagent. The reaction 
produces a soluble formazan dye that can be measured by absorbance at 490nm.  Cell adhesion 
to each scaffold was analyzed at 1 and 2 hours after cell seeding. The loosely attached cells were 
removed by washing with PBS and the adherent cells on the scaffolds were analyzed.  
After one hour, a significant increase in adhesion of hMSCs to scaffolds conjugated with the 
CGDGEA peptide was observed in comparison to the non-functionalized scaffolds. A trend of 
enhancing cell adhesion as CGDGEA concentration increased was clearly shown, 5 mol% 
CGDGEA-conjugated scaffolds exhibited significantly enhanced attachment and the 2, 1 and 0.5 
mol% CGDGEA concentration followed the trend in this specific order. In contrast, the presence of 
the CGDGEA scrambled peptide (CGDEGA), and unfunctionalized scaffolds showed significantly 
lower cell adhesion. The concentration-dependent trend continued to rise up to 2 hours in culture. 
The 5 mol% CGDGEA-containing fibres showed the highest level of cell adhesion, followed by the 
2, 1 and 0.5 mol% CGDGEA–containing fibres. As expected, all different CGDGEA scaffolds with 
varying concentrations showed higher cell adhesion when compared to the scrambled peptides 
(CGDEGA), which presented attachment comparable to unfunctionalized scaffolds. This 
demonstrates the efficacy and bioactivity of the CGDGEA peptide in promoting cell adhesion, 
which is in agreement with studies previously performed by Culpepper and colleagues [80]. They 
have shown enhancement of cell adhesion for DGEA- and collagen 1-coated HA disks in 
comparison to uncoated HA disks [80]. Though, the experiments shown here reveal that CGDGEA 
ligands were not able to support attachment equivalently to collagen 1.  
The hMSCs initial adhesion to the CGDGEA peptides conjugated fibrous scaffolds were 
demonstrated to be dose-dependent; increasing DGEA concentration on the scaffold further 
increased cell adhesion. Interestingly, the cell adhesion strength to the peptides immobilized on a 
substrate has been previously shown to correspond to the amount of integrin-ligand bonds [278-
280]. Furthermore, Palacek et al. and Asthagiri et al. have revealed that a parameter, short term 
cell-substratum adhesion strength, can illustrate three critical factors: ligand surface density, 
receptor expression level and receptor-ligand binding affinity [278, 280, 281].  
A few groups have suggested that collagen mimetic peptides, such as DGEA are attractive for the 
conjugation of biomaterials for a number of reasons [42, 80, 282]. Firstly, collagen 1 binds to 




different integrin receptors from FN, VN and Fbg, and the integrin-collagen 1 interaction is believed 
to be RGD independent [42]. Consequently, DGEA may not compete with adsorbed FN, VN and 
Fbg for interaction with integrins [42, 282]. In addition, it is possible that collagen 1 would not 
adsorb to the surface of a scaffold in a high rate after implantation of the scaffold, because 
collagen 1 is not abundant in blood in comparison to fibronectin [42]. 
As 5 mol% of CGDGEA stimulated the highest cell binding for hMSCs after 2 hours when 
compared to other concentrations, it was chosen to be used in further experiments described in 
this chapter. 
 
Figure 6.2 Effect of varying the concentration of CGDGEA peptides on the fibrous scaffolds on hMSC 
adhesion after 1 and 2 hr, determined using MTS assay. Mean ± SD, n = 3. (*) indicates that the difference 
between the marked bar and the control (unfunctionalized acrylate scaffold) of the same time period is 
statistically significant. (¥) indicates that the difference between the marked bar and scrambled peptide, 
(DEGA) of the same time period is statistically significant (p<0.05).  
In addition, the effect of varying CGRGD concentration on hMSCs adhesion to the fibrous scaffolds 
was assessed (Figure 6.3). After one hour, scaffolds with 2 mol% CGRGD presented the highest 
cell adhesion, followed by 5 and 1 mol%. There was no significant difference between 0.5 mol% 
CGRGD and the unfunctionalized scaffolds or the scrambled peptide (CGRGE). After 2 hours, 2 
mol% RGD peptides further enhanced cell attachment still followed by the 1 and 5 mol% scaffolds. 
The highest concentration of CGRGD peptides (5 mol%) was not able to stimulate cell adhesion 
above that of 2 mol%. The scrambled peptide, CGRGE immobilised onto scaffolds at different 
concentrations showed low cell adhesion levels, similar to the unfunctionalized scaffolds. This 
demonstrates the efficacy and bioactivity of CGRGD peptide in promoting cell adhesion. 




The hMSCs adhesion rates to the CGRGD functionalized-scaffolds showed that an increase in 
peptide concentration for CGRGD does not always guarantee an increased cell adhesion. This 
was in agreement with Yang and colleagues, who demonstrated that the highest cell spreading of 
MSCs occurred at the minimum concentration investigated of 0.03 µM PLL-CRGDS coated onto 
PLA disks [35, 283]. The coating of PLL-GRGDS on PLA disks significantly enhanced cell 
spreading in concentrations of 0.3 and 0.03 µM but not at the higher concentrations of 3 and 30 
µM [35, 284]. They suggested that the inhibitory effects of increased PLL concentrations 
dominated compared to the adhesive characteristic of the RGD peptide at high concentrations [35]. 
In contrast, Harbers and Healy have shown that with increasing RGD ligand density by grafting 
RGD on polystyrene surfaces, cell adhesion increased; this was characterized with the use of a 
centrifugal adhesion assay [280]. Hence, it is clear that the literature is controversial with regards 
to optimal concentrations for RGD-peptides immobilization on biomaterials.  
Sawyer and colleagues also demonstrated that increasing RGD concentrations hinders cell 
attachment by immobilizing poly-glutamate E7GRGDSPCA onto hydroxyapatite disks [285]. This 
decrease in cell adhesion as the peptide concentration increases was suggested to be due to the 
ligands being too closely packed at high concentrations and impeding the access to integrin 
receptors [35]. This could also explain the decrease in cell adhesion for the system investigated 
here. When CGRGD peptides concentration was increased up to 5 mol% cell attachment was 
reduced when compared to the intermediate concentration of 2 mol%, which showed optimal cell 
adhesion. It seems likely that the reduction in cell attachment is in fact due to lowered accessible 
ligand concentrations, even though this was not seen with the CGDGEA peptides. This distinction 
may be due to CGDGEA and CGRGD binding to different integrin receptors [42].  
The amount of peptide presented to the cells and the degree of functionalization are evidently 
important factors affecting the potential of a biomaterial as a cell adhesive material [35]. It is 
important to note that there are many analytical methods and representations of the amount of 
peptide immobilized onto the scaffolds in the literature making quantitative comparisons between 
the scaffolds developed here and other systems complicated. The nature of the scaffolds should 
have an impact on the level of quantification based on the same quantitative methods. 
Correspondingly, even if the same methodology for reporting quantification has been used, 
difference in degrees of swelling or bulk or surface modifications mean that actual ligand densities 
or concentrations can be different to those reported. For this reason, we have not compared the 
specific amount of peptides immobilised and their specific cell response in the literature to our 
system.  
In addition, there has been a lot of controversy about the use of RGD peptides on biomaterials. 
Some studies have shown inhibitory effects of RGD to cell growth on implants [286, 287]. The 




inhibitory effects of RGD on cytocompatibility in vivo have not been indentified [42]. According to 
Hennessy et al., they suggest that synthetic RGD peptides on the biomaterial surface compete 
with adsorbed FN, VN and Fbg protein molecules which are abundant in blood for binding of cell 
surface integrins [42, 288-290]. These adhesion proteins interact with integrins through an RGD 
dependent mechanism [291-293]. Hence, this may imply that RGD peptides avert integrin 
receptors from binding and interacting with the adsorbed proteins, and consequently decreasing 
the overall effects of  integrin signalling, as it is known that RGD peptides are weaker integrin 
ligands than the native full length adhesion proteins [132, 287, 294]. 
As 2 mol% CGRGD stimulated the highest cell binding after 2 hours in comparison to the other 
concentrations tested, it was chosen to be used in all further experiments reported in this chapter.   
 
 
Figure 6.3 Effect of varying the CGRGD peptides concentration on the fibrous scaffolds on hMSC cell 
adhesion after 1 and 2 hr, determined using MTS assay. Mean ± SD, n = 3. (*) indicates the difference 
between the marked bar and the control (unfunctionalized acrylate scaffold) of the same time period is 
statistically significant. (¥) indicates that the difference between the marked bar and scrambled peptide 
(CGRGE) of the same time period is statistically significant (p<0.05).  
 
 




6.4.2 Comparison of the effect of CGDGEA and CGRGD conjugation on hMSCs 
adhesion and viability 
To further evaluate the cell adhesion at a longer time period and compare the efficacy of the 
CGDGEA and CGRGD ligands, the cell adhesion assay described above was repeated after 
longer time periods - 3, 6 and 9 hours (Figure 6.4). Based on results from previous adhesion 
experiments, the peptide concentrations used were 5 mol% for CGDGEA and 2 mol% for CGRGD.  
After 3 hours, both DGEA and RGD peptides presented significantly higher cell adhesion in 
comparison to the control and the scrambled peptides. However, DGEA showed increased 
stimulation of adhesion when compared to RGD peptides. After 6 hours, similar results were 
depicted.  This trend was more prominent after 9 hours, DGEA peptides supported higher levels of 
cell adhesion in comparison to RGD. Slight difference in cell adhesion was observed between 
CDEGA and RGE containing scaffolds with the control (unfunctionalized scaffold). However, even 
after 9 hours DGEA ligands were not able to support attachment equivalent to that of collagen 1.  
 
Figure 6.4 Effect of CGDGEA and CGRGD peptides immobilized on the fibrous scaffolds on hMSC cell 
adhesion after 3, 6 and 9 hours, determined using MTS assay. Mean ± SD, n = 3. The concentration for 
CGDGEA and CGRGD was 5 and 2 mol% respectively. (*) indicates the difference between the marked bar 
and the control (unfunctionalized scaffold) of the same time period is statistically significant. (¥) indicates that 
the difference between the marked bar and scrambled peptide with same peptide sequence of the same time 
period is statistically significant (p<0.05). 
The reduced cell adhesion for RGD ligands in comparison to DGEA ligands is also in agreement 
with the investigation of Hennessy et al. [42]. They demonstrated the reduced potential of RGD in 
stimulating hMSCs adhesion to RGD-adsorbed hydroxyapatite disks when compared to DGEA. 




Studies by Yoo et al. have also shown an enhanced adhesion of preosteoblast (MC3T3) on to 
DGEA peptides immobilized onto genetically engineered M13 phage tissue matrices in comparison 
to RGD peptides [38]. This is in contrast to other studies that  showed that surfaces modified with a 
RGD containing peptide were found to exhibit greater cell attachment of hMSCs over short 
incubation periods [80, 295, 296]. These studies showed that DGEA peptides did not inhibit 
hMSCs adhesion but did not enhance cell adhesion either.  
The binding of integrins with ligands induces a cascade of intracellular signals such as the 
activation of kinases, release of phosphatidylinositol by phospholipases and increased 
concentration of intracellular-free calcium [297, 298]. A study by Mineur has shown that the 
increase in intracellular Ca2+ occurs in an increasing number of cells as a function of the free 
DGEA and RGD peptide concentration [298]. In addition, they have demonstrated using blocking 
antibodies that free integrins and associated focal complexes generate Ca2+ signal due to 
interaction with DGEA and RGD by different cellular pathways [298]. Most importantly, one critical 
issue that was addressed in these adhesion experiments was that the overall bioactivity of the 
peptides, which was not altered after electrospinning and photocrosslinking.  
To evaluate cell morphology and spreading, hMSCs were seeded onto different scaffolds, 
CGDGEA- and CGRGD-immobilized scaffolds and unconjugated scaffolds (control), as well as 
collagen 1 adsorbed surfaces and TCP. Following a 6 hours attachment interval, cells were stained 
with Alexa-phalloidin-488 and DAPI to visualize the actin filaments and nuclei, respectively.  Figure 
6.5 demonstrates the increase of hMSCs spreading with overall area for both peptide-conjugated 
scaffolds in comparison to the unconjugated scaffolds (control). hMSCs seeded on the CGDGEA-
immobilized scaffolds had a well-spread morphology comparable to collagen 1 and TCP. This 
suggests that the DGEA peptides interacted with integrin receptors and generated enough integrin 
activation to induce the reconstruction of the actin cytoskeleton. In contrast, the CGRGD-
immobilized scaffolds showed reduced cell number and less spreading compared to the CGDGEA-
immobilized scaffolds, which confirms the results from the previous cell adhesion assays shown in 
Figure 6.3 and Figure 6.4.  





Figure 6.5 Actin and nuclei (DAPI) immunostaining of hMSCs seeded on fibrous scaffolds with CGDGEA and 
CGRGD peptides, control, TCP and collagen 1 after 6 hours. The concentration for CGDGEA and CGRGD 
was 5 and 2 mol%, respectively. Actin filaments were labelled with Alexa-phalloidin 488, appearing in green. 
Nuclei were labelled with DAPI, appearing in blue. Scale bar: 100µm.  
Human MSCs viability on the peptide-conjugated photocrosslinked fibres was evaluated at days 1, 
5 and 10, using the AlamarBlue® assay (Figure 6.6), an assay that measures enzymatic activity by 
assessing the cytoplasmic reduction potential of metabolically active cells. During the first 24 
hours, the CGDGEA-functionalized scaffolds showed significant increase in hMSCs viability in 
comparison to the unconjugated and CGDEGA-functionalized scaffolds. The cell viability results 
were comparable to collagen 1-adsorbed surface and TCP. However, CGRGD-functionalized 




scaffolds showed lower cell viability when compared to unconjugated scaffolds, but no statistical 
significance was shown. This result was also depicted on day 5. On day 10, CGDGEA-
functionalized scaffolds showed the highest increase in cell viability, followed by the CGRGD-
functionalized scaffolds. The scaffolds conjugated with both peptides showed significant 
enhancement of hMSCs cellular activity in comparison to the other scaffolds. Significant increase 
of cell viability on the CGRGD-conjugated scaffolds was only shown at day 10.  
Scaffolds functionalized with both peptides CGRGD and CGDGEA were able to enhance hMSCs 
viability. As shown in studies performed by Yoo et al., MC3T3 cells grown on DGEA-phage 
matrices showed the highest metabolic activities which were similar to RGD-phage matrices after 
10 days [38]. It is important to note that once cells cover the surface with their own matrix, the 
original surface, in this case of the peptide-conjugated scaffold, is no longer seen by cell integrins 
and becomes irrelevant to their continued adhesion and viability. ECM proteins production by cells 
adhered to a surface indicates that the cells are healthy, allowing them to maintain long-term 
attachment. However, initial cell adhesion is critical because most cells grown in vitro must initially 
adhere to the substrate to assemble and survive, and then grow and proliferate at later time points 
[277]. This can be evidently observed on the low viability of hMSC seeded on the unconjugated 












Figure 6.6 Effect of the peptide-functionalization of the photocrosslinked fibrous scaffolds on hMSC cell 
viability, determined using AlamarBlue
®
 assay. Comparison of the effect of the difference peptides CGDGEA 
and CGRGD and controls (scrambled peptides). The concentration for CGDGEA and CGRGD used was 5 
and 2 mol%, respectively. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (unfunctionalized) of the same time period is statistically significant. (¥) indicates that the difference 
between the marked bar and scrambled peptide with same peptide sequence of the same time period is 
statistically significant (p<0.05) 
To determine whether the CGDGEA- and CGRGD-conjugated scaffolds affect hMSCs death, the 
hMSCs apoptosis levels was evaluated using the Caspase-glo® assay that measures the activity of 
caspases 3 and 7 (Figure 6.7). Confirming the results obtained with the AlamarBlue® assay 
discussed previously, a significant decrease in the apoptotic level was observed for hMSCs 
cultured in the CGDGEA fibrous scaffolds when compared to the unfunctionalized scaffold and 
DEGA. Decreased levels of apoptosis were also observed for cells cultured on CGRGD scaffolds, 
but no significance was shown. The scrambled peptides, CGDEGA and CGRGE showed levels of 
cell death similar to the unconjugated scaffolds. The effect of bioactive peptides on cell viability 
was most evident at day 10; apoptosis was significantly reduced for CGDGEA and CGRGD 
scaffolds.  
 





Figure 6.7 Effect of the peptide-functionalized photocrosslinked fibrous scaffolds on hMSC apoptosis, 
determined using Caspase glo
®
 assay. Comparison of hMSCs cultured on MA-DEGMA photocrosslinked 
fibrous scaffolds, flat surfaces and TCP. The concentrations for CGDGEA and CGRGD used were 5 and 2 
mol%, respectively. Cells treated with Staurosporine for 6 hours were used as positive control. The effect of 
the difference peptides CGDGEA and CGRGD and controls (scrambled peptides) were compared. Mean ± 
SD, n = 3. (*) indicates the difference between the marked bar and the control (unfunctionalized) of the same 
time period is statistically significant. (¥) indicates that the difference between the marked bar and scrambled 















6.4.3 Determination of the effect of varying glycine spacers on DGEA and RGD 
peptides on hMSCs adhesion and viability 
It is well known that to enhance cell adhesion ligands must be spatially accessible to the cell-
surface integrins [35]. Varying the length of the spacer arms is essential for or cell-ligand 
interactions as it has been shown to regulate adhesion and spreading of certain cell types [133]. 
Thus, we investigated the effect of varying the length of the peptide sequences‘ spacers (glycine) 
on cell adhesion (peptide sequences illustrated in Figure 6.8 and Figure 6.9). The amount of 
glycine added to the peptides varied between 1, 3 and 6 amino acid residues. Glycine, an aliphatic 
amino amino, was chosen as the spacer because it has been shown to have a nominal effect on 
the reactivity of the thiol group, as it is extremely inert [141].  
 
 
Figure 6.8 DGEA sequences used in the study of varying amount of the glycine spacer. A) CDGEA; B) 









Figure 6.9 RGD peptide sequences used in the study of varying amount of the glycine spacers. A) CRGD; B) 
CGRGD; C) CGGGRGD; D) CGGGGGGGRGD.  
After 3 hours, a significant increase in cell attachment was shown for DGEA-conjugated scaffolds 
with at least one glycine (Figure 6.10). Scaffolds functionalized with CDGEA supported the lowest 
cell adhesion for all time-points with cell metabolic activity levels comparable to the unconjugated 
scaffolds. The trend of increasing cellular adhesion with increasing number of glycines in the 
peptide sequence was observed after 9 hours. The effect of adding at least one glycine in the 
peptide sequence was most prominent after 9 hours. Additionally, the scaffolds functionalized with 
CG6DGEA ligands demonstrated the highest cell adhesion levels.  





Figure 6.10 Effect of different number of spacer residues (glycine) to the DGEA peptides conjugated onto the 
fibrous scaffolds on hMSC cell adhesion after 3, 6 and 9 hours, determined using MTS assay. Mean ± SD, n 
= 3. The concentration for DGEA peptides used was 5 mol%. (*) indicates the difference between the 
marked bar and the control (unfunctionalized scaffold) of the same time period is statistically significant 
(p<0.05). 
Similar experiments were repeated for RGD ligands with different numbers of glycine amino acids 
as spacer residues (Figure 6.11). After 3 hours, the CGRGD peptide-conjugated scaffolds 
supported higher cell adhesion in comparison to the other peptides-functionalized scaffolds and 
the control surfaces. The effect of adding more than one glycine spacer was only observed after 6 
hours; CGRGD, CG3RGD and CG6RGD showed a significant increase in cell adhesion. After 9 
hours, the CG6RGD-conjugated scaffolds demonstrated the highest cell adhesion level.  These 
results clearly indicate that introduction of spacer residues (glycine) to an adhesion peptide is 
important in regulating the attachment of cells adherence, and at least one glycine unit is needed 
for hMSCs attachment onto the scaffold system we studied. 
 





Figure 6.11 Effect of different number of spacer residues (glycine) on RGD peptides-conjugated onto the 
fibrous scaffolds on hMSC cell adhesion after 3, 6 and 9 hours, determined using MTS assay. Mean ± SD, n 
= 3. The concentration for RGD was 2 mol%. (*) indicates the difference between the marked bar and the 
control (unfunctionalized scaffold) of the same time period is statistically significant (p<0.05). 
In addition, hMSCs viability on the DGEA scaffolds containing varying number of glycine residues 
was evaluated using the AlamarBlue® assay (Figure 6.12). On day 1, scaffolds functionalized with 
DGEA peptides with at least one glycine showed a significant increase in cell viability in 
comparison to the unconjugated scaffolds (control). All three peptides with glycines, CGDGEA and 
CG3DGEA and CG6DGEA revealed similar cellular activity. Similarly, this trend was observed at 
days 5 and 10. A higher viability was observed for all DGEA peptides with a glycine spacer arm. 
Similar values of cell viability were shown for the scaffolds functionalized with all the three DGEA 
peptides containing the different amount of glycine spacers. Hence, the incorporation of an 
increasing number of glycine residues significantly increased the overall bioactivity of DGEA, 
independently of the number of glycine residues used.  
 





Figure 6.12 Effect of the different number glycine spacer residues on DGEA peptides on the functionalized 
photocrosslinked fibrous scaffolds on hMSC cell viability, determined using AlamarBlue
®
 assay. The 
concentration for DGEA used was 5 mol%. Comparison of the effect of the different peptides of DGEA, 
collagen 1 adsorbed scaffold and unfunctionalized scaffold. Mean ± SD, n = 3. (*) indicates the difference 
between the marked bar and the control (TCP) of the same time period is statistically significant (p<0.05). 
In addition, hMSCs viability was also evaluated on the scaffolds containing the RGD sequence with 
varying number of glycine residues using the AlamarBlue® assay (Figure 6.13). On day 1, scaffolds 
with all three RGD peptides with different number of glycine residues were observed to significantly 
increase cell viability in comparison to the control (unconjugated scaffold). On day 5, scaffolds 
functionalized with CGRGD and CG3RGD peptides showed enhanced cell viability, similar to that 
observed for the CG6RGD functionalized scaffolds. The same trend was observed at day 10, with 
scaffolds functionalized with CGRGD, CG3RGD and CG6RGD demonstrating enhanced cellular 
viability. Hence, similar to what was observed for the DGEA peptide-conjugated scaffolds, the data 
presented here demonstrates that the presence of a glycine residues significantly increased the 
overall bioactivity of RGD, independently of the number of glycine residues added.  
 





Figure 6.13 Effect of different number of spacer residues (glycine) for the RGD peptides conjugated to the 
photocrosslinked fibrous scaffolds on hMSC cell viability, determined using AlamarBlue
®
 assay. The 
concentration of RGD used was 2 mol%. Comparison of the effect of the different peptides of RGD and 
unfunctionalized scaffolds. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (TCP) of the same time period is statistically significant (p<0.05). 
The results presented above for both DGEA and RGD ligands have demonstrated the importance 
of using glycine residues as a spacer arm. Studies conducted by Lee et al. also showed the 
influence of glycine spacer arms on RGD sequences immobilized on alginate gels on cell adhesion 
and viability [133]. However, they found that a minimum number of four glycines was essential for 
enhancement of cell adhesion and viability.  
A few groups have shown that PEG-diacrylate (PEG-DA) based hydrogels synthesized require a 
peptide with a long spacer arm between the scaffold and the ligand to enhance cell adhesion [18, 
134, 135]. This is because PEG-DA hydrogels have two acylate groups and form a highly cross-
linked network of long chains extending from the backbone [35, 135]. They suggested that the 
peptide conjugated into the backbone would be buried inside the bulk of the network unless it was 
attached to a spacer arm [35]. Specifically, work reported by Salinas and Anseth has demonstrated 
that incorporating RGD peptides with 8 glycines as a spacer arm in a PEG hydrogel system 
enhanced hMSCs viability up to  88%, whereas short tethering of the RGD as pendant group 
without a spacer enhanced cell survival up to  80% [135]. The short RGD sequence system 
reported slightly increased levels of cell viability and integrin up-regulation, while the RGD with a 
spacer arm sequence showed the highest level of cell survival and αvβ3 production [135].  
Although, the level of cell viability and αvβ3 production observed when cells were cultured in the 




hydrogel functionalized with the RGD sequence containing the spacer arm was not statistically 
significantly different from the short tethered RGD sequence [135]. Another group demonstrated 
that, by polymerizing a coating of acrylate-containing RGD, a system that utilized residual double 
bonds, the shortest spacer arm did not affectively promote cell adhesion. It only had an effect at 
high peptide concentrations [299]. The longer spacer arms were all equally effective at promoting 
cell attachment.  
Beer and colleagues developed Gn-RGDF peptides with 1 to 19 glycine spacers and functionalized 
these peptides onto polyacrylonitrile beads [35, 300]. The agglutination of platelets was evaluated 
and Beer et al., demonstrated that, as the length of the spacer arm increased to 9 glycine residues, 
the overall agglutination increased. On the other hand, as the spacer was further increased, 
agglutination declined. The decrease in agglutination with the longer spacer arm lengths was 
suggested to be due to the increased conformational entropy associated with the flexibility of 
spacer [35]. Based on the crystal structure of αvβ3 integrin and the binding site for RGD [301, 302], 
it was found that the RGD binding site is located very close to the surface of the integrin and that a 
long spacer was required to access it [35, 300]. The spacer arm is thought to prevent steric 
hindrance and electrostatic effects between the integrin and the scaffold [35]. Thus, this further 
explains why the length of the spacer is substrate specific. The results obtained from our study 
verified this conclusion, by which cells adhesion increases if RGD is spaced away from the 
scaffold.  
 
6.4.4 Determination of the integrin specificity in hMSCs adhesion in competitive 
adhesion assays  
Firstly, to further confirm the specificity of the peptides conjugated onto the scaffolds, effects on 
cell spreading were investigated using a soluble DGEA and RGD competitive assay (Figure 6.14 
and Figure 6.15A). This was performed by determining the specificity of cell adhesion utilising 
soluble peptides that block the integrin binding sites and hence prevent cell adhesion by peptide-
integrin specific routes. hMSCs were pre-incubated with different concentrations of soluble 
peptides of either DGEA, RGD or their controls DEGA or RGE, respectively, prior to seeding on 
the peptide-conjugated scaffolds. hMSCs were then cultured for one hour with serum-free media 
and cell attachment was analyzed using the MTS assay.  
In Figure 6.14A, it is clear that as the concentration of soluble CGDGEA peptide increases, cell 
adhesion of the hMSCs significantly declines. Without the competing peptide treatment, hMSCs 
exhibited increased adhesion. The DGEA pre-treatment caused the decreased of hMSCs 
adhesion, which is caused by the competition of the DGEA soluble ligands. However, with the 




CGRGD peptide treatment, only a slight decrease was observed in cell adhesion, as most of the 
cells maintained cell attachment. Cross-talk involving RGD and DGEA binding to integrins can be 
assessed by observing the effect of the soluble RGD peptide on cell binding to DGEA-conjugated 
scaffold. This observation shows that initial cell adhesion (after one hour) of hMSCs was mainly 
dependent on the presence of the DGEA motif. The control peptide CGDEGA did not block cell 
binding to the DGEA-conjugated scaffolds. The same observation was made by Yoo et al. when 
assessing adhesion of MC3T3 cells after pre-incubation with soluble DGEA and RGD peptides on 
DGEA-phages [38]. In addition, they have shown that after 24 hours, RGD-peptide cultures 
recovered full cell adhesion and viability [38]. This was due to higher dependency of cell adhesion 
on the DGEA ligands compared to the RGD ones. 
Additionally, antibody-blocking studies were conducted to establish which integrins the DGEA and 
RGD peptides recognize. Various integrin receptors such as α1, α2, α3, α4, α5, αv, β1, β3 and β4 
are known to be expressed on hMSCs [303]. The DGEA sequence has been shown to be specific 
to the α2β1 integrin [36, 37], whereas the RGD sequence binds to both  αvβ3 and α5β1 [287]. For 
the integrin-blocking studies, instead of pre-incubating the cells with soluble peptides, hMSCs were 
pre-incubated with a 1:200 dilution of one of the following three antibodies: anti-α2, anti-β3, or anti-
hamster IgG. Figure 6.14B clearly shows that the anti-α2-antibody inhibited most cell attachment to 
the DGEA-conjugated scaffold but the same effect was not observed with the anti-β3 antibody. The 















Figure 6.14 A) Competitive binding assay using CGDGEA, CGRGD and CGDEGA peptides against DGEA-
functionalized fibrous scaffolds, analyzed using MTS assay. hMSCs were seeded on the DGEA-immobilized 
scaffolds after being pre-treated with soluble CGDGEA, CGRGD, CGDEGA peptides at different 
concentrations for one hour. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (0 mol% peptide concentration) of the same time period is statistically significant (p<0.05). B) 
Competitive binding assay using blocking antibodies against DGEA-immobilized fibrous scaffolds, analyzed 
using MTS assay. hMSCs were seeded on the DGEA-immobilized scaffolds after being pre-treated with 
soluble anti-α2, anti-β3 or anti-IgG for one hour. 
In Figure 6.15A, as the concentration of soluble CGRGD peptide increases, cell adhesion 
decreases. Without the competing soluble peptide treatment, hMSCs revealed increased adhesion 
on the peptide functionalized scaffolds. Similarly, the soluble RGD pre-treatment of the cells 
caused a decreased in adhesion of hMSCs, which was caused by the competition of blocking of 
the receptors provided by the RGD soluble ligands. However, only a slight decrease in cell 
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adhesion was observed with the CGDGEA peptide pre-treatment; most of the cells still maintained 
cell attachment. Cross-talk of the RGD and DGEA binding integrins could be extrapolated by 
examining the effect of the soluble DGEA peptide on cell binding to the DGEA-conjugated 
scaffolds. The control peptide CGRGE did not inhibit cell binding to the DGEA-conjugated 
scaffolds. In Figure 6.15B, no decrease in cell attachment was observed when hMSCs were pre-
treated with anti-α2 but the anti-β3- antibody blocked about half of the overall hMSCs attachment 
to the RGD-conjugated scaffolds. This was not observed for DGEA-conjugated scaffolds (Figure 
6.14B). The incomplete blocking of the β3-antibody could be observed and the incomplete 
inihibition could be due to conjugated RGD engagement of the α5β1. The control IgG antibody had 
no effect on cell binding to the peptide-conjugated scaffolds. 
Similar observations of integrin blocking using antibodies were shown using MC3T3-E1 cells on 
RGD- and DGEA-conjugated hydroxyapatite binding domains [304]. The authors further 
demonstrated that both peptides could engage in an integrin-specific signalling pathways by 
showing the ability of both peptides‘ to induce FAK phosphorylation, but only DGEA was able to 
initiate ERK1/2 phosphorylation [304]. The specificity of another collagen mimic peptide, GFOGER 
was assessed in a competitive assay of anti-α2 antibody HT1080 cells, which have been shown to 
adhere to type 1 collagen by a single mechanism involving α2β1 integrin, were incubated with an 
anti-α2 antibody, which completely blocked all adhesion through α2β1  integrin [282]. As shown in 
our study with the DGEA soluble peptides, they demonstrated low cell adhesion with an anti-α2 
antibody, which reflects on the specificity for the α2β1 integrin. 
Incorporating DGEA, a collagen type 1 mimetic peptide, in the scaffold offers an attractive 
approach for improving cell-material interactions and inducing cell adhesion, as was demonstrated 
in this section. However, RGD peptides are recognized by a number of integrins, including α5β1, 
αvβ3 and αIIbβ3 [126, 292]. Hence, the lack of specificity of the RGD peptide causes minimal control 











Figure 6.15 A) Competitive binding assay with CGDGEA, CGRGD and CRGE peptides against RGD-
immobilized fibrous scaffold, analyzed using MTS assay. hMSCs were seeded on the RGD-immobilized 
scaffolds after being pre-treated with soluble CGDGEA, CGRGD and CRGE peptides at different 
concentrations for one hour. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (0 mol% peptide concentration) of the same time period is statistically significant (p<0.05) B) 
Competitive binding assay with blocking antibodies against RGD-immobilized fibrous scaffold, analyzed 
using MTS assay. hMSCs were seeded on the RGD-immobilized scaffolds after being pre-treated with 








6.4.5 Assessment of ALP activity and OCN secretion on CGDGEA- and CGRGD-
functionalized scaffolds 
Based on our previous observations, CGDGEA-functionalized scaffolds demonstrated higher 
cellular adhesion and viability of hMSCs. In addition, many reports have been published describing 
activation of a collagen-selective integrin, α2β1 integrin [42]. It induces osteoblast differentiation 
mediated by collagen- α2β1 integrin interaction [36, 38, 42]. In addition, few studies have already 
reported the potential of RGD peptides to enhance osteogenic differentiation [234, 295, 296]. 
Accordingly, further investigation on CGDGEA and CGRGD peptides serving as differentiation 
factors for hMSCs was conducted. To evaluate this hypothesis, hMSCs were cultured on 
CGDGEA- and CGRGD-conjugated scaffolds for 14 days with or without osteogenic media and 
assessed for ALP activity and OCN secretion, as osteoblastic differentiation of hMSCs can be 
characterized by the activation of both ALP activity and OCN production as an early and late 
markers, respectively [126]. Specifically, ALP is an enzyme that induces phosphate precipitation 
and is an early marker of osteoblastic differentiation [126, 305]. OCN is a protein that is frequently 
utilized as an indicator of a mature osteogenic phenotype [126, 306]. 
As shown in Figure 6.16, CGDGEA-conjugated scaffolds showed higher levels of ALP activation 
than other scaffolds, signifying increased levels of osteogenic differentiation. As a negative control, 
hMSCs were cultured on TCP in osteogenic media. Type 1 collagen-coated surfaces also revealed 
high levels of ALP activation. All other CGRGD, CRGE or CGDEGA peptide-conjugated scaffolds, 
showed lower degrees of ALP activity when compared to TCP. These observations suggest that 
the collagen mimetic peptide CGDGEA, might be able to induce bone matrix mineralization, as 
also observed to type 1 collagen.  
 
 





Figure 6.16 Effect of peptide-functionalized photocrosslinked fibrous scaffolds on alkaline phosphatase 
activity, determined using Alkaline Phosphatase assay. hMSCs were seeded on CGDGEA-conjugated 
scaffolds for 21 days, with osteogenic media. The concentration of CGDGEA and CGRGD used was 5 and 2 
mol%, respectively. Comparison of the effect of the different peptides-containing scaffolds: CDGEA, RGD, 
and unfunctionalized. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the control 
(unfunctionalized scaffold) of the same time period is statistically significant (p<0.05). 
To confirm the CGDGEA stimulation of hMSCs osteoblastic differentiation, a measurement of 
secreted OCN was evaluated using an enzyme immunosorbent assay (EIA) assay (Figure 6.17). 
The cells adherent to CGDGEA-functionalized scaffolds secreted significantly more OCN than the 
cell adherent to the other scaffolds when cultured in the presence of osteogenic media. 
Furthermore, CGDGEA-functionalized scaffolds stimulated OCN levels that were comparable to 
those measured on hMSCs cultured on the type 1 collagen-coated surfaces. These observations, 
together with the results obtained from the ALP activity assay, suggest that CGDGEA is able to 
induce hMSCs osteoblastic differentiation.  
 





Figure 6.17 Effect of peptide-functionalized photocrosslinked fibrous scaffolds on osteocalcin secretion, 
determined using an enzyme immunosorbent assay (EIA) assay. hMSCs were seeded on CGDGEA-
conjugated scaffolds for 21 days with osteogenic media. The concentration of CGDGEA and CGRGD used 
was 5 and 2 mol%, respectively.  Comparison of the effect of the different peptide-conjugated scaffolds: 
CDGEA, RGD and unfunctionalized. Mean ± SD, n = 3. (*) indicates the difference between the marked bar 
and the control (unfunctionalized scaffold) of the same time period is statistically significant (p<0.05). 
Results shown in Figure 6.16 and Figure 6.17 indicated that DGEA was capable of inducing 
osteoblastic differentiation on hMSCs cultured with osteogenic media. Nevertheless, previous 
investigations have shown that activation of α2β1 could induce osteogenic differentiation even 
without differentiation inducers [42, 295]. Thus, a study was performed to investigate whether 
DGEA was able to stimulate osteoblastic differentiation without osteogenic media. To achieve this, 
hMSCs on peptide-conjugated scaffolds were cultured in growth media for three weeks and the 
ALP and OCN levels were evaluated.  
Though levels of ALP activity and OCN secretion were much lower compared to the presence of 
osteogenic media, the cells grown on the DGEA-conjugated and type 1 collagen scaffolds showed 
higher ALP activity and OCN production than the cells grown on the other scaffolds (Figure 6.18 
and Figure 6.19). These results suggest that the presence of DGEA is capable of activating 
collagen-binding integrins and stimulate osteogenic differentiation to a certain degree without the 
presence of the standard differentiation factors.  
 





Figure 6.18 Effect of peptide-functionalized photocrosslinked fibrous scaffolds on alkaline phosphatase 
activity, determined using Alkaline Phosphatase assay. hMSCs were seeded on CGDGEA-conjugated 
scaffolds for 21 days without osteogenic media. The concentration of CGDGEA and CGRGD used was 5 
and 2 mol%, respectively. Comparison of the effect of the different peptide-conjugated scaffolds: CDGEA, 
RGD and unfunctionalized. Mean ± SD, n = 3. (*) indicates the difference between the marked bar and the 
control (unfunctionalized scaffold) of the same time period is statistically significant (p<0.05). 
 
Figure 6.19 Effect of peptide-functionalized photocrosslinked fibrous scaffolds on osteocalcin secretion, 
determined using enzyme immunosorbent assay (EIA) assay.  hMSCs were seeded on CGDGEA-
conjugated scaffolds for 21 days without osteogenic media. The concentration of CGDGEA and CGRGD 
used was 5 and 2 mol%, respectively. Comparison of the effect of the different peptide-conjugated scaffolds: 
CDGEA, RGD and unfunctionalized. Mean ± SD, n = 3. (*) indicates the difference between the marked bar 
and the control (unfunctionalized scaffold) of the same time period is statistically significant (p<0.05). 
 




These observations strongly suggest that the presentation of DGEA peptides to cells may serve as 
an osteogenic differentiation factor. The enhancement of osteoblastic differentiation was exhibited 
both in the presence and in the absence of osteogenic media, suggesting that DGEA can induce 
osteogenic differentiation even without osteogenic factors. This was also demonstrated in an 
investigation conducted by Hennessy et al. on hydroxyapatite surfaces [42, 80]. The authors have 
also demonstrated further that DGEA-coated HA disks implanted into rat tibiae improved bone 
ingrowth and induced increased levels of bone-implant direct contact than unmodified the HA disks 
[42]. Additionally, Yoo et al. have also shown early osteogenic differentiation on mouse 
preosteoblast cells stimulated by DGEA ligands on nanofibrous phage tissue matrices [38]. They 
further demonstrated osteogenic protein expression through mRNA quantification and bone cell 
protein marker expression induced by DGEA-engineered phage matrices.  Moreover, the authors 
have also shown the higher potential of DGEA to induce osteogenic differentiation in comparison 
with RGD.  
Other studies have demonstrated that RGD-modified surfaces are also able to promote osteogenic 
differentiation [234, 295, 296]. For example, PEG-DA hydrogels containing varying concentrations 
of RGD were synthesized to encapsulate MSCs and the expression of bone-related markers was 
examined [234]. The expression of alkaline phosphatase and osteocalcin were induced in the 
presence of RGD and a concentration-dependent trend was revealed with the increase in RGD 
concentration. In addition, investigations performed by Anderson et al. have shown that RGD has 
higher potential to stimulate osteogenesis compared to DGEA [295, 296]. But there studies were 
performed on self-assembled peptide amphiphiles, which may have caused differences in 
osteogenic response. 
Integrins are focal transducers of ECM signals that influence osteoblast commitment and 
differentiation [126]. The α1β1 and α2β1 integrins are the main collagen-binding integrins, with α1β1 
possessing an increased affinity for type IV collagen while α2β1 possessing an increased affinity for 
the fibrillar type 1 collagen [126, 307, 308]. Moreover, α2β1 is substantially expressed in osteoblast-
like cells and it is one of the major adhesion receptors used by these cells to attach to the collagen 
matrix [309].  
Several investigations have indicated that the α2β1 integrin interaction with type 1 collagen is a 
pivotal signal for the regulation of osteoblastic differentiation and matrix mineralization [36, 37, 120, 
126, 128, 310]. Engagement of the α2β1 integrin is related to the activation of osteoblast-specific 
factor (Runx-2 or Cbfa-1), a transcription factor that mediates osteogenic differentiation, 
specifically into the osteoblast phenotype, and is needed for the osteoblast-specific expression of 
the osteoblast-specific protein OCN [107, 110, 112, 126, 127, 280]. Moreover, the collagen type 1-
α2β1 integrin binding has been demonstrated to stimulate the osteogenic phenotype in MSCs [36, 




37, 126]. This stimulation of osteoblastic phenotype in cells is due to the interaction of α2β1 integrin 
to collagen type 1 which induces tyrosine phosphorylation of FAK and, consequently, the activation 
of ERK and MAPK which has been shown to influence osteoblast-specific gene expression and 
matrix mineralization [109, 111, 126, 128, 129]. Studies have reported that disrupting the α2β1 
interaction with type 1 collagen, by utilizing function-blocking antibodies, inhibits the expression of 
osteoblast specific genes, such as OCN and prevents the formation of mineralized matrix [36, 111, 
126, 310]. 
A different collagen type-1 binding peptide, GFOGER (glycine-phenylalanine-hydroxyproline-
glycine-glutamate-arginine) with a triple helical-like structure can also engage with the α2β1 integrin 
receptor [311, 312] and has been shown to support cell adhesion and osteogenic differentiation 
comparable to collagen type 1 [282]. In addition, the authors demonstrated that α2β1 integrin-
specific GFOGER peptide induces FAK and ALP activation in MC3T3-E1 preosteoblast cells [126]. 




6.5 CONCLUSION  
In the present chapter, the effects of DGEA- and RGD-conjugation of the MA/DEGMA fibrous 
scaffolds on hMSCs adhesion, morphology, viability and osteogenic differentiation were 
investigated. The results presented here strongly demonstrated the potential of DGEA- and RGD-
conjugated fibrous scaffolds to support hMSCs adhesion and viability. Through cell adhesion and 
soluble peptide/antibody blocking competition assays, the bioactivity and specificity of each 
peptide-conjugated scaffolds were confirmed. hMSCs adhesion to DGEA peptides-conjugated 
scaffolds was found to be peptide concentration-dependent, whereby increasing DGEA 
concentration on the scaffolds further increased cell adhesion. In contrast, for the RGD-conjugated 
scaffold we found that increasing the peptide concentration (RGD) is not always guaranteed to 
enhance cell adhesion. Importantly, both DGEA and RGD peptides presented significantly higher 
cell adhesion levels in comparison to the control and the scrambled peptides. However, DGEA 
showed increased stimulation of adhesion compared to RGD peptides.  
In addition, the effect of varying spacer glycine residue numbers for the DGEA and RGD peptide 
sequences on hMSCs adhesion and viability was also investigated. The results indicate that the 
introduction of spacer glycine residues to an adhesion peptide is vital in controlling the attachment 
of adherent cells. In the system studied, at least one glycine unit was shown to be beneficial for 
hMSCs adhesion onto the scaffold. Furthermore, increasing the number of glycine residues added 
to the peptides, significantly increased the adhesion and viability of hMSCs grown on the 
conjugated scaffold. 
Lastly, hMSCs cultured on the DGEA-conjugated scaffolds were proven to activate osteogenic 
differentiation. Osteogenic differentiation markers, as ALP and OCN, were shown to be enhanced 
when hMSCs were grown on the DGEA-conjugated scaffolds for 14-21 days. Importantly, the 
enhanced osteoblastic activity was demonstrated both with and without osteogenic media, 
suggesting that the DGEA peptide is capable of stimulating osteogenic differentiation even in the 
absence of osteogenic factors.  
Hence, the results here give evidence the high potential of DGEA-conjugated fibrous scaffolds for 
TE applications since these scaffolds were shown to significantly enhance cell viability and 
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The feasibility of electrospinning photocrosslinkable and low molecular weight acrylate monomers 
was investigated in this thesis. MA and DEGMA were the monomer and crosslinker of choice 
respectively with the aid of PEO as a polymer carrier and viscosity modifier. In Chapter 3, the 
ability to produce topologically and mechanically diverse fibrous scaffold materials was 
demonstrated. Photocrosslinked fibres were successfully developed by electrospinning different 
MA and DEGMA compositions and post-UV crosslinking. The effects of various processing 
parameters of electrospinning were investigated, including carrier polymer concentration, 
accelerating voltage, rate of delivery and monomer/carrier polymer ratios. With the use of high 
molecular weight PEO, all parameters were observed to have a profound effect on the electrospun 
fibres morphology. The analysis of this study lead to the determination of the optimal range of 
parameters required to produce uniform and bead-free electrospun MA/DEGMA fibrous scaffolds. 
When exposed to ultraviolet light in the presence of a photoinitiator, the crosslinked network was 
formed by converting the double bonds and a corresponding increase in mechanical strength was 
observed. PEO was extracted with thorough washing with water, and scaffolds swelled after 
incubation in water. Most importantly, varying MA and DEGMA composition affected overall fibre 
morphology, swelling and mechanics of the fibrous scaffold. A unique characteristic of the fibrous 
scaffold was that swelling could be observed when the scaffold is immersed in water or media. 
Swelling significantly increases with decreasing crosslinker concentration, the 90:10 ratio scaffolds 
displayed the highest degree of swelling, followed by 70:30 and 50:50 percentage MA:DEGMA 
compositions. Whereas, an increase in DEGMA (crosslinker) concentration lead to higher tensile 
modulus, which suggests an increase of crosslinking of acrylate within the network. 
An assessment of biological activity of the acrylate fibrous scaffold was performed and described 
in Chapter 4. These studies were intended to evaluate the effect of varying ratios of MA:DEGMA of 
the fibrous scaffold on the viability of two different cell types, Saos-2 and hMSCs. Additionally, the 
effect of surface morphology on cellular activity was assessed by comparing the fibrous scaffolds 
to flat surfaces with equivalent chemical compositions. Lastly, the response of protein adsorption to 
all fibrous scaffolds and flat surfaces was evaluated. 
The results presented in Chapter 4 strongly demonstrated the potential of MA/DEGMA fibrous 
scaffolds to support Saos-2 cell viability and proliferation. In agreement with literature, the 
MA:DEGMA photocrosslinked fibres increased the viability of Saos-2 cells in comparison to flat 
surfaces with similar chemistry. However, the considerable increase in apoptosis of hMSCS grown 
in all fibrous scaffolds and flat samples demonstrated the lower potential of the MA/DEGMA 
scaffold to support hMSCs attachment and viability. This was also evident in the cell activity 
assays, which showed decreased hMSCs metabolic activity assessed by alamarblue® assay in 
comparison to the negative control, TCP. On the other hand, in order to further explore the 
biological potential of the fibrous scaffolds, investigation of their ability to sustain cell viability over a 
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longer period of time was conducted. From day 15 onwards, a significant increase in cell viability 
was observed for hMSCs cultured on the 90:10 (MA:DEGMA) fibres. Such a result was not 
observed for the other scaffold compositions. Hence, this gives evidence that the 90:10 
(MA:DEGMA) fibrous scaffolds could potentially support hMSCs viability better than the other 
scaffolds produced.   
Furthermore, amongst the fibrous scaffolds and flat surfaces, the 90:10 (MA:DEGMA) fibres 
presented the highest cellular activity for both Saos-2 and hMSCs, which could be correlated to 
displaying of the best fibrous morphology from all the scaffold (shown in Chapter 3).  Hence, as it 
has showed the highest cell response, best fibrous morphology and capability of maintaining 
mechanical integrity, the 90:10 (MA:DEGMA) composition was chosen as the best fibrous scaffold 
for bone tissue engineering purposes among the different compositions analysed. For this reason, 
the studies described in the following chapters were performed using this specific MA:DEGMA 
composition. Lastly, the response of protein adsorption to all fibrous scaffolds and flat surfaces 
was evaluated. Both fibrous scaffolds and flat surfaces displayed significantly lower protein 
adsorption compared to TCP. However, the fibrous scaffolds adsorbed higher amounts of serum 
proteins than the flat surfaces. Furthermore, this was most evident for the 90:10 (MA:DEGMA) 
ratio constructs, whereby the protein adsorption of the flat surface decreased to half when 
compared to the fibrous scaffold. This interesting result gives evidence that the fibrous architecture 
can alter protein adsorption.  
The development of electrospun acrylate scaffolds conjugated with biological active peptides, RGD 
and DGEA were described in Chapter 5. The synthesis of the functionalized scaffold utilizes 
cysteine-functionalized RGD or DGEA peptide sequences in combination with MA/DEGMA 
monomers and employs a photoinitiated mixed-mode thiol-acrylate polymerization mechanism. 
Firstly, immobilization of DGEA and RGD peptides on the acrylate fibrous scaffold was analyzed 
by varying cysteine-conjugated DGEA and RGD concentrations. Measurement of peptide 
incorporation was determined by measuring free primary amine. The amount of free amine 
measured was compared to the initial concentration of free amine prior to UV crosslinking. The 
measurement of peptide incorporation was further confirmed by quantifying free sulfhydryl groups 
in solution. Cysteine-functionalized DGEA and RGD peptides were shown to be efficiently 
incorporated in the synthesized acrylate scaffolds with   85% peptide incorporation. It was 
observed that immobilization of the peptides had no major effect on the overall morphology of the 
fibres, even as the peptide concentration was varied from 0.5 to 5 mol%. Except for the highest 
peptide concentration (5 mol%), all fibres conjugated with different concentrations of CGDGEA 
showed no significant differences for swelling behaviour and mechanical properties to when 
compared to the unfunctionalized fibrous scaffolds. In addition, the degradation of the CGDGEA 
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and unfunctionalized scaffolds were studied and both scaffolds degraded with mass loss of   51% 
and   45% at 16 weeks. 
Most importantly, the presentation and distribution of the peptides on the surface of the scaffolds 
were investigated using ToF-SIMS. The ToF-SIMS results demonstrated the distribution of the 
immobilized peptides on the surface of the fibres. The peptides were clearly present and 
distributed evenly on the surface of the fibres. This novel method of using ToF-SIMS to analyze 
peptide conjugation distribution was critical because the process of functionalization was done in 
bulk throughout the whole scaffold and not only on the surface. It is important for the peptides to be 
distributed on the surface of the fibres to ensure that the peptide ligands are spatially accessible to 
the cell-surface integrins.  
The efficiency of conjugation of peptides using thiol-acrylate reaction regardless of the number of 
glycine spacer arm length was also investigated. Glycine, an aliphatic amino amino was chosen as 
the spacer because it has been shown to have nominal effect on the reactivity of the thiol group as 
it is extremely inert [141]. Hence, it would have negligible effects on the thiol-acrylate reaction 
during functionalization of the scaffold. Varying the amount of spacer arms is essential for cell-
scaffold interactions as it has been shown to influence the adhesion and spreading of certain cell 
types [35, 133]. The efficiency of the peptides conjugation using the thiol-acrylate reaction was 
similar, regardless of the length of the glycine spacer arms. For all peptide sequences, 
independently of the length of the arm spacer, the percentage of incorporation determined was 
approximately 80-86%. 
The effect of DGEA- and RGD-conjugated fibrous scaffolds on hMSCs adhesion, morphology, 
viability and osteogenic differentiation were investigated in Chapter 6.  The results presented 
demonstrated the potential of DGEA- and RGD-conjugated fibrous scaffolds to support hMSCs 
adhesion and viability. Through cell adhesion and soluble peptide/antibody blocking competition 
assays, the bioactivity and specificity of each peptide conjugated to the scaffolds were confirmed. 
The hMSCs adhesion to DGEA peptides have demonstrated to be concentration dependent, 
whereby increasing DGEA concentration on the scaffold further increased cell adhesion.  In 
contrast, RGD-conjugated scaffolds have shown that an increase in peptide concentration for RGD 
is not always guaranteed to increase cell adhesion. Both DGEA and RGD peptides presented 
significantly higher cell adhesion in comparison to control and scrambled peptides. However, 
DGEA showed increased stimulation of adhesion compared to RGD peptides.  
 In addition, the effect of varying spacer arms (glycine) for the peptide sequence of DGEA and 
RGD ligands on hMSCs adhesion and viability was investigated. The results indicate that 
introduction of a spacer arm (glycine) to an adhesion peptide is vital in controlling the attachment 
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of adherent cells, and at least one glycine unit is required for hMSCs adhesion on the scaffold. 
Furthermore, increasing the amount of glycine increased the adhesion and viability of hMSCs. 
Lastly, hMSCs cultured on DGEA conjugated scaffolds exhibited the activation of osteogenic 
differentiation markers, ALP and OCN. This enhanced osteoblastic activity was observed both in 
the presence and the absence of osteogenic media, indicating that DGEA can stimulate 
osteoblastic differentiation even in the absence of osteogenic media. Nevertheless, further studies 
are required to better comprehend the effect of the differentiation of the hMSCs. Further gene 
expression studies of Runx-2/Cbfa and other differentiation transcription factors should be 
assessed. In addition, the assessment of the differentiation effect of the peptide-conjugated 
scaffolds in vivo would be of interest, as it is acknowledged that results obtained in vitro cannot be 
directly translated to in vivo conditions.  
Moreover, further improvements could be studied for the fibrous scaffold, especially to improve the 
limitation of cell infiltration of the scaffold. Though this was not investigated in the studies here, cell 
infiltration into these fibres is slow. To address this issue, by utilizing the UV system and the use of 
a UV mask on top of the scaffold during photocrosslinking could be investigated to increase 
porosity of the scaffold. Subsequently, uncrosslinked monomers could be leached out during 
washing and this could produce pores to improve infiltration throughout the fibrous scaffold. 
Alternatively, pores could be introduced by introducing salt particles which can then be leached 
out.  
The mechanical properties of the scaffold could also be improved by aligning the fibres and varying 
fibre size. In addition, tri-laminar electrospun scaffolds could also be developed by using this UV 
system by sequential electrospinning in a continuous construct and UV patterning to create 
scaffolds that offers zone specific structural organization for the tissue function. 
Furthermore, the concept of immobilizing synthetic peptides onto a scaffold in a facile and 
inexpensive manner was presented in this thesis thus this may form a platform for advanced 
development of the scaffold by adding different types of peptides with other functions such as 
growth factor or protein activation to modulate cellular functions. This would increase the overall 
functions and complexity of the scaffold.  
As mentioned previously, further studies are required to better understand and control the cellular 
response to the fibrous acrylate scaffolds. In addition, further structural and functional 
improvements could be made to improve the scaffold for TE applications. However, our studies 
have clearly demonstrated the feasibility of producing fibrous scaffold materials using 
electrospinning photocrosslinkable and low molecular weight acrylate monomers, MA and DEGMA 
and post-UV crosslinking. Furthermore, cysteine-functionalized DGEA and RGD peptides were 
efficiently incorporated in the synthesized acrylate scaffolds by employing a photoinitiated mixed-
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mode thiol-acrylate polymerization mechanism. The peptide-conjugated fibrous scaffolds showed 
increased hMSCs adhesion and viability, and additionally hMSCs cultured on DGEA-conjugated 
scaffolds showed the activation of osteogenic differentiation markers, ALP and OCN. This thesis 
has therefore been able to illustrate the great potential of these scaffolds for bone TE applications, 






Glycine Standard Curve for Ninhydrin Assay and Fluoraldehyde (OPA) assay 
1. A gradient of concentrations was serial diluted from 10ml of 0.1M glycine with 50% (v/v) ethanol.  
2. 0.5 ml of each concentration was placed in a 2 ml glass vial. 
3. 100μL of 1M Ninhydrin (Section 5.3.3 and 5.3.4) was added to each vial. Immediate colour 
change was observed. 
4. The vials were then incubated at room temperature for 4 hours, placed on an orbital shaker, to 
ensure the reaction between ninhydrin and the amine groups on all samples. 
5. The samples were then removed and the absorbance of the solution was measured at 570nm, 
on a microplate reader (Spectramax M5, Molecular devices). 
6. The optical densities (570nm) were plotted against the concentration of glycine which is 
represented by amine concentration.  
 
Cysteine Standard Curve for Ellman’s Assay 
1. Cysteine hydrochloride monohydrate was dissolved with reaction buffer (0.1 M of sodium 
phosphate) to attain a set of cysteine standards of specific serial concentrations.  
2. A set of 5 ml vials containing 250 µl of Ellman‘s reagent solution (DNTB) and 2.5ml of reaction 
buffer was prepared. 
3. 250μL of each standard or unknown samples (Section 5.3.5) was added to each test tube 
prepared in step 2.  
4. All standards and samples was mixed and incubated for 3 hours in 5 ml glass vials, at room 
temperature and placed on an orbital shaker. 
5. Absorbance was measured at 412nm using a microplate reader (Spectramax M5, Molecular 
devices). 











MALDI mass spectral analysis of peptides. MALDI mass spectrum for CGRGD and CGDGEA peptides, with 
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